<SEC-DOCUMENT>0001193125-18-094194.txt : 20180323
<SEC-HEADER>0001193125-18-094194.hdr.sgml : 20180323
<ACCEPTANCE-DATETIME>20180323163108
ACCESSION NUMBER:		0001193125-18-094194
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20180516
FILED AS OF DATE:		20180323
DATE AS OF CHANGE:		20180323
EFFECTIVENESS DATE:		20180323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				263667538
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12111
		FILM NUMBER:		18710463

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d463041ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington D.C. 20549 </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>SCHEDULE 14A INFORMATION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the Securities </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;) </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Filed by the Registrant&nbsp;&nbsp;&#9746; </FONT></P> <P STYLE="margin-top:3px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744; </FONT></P> <P STYLE="margin-top:3px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material under Rule 14a-12 </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>MEDNAX, INC. </B></FONT></P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified In Its Charter) </B></FONT></P> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing
Fee (Check the appropriate box): </FONT></P> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">No Fee Required. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and
state how it was determined): </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials: </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid: </FONT></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party: </FONT></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed: </FONT></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g463041g10m40.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px">


<IMG SRC="g463041g38o41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">1301 Concord Terrace </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sunrise, Florida 33323-2825 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(954) 384-0175 </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;23, 2018 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear MEDNAX
Shareholder: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are cordially invited to attend the 2018 Annual Shareholders&#146; Meeting of MEDNAX, Inc.
(&#147;MEDNAX&#148;) on Wednesday, May&nbsp;16, 2018, beginning at 9:30 a.m. (ET) at the DoubleTree by Hilton Sunrise, located at 13400 West Sunrise Boulevard, Sunrise, Florida, 33323. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the annual meeting, we will ask you to vote on the election of Roger J. Medel, M.D., Cesar L. Alvarez, Karey D. Barker, Waldemar A.
Carlo, M.D., Michael B. Fernandez, Paul G. Gabos, Pascal J. Goldschmidt, M.D., Manuel Kadre and Enrique J. Sosa, Ph.D. to MEDNAX&#146;s Board of Directors, to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public
accounting firm for the 2018 fiscal year, to conduct an advisory vote regarding executive compensation and act upon any other business properly brought before the meeting. Please vote on all the matters described in our Proxy Statement. Your Board
of Directors unanimously recommends a vote &#147;FOR&#148; the election of each of the nine nominees for Director stated above, &#147;FOR&#148; ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public
accounting firm for the 2018 fiscal year, and &#147;FOR&#148; the approval of the compensation of our named executive officers. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the rules of the Securities and Exchange Commission (the &#147;SEC&#148;), we are providing access to our proxy materials over the
Internet. Accordingly, we are sending a Notice of Internet Availability of Proxy Materials (the &#147;E-Proxy Notice&#148;) on or about March&nbsp;30, 2018, to MEDNAX&#146;s shareholders of record at the close of business on March&nbsp;12, 2018. The
E-Proxy Notice contains instructions for your use of this process, including how to access our Proxy Statement and Annual Report and how to vote online. In addition, the E-Proxy Notice contains instructions on how you may (i)&nbsp;receive a paper
copy of the Proxy Statement and Annual Report or (ii)&nbsp;elect to receive your Proxy Statement and Annual Report over the Internet. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Whether or not you plan to attend in person, it is important that your shares be represented and voted at the annual meeting. You may vote your shares over the Internet as described in the E-Proxy Notice.
As an alternative, if you received a paper copy of the proxy card by mail, please mark, sign, date and promptly return the card in the self-addressed stamped envelope provided. You may also vote by telephone as described in your proxy card. Voting
by telephone, over the Internet or by mailing a proxy card will not limit your right to attend the annual meeting and vote your shares in person. We appreciate your continued support of our company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sincerely, </FONT></P> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%">


<IMG SRC="g463041g82y68.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger J. Medel, M.D. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Chief Executive Officer</I> </FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MEDNAX, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF 2018 ANNUAL MEETING OF SHAREHOLDERS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>TO BE HELD ON MAY 16, 2018 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the Shareholders of MEDNAX, Inc.: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE IS HEREBY GIVEN that the 2018 Annual Shareholders&#146; Meeting of MEDNAX, Inc., a Florida corporation (&#147;MEDNAX&#148;), will
be held at 9:30 a.m., ET, on Wednesday, May&nbsp;16, 2018, at the DoubleTree by Hilton Sunrise, 13400 West Sunrise Boulevard, Sunrise, Florida, 33323, for the following purposes, as more fully described in our Proxy Statement: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to elect Roger J. Medel, M.D., Cesar L. Alvarez, Karey D. Barker, Waldemar A. Carlo, M.D., Michael&nbsp;B. Fernandez, Paul G. Gabos, Pascal J.
Goldschmidt, M.D., Manuel Kadre and Enrique&nbsp;J.&nbsp;Sosa, Ph.D. as Directors, each for a term expiring at the next annual meeting or until his or her successor has been duly elected and qualified; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2018 fiscal year;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to cast an advisory vote approving MEDNAX&#146;s executive compensation; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to consider and act upon such other business as may properly come before the annual meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors of MEDNAX has fixed the close of business on March&nbsp;12, 2018, as the record date for determining those
shareholders entitled to notice of, to attend and to vote at the meeting and any postponement or adjournment thereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Whether
or not you plan to attend, please vote your shares over the Internet, as described in the Notice of Internet Availability of Proxy Materials (the &#147;E-Proxy Notice&#148;). As an alternative, if you received a paper copy of the proxy card by mail,
please mark, sign, date and promptly return the proxy card in the self-addressed stamped envelope provided. You may also vote by telephone as described in your proxy card. Shareholders who vote over the Internet, following the instructions provided
in the E-Proxy Notice, who return proxy cards by mail or vote by telephone prior to the meeting may nevertheless attend the meeting, revoke their proxies and vote their shares in person. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors, </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%">


<IMG SRC="g463041g18l82.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dominic J. Andreano </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">General Counsel and Secretary </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sunrise, Florida </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;23, 2018 </FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_1">QUESTIONS AND ANSWERS ABOUT OUR ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_2">What Is the Date, Time and Place of the Annual Meeting?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_3">What Is the Purpose of the Annual Meeting?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_4">Who Is Entitled to Vote at the Annual Meeting?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_5">What Are the Voting Rights of MEDNAX&#146;s Shareholders?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_6">What Constitutes a Quorum?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_7">What Are &#147;Broker Non-Votes&#148;?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_8">How Are Abstentions and Broker Non-Votes Treated?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_9">Will My Shares Be Voted if I Do Not Provide My Proxy?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_10">How Do I Vote?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_11">What Vote Is Required for the Proposals?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_12">How Does the Board of Directors Recommend I Vote on the Proposals?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_13">How Will My Proxy Holders Vote?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_14">Can I Change My Vote After I Have Voted?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_15">Who Pays for the Preparation of the Proxy Statement?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_16">PROPOSAL 1: ELECTION OF MEDNAX&#146;S DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_17">GOVERNANCE AND RELATED MATTERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_18">Questions and Answers About Our Corporate Governance Practices</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_19">What Committees Have Our Board of Directors Established?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_20">How Many Times Did Our Board of Directors Meet During 2017?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_21">Are a Majority of Our Directors Independent?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_22">Who Are the &#147;Chairman of the Board&#148; and &#147;Lead Independent
Director&#148;?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_23">What Role Does the Board of Directors Serve in Risk Oversight for the Company?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_24">How Can Shareholders Communicate with the Board of Directors?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_25">Has MEDNAX Adopted a Code of Conduct?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_26">Has MEDNAX Adopted a Clawback Policy?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_27">Does MEDNAX Require its Executive Officers and Board of Directors to Retain a Certain Amount of MEDNAX Common
 Stock?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_28">Has MEDNAX Adopted an Anti-Hedging and Anti-Pledging Policy?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_29">Does MEDNAX Have a Director Retirement Age Policy?</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_30">Report of the Audit Committee</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_31">DIRECTORS AND EXECUTIVE OFFICERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_32">MEDNAX&#146;s Directors and Executive Officers</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_33">Committees of the Board of Directors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_34">Audit Committee</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_35">Compensation Committee</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_36">Nominating and Corporate Governance Committee</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_37">Risk Considerations in Our Compensation Programs</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_38">Certain Relationships and Related Person Transactions</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_39">Review and Approval of Related Person Transactions</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_40">Transactions with Related Persons</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_41">Compensation Committee Interlocks and Insider Participation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i)
</FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_42">EXECUTIVE COMPENSATION: COMPENSATION DISCUSSION AND ANALYSIS (&#147;CD&amp;A&#148;)</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_43">SECTION I: A MESSAGE TO OUR SHAREHOLDERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_44">SECTION II: EXECUTIVE SUMMARY</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_45">2017 Business Highlights</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_46">Response to Say-on-Pay Vote and Shareholder Outreach</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_47">CEO Pay At-A-Glance</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_48">SECTION III: OVERVIEW OF THE EXECUTIVE COMPENSATION PROGRAM</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_49">The Guiding Principles of Our Pay Philosophy</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_50">Elements of Pay</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_51">Pay Mix</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_52">How Pay Decisions Are Made</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_53">SECTION IV: THE EXECUTIVE COMPENSATION PROGRAM IN DETAIL</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_54">Base Salary</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_55">Annual Bonuses</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_56">Equity-Based Awards</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_57"><I>2017 Equity-Based Awards</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_58">Other Practices, Policies&nbsp;&amp; Guidelines</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_59"><I>Equity Grant Practices</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_60"><I>Clawback Policy</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_61"><I>Stock Ownership and Retention Policy</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_62"><I>Anti-Hedging and Anti-Pledging Policy</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_63"><I>Retirement and Deferred Compensation Plans</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_64"><I>Benefits and Perquisites</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_65"><I>Termination of Employment and Change in Control Agreements</I></A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_66">Summary Compensation Table</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_67">Grants of Plan-Based Awards in 2017</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_68">Outstanding Equity Awards at 2017 Fiscal Year-End</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_69">Options Exercised and Stock Vested in Fiscal Year 2017</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_70">Potential Payments Upon Termination or Change in Control</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_71">CHIEF EXECUTIVE OFFICER PAY RATIO</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_72">DIRECTOR COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_73">SHARE OWNERSHIP INFORMATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_74">Section&nbsp;16(a) Beneficial Ownership Reporting Compliance</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_75">Security Ownership of Certain Beneficial Owners and Management</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_76">INDEPENDENT AUDITORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_77">Independent Auditors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_78">Fees Paid to Independent Auditors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_79">Audit Fees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_80">Audit-Related Fees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_81">Tax Fees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_82">All Other Fees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_83">Pre-Approval Policies and Procedures</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_84">PROPOSAL 2: RATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_85">PROPOSAL 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_86">OTHER BUSINESS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_87">AVAILABILITY OF ANNUAL REPORT ON FORM 10-K</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc463041_88">INFORMATION CONCERNING SHAREHOLDER PROPOSALS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(ii)
</FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MEDNAX, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1301 Concord Terrace </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Sunrise, Florida 33323-2825 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are furnishing this Proxy Statement and related materials to MEDNAX&#146;s shareholders as part of the solicitation of proxies by
MEDNAX&#146;s Board of Directors for use at MEDNAX&#146;s 2018 Annual Shareholders&#146; Meeting and at any postponement or adjournment of the meeting. As used in this Proxy Statement, unless the context otherwise requires, the terms
&#147;MEDNAX,&#148; &#147;we,&#148; &#147;us,&#148; &#147;our&#148; and the &#147;Company&#148; refer to the parent company, MEDNAX, Inc., a Florida corporation, and the consolidated subsidiaries through which its businesses are actually conducted,
together with MEDNAX&#146;s affiliated business corporations or professional associations, professional corporations, limited liability companies and partnerships. All share and per share data set forth herein give effect to the two-for-one splits
of our common stock that became effective on April&nbsp;13, 2006 and December&nbsp;19, 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;31, 2008,
Pediatrix Medical Group, Inc., a Florida corporation (&#147;Pediatrix&#148;), and MEDNAX completed a holding company formation transaction that established MEDNAX as the parent company of Pediatrix, now known as MEDNAX Services, Inc. Throughout this
Proxy Statement, when we refer to MEDNAX or to the Company in reference to activities that occurred prior to the reorganization on December&nbsp;31, 2008, we are referring to Pediatrix, and when we refer to the Company in reference to activities
occurring after the reorganization, we are referring to MEDNAX, except to the extent the context otherwise indicates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under
the rules and regulations of the SEC, we are furnishing our proxy materials to our shareholders over the Internet and providing a Notice of Internet Availability of Proxy Materials (the &#147;E-Proxy Notice&#148;) by mail instead of mailing a
printed copy of our proxy materials, which include our Proxy Statement and Annual Report, to all MEDNAX shareholders. The E-Proxy Notice will instruct you on how you may access and review all of the important information contained in the proxy
materials. The E-Proxy Notice also instructs you how you may submit your proxy via the Internet. You will not receive a printed copy of the proxy materials unless you request to receive these materials in hard copy by following the instructions
provided in the E-Proxy Notice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are mailing the E-Proxy Notice on or about March&nbsp;30, 2018, to MEDNAX&#146;s
shareholders of record at the close of business on March&nbsp;12, 2018. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_1"></A>QUESTIONS AND ANSWERS
ABOUT OUR ANNUAL MEETING </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_2"></A>What Is the Date, Time and Place of the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s 2018 Annual Shareholders&#146; Meeting will be held on Wednesday, May&nbsp;16, 2018, beginning at 9:30 a.m. (ET) at the
DoubleTree by Hilton Sunrise, 13400 West Sunrise Boulevard, Sunrise, Florida, 33323. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_3"></A>What Is the Purpose of the
Annual Meeting? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the annual meeting, MEDNAX&#146;s shareholders will be asked to: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">elect nine Directors, each for a term expiring at the next annual meeting or until his or her successor has been duly elected and qualified;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2018 fiscal year;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cast an advisory vote regarding executive compensation; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">consider and act upon such other business as may properly come before the meeting. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_4"></A>Who Is Entitled to Vote at the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only holders of record of our common stock at the close of business on March&nbsp;12, 2018, the record date for the meeting, are entitled
to notice of, to attend and to vote at the annual meeting, or any postponements or adjournments of the meeting. At the close of business on the record date, 94,382,958 shares of our common stock were issued and outstanding and were held by
approximately 372 holders of record. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_5"></A>What Are the Voting Rights of MEDNAX&#146;s Shareholders? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s shareholders have one vote per share of MEDNAX common stock owned on the record date for each matter properly presented at
the annual meeting. For example, if you owned 100 shares of our common stock at the close of business on March&nbsp;12, 2018, you can cast 100 votes for each matter properly presented at the annual meeting. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_6"></A>What Constitutes a Quorum? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A quorum will be present at the meeting if holders of a majority of the issued and outstanding shares of our common stock on the record date are represented at the meeting in person or by proxy. If a
quorum is not present at the meeting, MEDNAX expects to postpone or adjourn the meeting to solicit additional proxies. Abstentions, including broker non-votes (as described below), will be counted as shares present and entitled to vote for the
purposes of determining the presence or absence of a quorum. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_7"></A>What Are &#147;Broker Non-Votes&#148;?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Broker non-votes&#148; occur when shares held by a brokerage firm are not voted with respect to a proposal because
the firm has not received voting instructions from the shareholder and the firm does not have the authority to vote the shares at its discretion. Under the rules of the New York Stock Exchange, brokerage firms may have the authority to vote their
customers&#146; shares on certain routine matters for which they do not receive voting instructions, including the ratification of the appointment of independent auditors. The election of directors and the advisory vote on executive compensation are
considered &#147;non-routine&#148; matters under the New&nbsp;York Stock Exchange rules. In addition, other matters may properly be brought before the meeting that may be considered &#147;non-routine&#148; under the applicable New York Stock
Exchange rules. Shares held by a brokerage firm will not be voted on such non-routine matters by a brokerage firm unless it has received voting instructions from the shareholder and, accordingly, any such shares will be &#147;broker non-votes.&#148;
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_8"></A>How Are Abstentions and Broker Non-Votes Treated? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Abstentions and broker non-votes are counted as present for purposes of determining the presence of a quorum. Abstentions and broker
non-votes will not be counted as votes cast either in favor of or against the election of the nominees for Director or the advisory vote on executive compensation. Abstentions will not be counted as votes cast either in favor of or against the
ratification of the appointment of our independent auditors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_9"></A>Will My Shares Be Voted if I Do Not Provide My
Proxy? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are held in the name of a brokerage firm, they will not be voted by the brokerage firm except as
described above if you do not give the brokerage firm specific voting instructions. If you are a registered shareholder and hold your shares directly in your own name, your shares will not be voted unless you provide a proxy or fill out a written
ballot in person at the meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_10"></A>How Do I Vote? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You can vote in any of the following ways: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To vote via the Internet: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Follow the instructions on your proxy card and E-Proxy Notice; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vote your shares as instructed on your proxy card and E-Proxy Notice. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by telephone if you are a registered shareholder who received a paper proxy card: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dial 1-800-690-6903 from any touch-tone telephone at any time up until 11:59 p.m. ET on May&nbsp;15, 2018; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Have your proxy card in hand and follow the instructions given to you on the line. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by mail if you are a registered shareholder who received a paper proxy card: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mark, sign and date your proxy card; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return it in the envelope provided. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To vote if you hold your shares in &#147;street name,&#148; follow the instructions of your bank or broker or vote in person as described below. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote in person if you hold your shares in &#147;street name&#148;: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Attend our annual meeting; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bring valid photo identification; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Obtain a legal proxy from your bank or broker to vote the shares that are held for your benefit, attach it to your completed proxy card and deliver it
in person. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote in person if you are a registered shareholder: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Attend our annual meeting; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bring valid photo identification; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deliver your completed proxy card or ballot in person. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_11"></A>What Vote Is Required for the Proposals? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Assuming that a quorum is present at the annual meeting, the nine Director nominees receiving the highest number of affirmative votes from
holders of our common stock will be elected as Directors of MEDNAX. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has a majority voting policy as part of its
corporate governance principles. The majority voting policy is applicable solely to uncontested elections, which are those elections in which the number of nominees for election is less than or equal to the number of directors to be elected. Under
the majority voting policy, any nominee for director who receives more &#147;withheld&#148; votes than &#147;for&#148; votes in an uncontested election must submit a written offer to resign as director. Any such resignation will be reviewed by the
Nominating and Corporate Governance Committee and, within 90 days after the election, the independent members of the Board of Directors will determine whether to accept, reject or take other appropriate action with respect to, the resignation, in
furtherance of the best interests of MEDNAX and its shareholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Assuming that a quorum is present, ratification of the
appointment of our independent registered public accounting firm and approval of the compensation of our named executive officers each requires a majority of the votes cast on the proposal at the annual meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_12"></A>How Does the Board of Directors Recommend I Vote on the Proposals?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors recommends that you vote: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;FOR&#148; the election of each of the nine nominees for Director named in this Proxy Statement; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;FOR&#148; the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2018
fiscal year; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;FOR&#148; the approval of the compensation of our named executive officers. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_13"></A>How Will My Proxy Holders Vote? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The enclosed proxy designates Roger J. Medel, M.D., our Chief Executive Officer, Dominic J. Andreano, our Senior Vice President, General Counsel and Secretary, and Vivian Lopez-Blanco, our Chief Financial
Officer and Treasurer, each with full power of substitution, to hold your proxy and vote your shares. Dr.&nbsp;Medel, Mr.&nbsp;Andreano and Ms.&nbsp;Lopez-Blanco will vote all shares of our common stock represented by proxies properly submitted via
telephone or the Internet or properly executed proxies received in time for the annual meeting in the manner specified by the holders of those shares. Dr.&nbsp;Medel, Mr.&nbsp;Andreano and Ms.&nbsp;Lopez-Blanco intend to vote all shares of our
common stock represented by proxies properly submitted via telephone, or the Internet, or that are properly executed by the record holder but otherwise do not contain voting instructions, as follows: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;FOR&#148; the election of each of the nine nominees for Director named in this Proxy Statement; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;FOR&#148; the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2018
fiscal year; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;FOR&#148; the approval of the compensation of our named executive officers; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">in accordance with the recommendation of MEDNAX&#146;s Board of Directors, &#147;FOR&#148; or &#147;AGAINST&#148; all other matters as may properly
come before the annual meeting. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_14"></A>Can I Change My Vote After I Have Voted? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Voting by telephone, over the Internet or by mailing a proxy card does not preclude a shareholder from voting in person at the meeting. A
shareholder may revoke a proxy, whether submitted via telephone, the Internet or mailed, at any time prior to its exercise by filing with MEDNAX&#146;s Secretary a duly executed revocation of proxy, by properly submitting, either by telephone, mail
or Internet, a proxy to MEDNAX&#146;s Secretary bearing a later date or by appearing at the meeting and voting in person. Attendance at the meeting will not itself constitute revocation of a proxy. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_15"></A>Who Pays for the Preparation of the Proxy Statement? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX will bear the cost of the solicitation of proxies from its shareholders, including preparing, printing and mailing this Proxy
Statement, should you request a printed copy of the proxy materials, and the <FONT STYLE="white-space:nowrap">E-Proxy</FONT> Notice. In addition to solicitations by mail, MEDNAX&#146;s Directors, officers and employees, and those of its subsidiaries
and affiliates, may solicit proxies from shareholders by telephone or other electronic means or in person but will receive no additional compensation for soliciting such proxies. MEDNAX will cause banks and brokerage firms and other custodians,
nominees and fiduciaries to forward solicitation materials to the beneficial owners of our common stock held of record by such banks, brokerage firms, custodians, nominees and fiduciaries. MEDNAX will reimburse such banks, brokerage firms,
custodians, nominees and fiduciaries for their reasonable out-of-pocket expenses in doing so. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_16"></A>PROPOSAL 1: ELECTION OF MEDNAX&#146;S DIRECTORS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Amended and Restated Articles of Incorporation, as amended (our &#147;Articles of Incorporation&#148;), and
Amended and Restated Bylaws provide that the number of Directors constituting MEDNAX&#146;s Board of Directors will be determined from time to time by resolution adopted by MEDNAX&#146;s Board of Directors. Upon the recommendation of the Nominating
and Corporate Governance Committee, the nominees for Director to be elected at the annual meeting in 2018 by the holders of our common stock are as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger J. Medel, M.D., who has served as a Director since 1979; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cesar L. Alvarez, who has served as Chairman of the Board of Directors since May 2004 and as a Director since March 1997; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karey D. Barker, who has served as a Director since May 2015; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Manuel Kadre, who has served as Lead Independent Director since March 2014 and as a Director since May 2007; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Waldemar A. Carlo, M.D., who has served as a Director since June 1999; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael B. Fernandez, who has served as a Director since October 1995; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul G. Gabos, who has served as a Director since November 2002; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pascal J. Goldschmidt, M.D., who has served as a Director since March 2006; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enrique J. Sosa, Ph.D., who has served as a Director since May 2004. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please see below under &#147;Directors and Executive Officers&#148; for the biographies of these nominees for Director. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each Director elected will serve for a term expiring at MEDNAX&#146;s 2019 Annual Meeting of Shareholders, which is expected to be held
in May 2019, or until his or her successor has been duly elected and qualified. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Board of Directors has no
reason to believe that any nominee will refuse to act or be unable to accept election; however, in the event that a nominee for a directorship is unable to accept election or if any other unforeseen contingencies should arise, proxies will be voted
for the remaining nominees and for such other person as may be designated by MEDNAX&#146;s Board of Directors, unless the proxies provide otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If a quorum is present at the annual meeting, the nine nominees receiving the highest number of votes &#147;FOR&#148; election will be elected to the Board of Directors of MEDNAX, subject to the majority
voting policy described above. Proxies will be voted &#147;FOR&#148; all such nominees absent contrary instructions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>MEDNAX&#146;s Board of Directors recommends a vote &#147;FOR&#148; the election of each of the nine nominees for Director.
</I></B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_17"></A>GOVERNANCE AND RELATED MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our business, property and affairs are managed under the direction of our Board of Directors, except with respect to those matters
reserved for our shareholders. Our Board of Directors establishes our overall corporate policies, reviews the performance of our senior management in executing our business strategy and managing our day-to-day operations and acts as an advisor to
our senior management. Our Board of Directors&#146; mission is to further the long-term interests of our shareholders. Members of the Board of Directors are kept informed of MEDNAX&#146;s business through discussions with MEDNAX&#146;s management,
primarily at meetings of the Board of Directors and its committees, and through reports and analyses presented to them. Significant communications between our Directors and senior management occur apart from such meetings. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_18"></A>Questions and Answers About Our Corporate Governance Practices
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_19"></A>What Committees Have Our Board of Directors Established? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The standing committees of MEDNAX&#146;s Board of Directors are the Executive Committee, the Audit Committee, the Compensation Committee,
the Nominating and Corporate Governance Committee and the Medical Science and Technology Committee. Copies of the charters for these committees, as well as our corporate governance principles, are available on our website at <U>www.mednax.com</U>.
Our website and the information contained therein, other than material expressly referred to in this Proxy Statement, or connected thereto, are not incorporated into this Proxy Statement. A copy of our committee charters and corporate governance
principles are also available upon request from MEDNAX&#146;s Secretary at 1301 Concord Terrace, Sunrise, Florida 33323. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_20">
</A>How Many Times Did Our Board of Directors Meet During 2017? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2017, MEDNAX&#146;s Board of Directors held eight
meetings. Committees of the Board of Directors held a combined total of 18 meetings and also took various actions by unanimous written consent. Each Director attended at least 75% of the total number of meetings of MEDNAX&#146;s Board of Directors
and its committees held during 2017 during the period he or she was a member thereof. Although MEDNAX has no formal policy with respect to its Directors&#146; attendance at MEDNAX&#146;s Annual Shareholders&#146; Meetings, in 2017 all of our
Directors attended the Annual Shareholders&#146; Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_21"></A>Are a Majority of Our Directors
Independent? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors has reviewed information about each of our non-employee Directors and made the
determination that all of the non-employee Directors on our Board of Directors are independent. In arriving at this conclusion, our Board of Directors made the affirmative determination that each of Drs. Carlo, Goldschmidt and Sosa, Ms.&nbsp;Barker
and Messrs. Alvarez, Fernandez, Gabos and Kadre and Donna E. Shalala, Ph.D., who resigned from our Board of Directors effective March&nbsp;7, 2018, meet the Board of Directors&#146; previously adopted categorical standards for determining
independence in accordance with the New York Stock Exchange&#146;s corporate governance rules. In making this determination, the Board of Directors considered transactions and relationships between each Director or any member of his or her immediate
family and MEDNAX and its subsidiaries and affiliates. These transactions consisted of those transactions reported below under &#147;Certain Relationships and Related Person Transactions &#151; Transactions with Related Persons.&#148; Our Board of
Directors determined that each of these transactions and relationships was within the New York Stock Exchange standards and our categorical standards and that none of the transactions or relationships affected the independence of the Director
involved. Our adopted categorical standards for determining independence in accordance with the New York Stock Exchange&#146;s corporate governance rules are contained in our corporate governance principles, a copy of which is available on our
Website at <U>www.mednax.com</U>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_22"></A>Who Are the &#147;Chairman of the Board&#148; and &#147;Lead
Independent Director&#148;? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To assist the Board of Directors in fulfilling its obligations, following each annual meeting
of the shareholders, MEDNAX&#146;s Board of Directors designates a non-management Director as &#147;Chairman of the Board.&#148; In addition, the Board of Directors, by a majority vote of the non-management Directors, may also designate a
non-management Director as &#147;Lead Independent Director.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX separates the roles of Chief Executive Officer and
Chairman of the Board in recognition of the differences between the two roles. The Chief Executive Officer is responsible for determining the strategic direction for the Company and the day-to-day leadership and performance of the Company. The
principal responsibility of the Chairman of the Board is to serve as chief administrative liaison between independent Directors and MEDNAX management and to monitor implementation of Board of Directors&#146; directives and actions. The principal
responsibility of the Lead Independent Director, if designated, is to work collaboratively </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
with the Chairman of the Board and the Chief Executive Officer with respect to Board of Directors governance and process. The Lead Independent Director has additional responsibilities and
authorities set out in our corporate governance principles. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At least once a year, the Chairman of the Board or Lead
Independent Director also presides over meetings of our independent Directors. Following our 2017 annual meeting of shareholders, our Board of Directors appointed Mr.&nbsp;Alvarez to serve as Chairman of the Board and Mr.&nbsp;Kadre to serve as Lead
Independent Director. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_23"></A>What Role Does the Board of Directors Serve in Risk Oversight for the
Company? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors provides oversight of the Company&#146;s risk exposure by receiving periodic reports from
senior management regarding matters relating to financial, operational, regulatory, legal and strategic risks and mitigation strategies for such risks. In addition, as reflected in the Audit Committee Charter, the Board of Directors has delegated to
the Audit Committee responsibility to oversee, discuss and evaluate the Company&#146;s policies and guidelines with respect to risk assessment and risk management, including internal control over financial reporting. As appropriate, the Audit
Committee provides reports to and receives direction from the full Board of Directors regarding the Company&#146;s risk management policies and guidelines, as well as the Audit Committee&#146;s risk oversight activities. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_24"></A>How Can Shareholders Communicate with the Board of Directors? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Anyone who has a concern about MEDNAX&#146;s conduct, including accounting, internal controls or audit matters, may communicate directly
with our Chairman of the Board of Directors, Lead Independent Director, our non-management Directors, the Chairman of the Audit Committee or the Audit Committee. Such communications may be confidential or anonymous, and may be submitted in writing
to the Chief Compliance Officer, MEDNAX, Inc., 1301 Concord Terrace, Sunrise, Florida 33323, or reported by phone at 877-835-5764. Any such concerns will be forwarded to the appropriate Directors for their review, and will be simultaneously reviewed
and addressed by the Company&#146;s General Counsel or Chief Compliance Officer in the same way that other concerns are addressed by us. MEDNAX&#146;s Code of Conduct, which is discussed below, prohibits any employee from retaliating or taking any
adverse action against anyone for raising or helping to resolve an integrity concern. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_25"></A>Has
MEDNAX Adopted a Code of Conduct? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has adopted a Code of Conduct that applies to all Directors, officers, employees
and independent contractors of MEDNAX and its affiliated professionals. MEDNAX intends to disclose any amendments to, or waivers from, any provision of the Code of Conduct that applies to any of MEDNAX&#146;s executive officers or Directors by
posting such information on its website at <U>www.mednax.com</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has also adopted a Code of Professional Conduct
&#151; Finance that applies to all employees with access to, and responsibility for, matters of finance and financial management, including MEDNAX&#146;s Chief Executive Officer, Chief Financial Officer and Treasurer and Chief Accounting Officer.
MEDNAX intends to disclose any amendments to, or waivers from, any provision of the Code of Professional Conduct &#151; Finance that applies to any of MEDNAX&#146;s Chief Executive Officer, Chief Financial Officer and Treasurer, Chief Accounting
Officer or persons performing similar functions by posting such information on its website at <U>www.mednax.com</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Copies
of our Code of Conduct and the Code of Professional Conduct &#151; Finance are available on our website at <U>www.mednax.com</U> and upon request from MEDNAX&#146;s Secretary at 1301 Concord Terrace, Sunrise, Florida 33323. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_26"></A>Has MEDNAX Adopted a Clawback Policy? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has adopted a Clawback Policy that permits the Company to seek to recover certain amounts of incentive compensation, including both
cash and equity, paid to any executive officer (as defined in the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)) on or after January&nbsp;1, 2014, if payment of such compensation was based on the achievement of financial results
that were subsequently the subject of a restatement of its financial statements due to misconduct, and if the executive engaged in improper conduct that materially contributed to the need for restatement, and a lower amount of incentive compensation
would have been earned based on the restated financial results. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_27"></A>Does MEDNAX Require its
Executive Officers and Board of Directors to Retain a Certain Amount of MEDNAX Common Stock? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has adopted a Stock
Ownership and Retention Policy which requires that each named executive officer and each non-management Director retain MEDNAX common stock worth a certain multiple of annual base salary, or cash retainer, respectively. Details of the policy and the
required ownership levels are described in further detail in the &#147;Executive Compensation: Compensation Discussion and Analysis&#148; section of this Proxy Statement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_28"></A>Has MEDNAX Adopted an Anti-Hedging and Anti-Pledging Policy? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has adopted a policy prohibiting its directors, management, financial and other insiders from engaging in transactions in MEDNAX securities or derivatives of MEDNAX securities that might be
considered hedging, or from holding MEDNAX securities in margin accounts or pledging MEDNAX securities as collateral for a loan, unless such person clearly demonstrates the financial capacity to repay the loan without resort to the pledged
securities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_29"></A>Does MEDNAX Have a Director Retirement Age Policy? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has adopted a Director Retirement Age Policy which provides that a Director must retire and may not stand for re-election during
the calendar year in which he or she attains age 80. Additionally, no Director may be nominated to a new term if he or she would attain age 80 by the end of the calendar year in which the election is held. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_30"></A>Report of the Audit Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>The following report of the Audit Committee does not constitute soliciting material and should not be deemed filed or incorporated by reference into any of MEDNAX&#146;s filings under the Securities
Act of 1933, as amended (the &#147;Securities Act&#148;), or the Exchange Act, except to the extent that we specifically incorporate such report by reference. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We act under a written charter that has been adopted by MEDNAX&#146;s Board of Directors. While we have the responsibilities set forth in this charter, it is not our duty to plan or conduct audits or to
determine that MEDNAX&#146;s financial statements are complete, accurate or in compliance with accounting principles generally accepted in the United States (&#147;GAAP&#148;). This is the responsibility of MEDNAX&#146;s management and independent
auditors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our primary function is to assist the Board of Directors in their evaluation and oversight of the integrity of
MEDNAX&#146;s financial statements and internal control over financial reporting, the qualifications and independence of MEDNAX&#146;s independent auditors and the performance of MEDNAX&#146;s audit functions. In addition, while we are also
responsible for assisting the Board of Directors in their evaluation and oversight of MEDNAX&#146;s compliance with applicable laws and regulations, it is not our duty to assure compliance with such laws and regulations or MEDNAX&#146;s Compliance
Plan and related policies. We are also responsible for overseeing, discussing and evaluating MEDNAX&#146;s guidelines, policies and processes with respect to risk assessment and risk management and the steps management has taken to monitor and
control risk exposure, and we advise the Board of Directors with respect to such matters, as appropriate. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also oversee MEDNAX&#146;s auditing, accounting and financial reporting processes
generally. Management is responsible for MEDNAX&#146;s financial statements and the financial reporting process, including the system of internal controls. We also review the preparation by management of MEDNAX&#146;s quarterly and annual financial
statements. MEDNAX&#146;s independent auditors, who are accountable to us, are responsible for expressing an opinion as to whether the consolidated financial statements present fairly, in all material respects, the financial position, results of
operations and cash flows of MEDNAX in conformity with GAAP. MEDNAX&#146;s independent auditors are also responsible for auditing and reporting on the effective operation of MEDNAX&#146;s internal control over financial reporting. We are responsible
for retaining MEDNAX&#146;s independent auditors and maintain sole responsibility for their compensation, oversight and termination. We are also responsible for pre-approving all non-audit services to be provided by the independent auditors, and on
an annual basis discussing with the independent auditors all significant relationships they have with MEDNAX to determine their independence. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In fulfilling our oversight role, we met and held discussions with MEDNAX&#146;s management and independent auditors. Management advised us that MEDNAX&#146;s consolidated financial statements were
prepared in accordance with GAAP, and we reviewed and discussed the consolidated financial statements for the fiscal year ended December&nbsp;31, 2017. In addition, we reviewed and discussed the Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations section of MEDNAX&#146;s periodic reports, key accounting and reporting issues and the scope, adequacy and assessments of MEDNAX&#146;s internal controls and disclosure controls and procedures with management and
MEDNAX&#146;s independent auditors. We discussed privately with the independent auditors matters deemed significant by the independent auditors, including those matters required to be discussed pursuant to U.S. Auditing Standard No.&nbsp;16
(Communications with Audit Committees), as adopted by the Public Company Accounting Oversight Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The independent auditors
also provided us with the written disclosures and the letter required by applicable requirements of the Public Company Accounting Oversight Board, regarding the independent accountant&#146;s communications with the Audit Committee concerning
independence, and we discussed with the independent auditors matters relating to their independence. We also reviewed a report by the independent auditors describing the firm&#146;s internal quality-control procedures and any material issues raised
in the most recent internal-quality control review or external peer review or inspection performed by the Public Company Accounting Oversight Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Based on our review with management and the independent auditors of MEDNAX&#146;s audited consolidated financial statements and internal controls over financial reporting and the independent
auditors&#146; report on such financial statements and their evaluation of MEDNAX&#146;s internal controls over financial reporting, and based on the discussions and written disclosures described above and our business judgment, we recommended to
the Board of Directors that the Company&#146;s audited consolidated financial statements for the fiscal year ended December&nbsp;31, 2017 be included in MEDNAX&#146;s Annual Report on Form 10-K for the year ended December&nbsp;31, 2017, for filing
with the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Submitted by the Audit Committee of the Board of Directors. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul G. Gabos </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karey D. Barker </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Manuel Kadre </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enrique J. Sosa, Ph.D. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_31"></A>DIRECTORS AND EXECUTIVE OFFICERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_32"></A>MEDNAX&#146;s Directors and Executive Officers </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Directors and Executive Officers are as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="49%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:82pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position with MEDNAX</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger J. Medel, M.D. (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cesar L. Alvarez (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chairman of the Board of Directors</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Manuel Kadre (1)(2)(3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lead Independent Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karey D. Barker (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Waldemar A. Carlo, M.D. (3)(4)(5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael B. Fernandez (3)(4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul G. Gabos (1)(2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pascal J. Goldschmidt, M.D. (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enrique J. Sosa, Ph.D. (2)(4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph M. Calabro</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Operating Officer</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vivian Lopez-Blanco</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer and Treasurer</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David A. Clark</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President, MEDNAX National Medical Group</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dominic J. Andreano</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, General Counsel and Secretary</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John C. Pepia</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Accounting Officer</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of the Executive Committee. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of the Audit Committee. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of the Compensation Committee. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of the Nominating and Corporate Governance Committee. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of the Medical Science and Technology Committee. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Roger J. Medel, M.D.,</I> has been a Director of the Company since he co-founded it in 1979. Dr.&nbsp;Medel served as the Company&#146;s President until May 2000 and as Chief Executive Officer until
December 2002. In March 2003, Dr.&nbsp;Medel reassumed the position of President, serving in that position until May 2004, and Chief Executive Officer, a position in which he continues to serve today. Dr.&nbsp;Medel has served as a member of the
Board of Trustees of the Dana Farber Cancer Institute, Inc. since January 2016. Dr.&nbsp;Medel was a member of the Board of Trustees of the University of Miami from January 2004 to February 2012. Dr.&nbsp;Medel participates as a member of several
medical and professional organizations and, from June 2006 to April 2009, served on the Board of Directors of MBF Healthcare Acquisition Corp. The Board of Directors has concluded that Dr.&nbsp;Medel&#146;s qualifications to serve on the Board
include his experience as our Chief Executive Officer and founder of the Company and a physician with training and experience in the Company&#146;s historical base service line of neonatology. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cesar L. Alvarez</I> has been a Director since March 1997 and was elected as Chairman of the Board of Directors in May 2004.
Mr.&nbsp;Alvarez is a Senior Chairman of the international law firm of Greenberg Traurig. He previously served as the firm&#146;s Executive Chairman for more than three years and as its Chief Executive Officer for 13 years. Mr.&nbsp;Alvarez also
serves on the Board of Directors of Fairholme Funds, Inc., Intrexon Corporation, Sears Holdings Corporation, St. Joe Company and Watsco, Inc. The Board of Directors has concluded that Mr.&nbsp;Alvarez&#146;s qualifications to serve on the Board
include his management experience as the current Senior Chairman and as former Chief Executive Officer and Executive Chairman of one of the nation&#146;s largest law firms with professionals providing services in multiple locations across the
country and abroad as well as his many years of corporate governance experience, both counseling and serving on the Boards of Directors of publicly traded and private companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Manuel Kadre</I> was elected as a Director in May 2007 and designated as Lead Independent Director in March 2014. Since December 2012,
Mr.&nbsp;Kadre has been the Chairman and Chief Executive Officer of MBB Auto, LLC and also serves as the Chairman and Chief Executive Officer of many other luxury automobile </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
dealerships in the Northeast. Mr.&nbsp;Kadre is a partner and director of Gold Coast Restaurants, which is the largest franchisee of TGI Friday&#146;s in the United States. From July 2009 until
2013, Mr.&nbsp;Kadre was the Chief Executive Officer of Gold Coast Caribbean Importers, LLC. From 1995 until July 2009, Mr.&nbsp;Kadre served in various roles, including President, Vice President, General Counsel and Secretary of CC1 Companies,
Inc., which distributes Coca-Cola and other beverage products in markets throughout the Caribbean. Mr.&nbsp;Kadre has served on the Board of Directors of Republic Services, Inc. since June 2014 and was appointed as Chairman of the Board of Directors
of Republic Services, Inc. in February 2017. Mr.&nbsp;Kadre also serves on the Board of Trustees of the University of Miami and on the Board of Governors of University of Miami Hospital. The Board of Directors has concluded that
Mr.&nbsp;Kadre&#146;s qualifications to serve on the Board include his experience in acquiring and managing businesses, including those in regulated industries and in government relations, his financial expertise as well as his experience as a
member of the Board of Trustees of the University of Miami. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Karey D. Barker </I>was elected as a Director in May 2015.
Ms.&nbsp;Barker founded Cross Creek Advisors, LLC in 2013 and has served as its Managing Director since that time. Ms.&nbsp;Barker previously served as Managing Director, Venture of Wasatch Advisors, Inc. from 2006 until 2012 and served as a member
of its Board of Directors from 1995 until 2012. Ms.&nbsp;Barker also serves as a board observer for several investment companies on behalf of Cross Creek Advisors. The Board of Directors has concluded that Ms.&nbsp;Barker&#146;s qualifications to
serve on the Board include her financial expertise and experience in managing venture capital and private equity funds.<I> </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Waldemar A. Carlo, M.D.,</I> was elected as a Director in June 1999. Dr.&nbsp;Carlo has served as Professor of Pediatrics and Director
of the Division of Neonatology at the University of Alabama School of Medicine since 1991. Dr.&nbsp;Carlo participates as a member of several medical and professional organizations. He has received numerous research awards and grants and has
lectured extensively, both nationally and internationally. Additionally, Dr.&nbsp;Carlo is a recipient of the Apgar Award, the highest recognition given to neonatologists by the American Academy of Pediatrics. The Board of Directors has concluded
that Dr.&nbsp;Carlo&#146;s qualifications to serve on the Board include his experience as a nationally known Professor of Neonatology leading one of the nation&#146;s largest academic neonatal practices as well as his experience performing
scientific research and developing and implementing educational programs for physicians. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Michael B. Fernandez</I> was
elected as a Director in October 1995. Mr.&nbsp;Fernandez has served as Chairman and Chief Executive Officer of MBF Healthcare Partners, L.P., a private equity firm focused on investing in healthcare service companies, since February 2005. He also
served as the Chairman of Simply Healthcare Holdings until its acquisition by Anthem, Inc. in February 2015, and Navarro Discount Pharmacies, LLC until its acquisition by CVS Caremark in September 2014. Mr.&nbsp;Fernandez has served as a member of
the Board of Trustees of the University of Miami and was on the Board of Directors of various private entities, including Healthcare Atlantic, Inc., a holding company that operates various healthcare entities. The Board of Directors has concluded
that Mr.&nbsp;Fernandez&#146;s qualifications to serve on the Board include his experience over many years as a founder, investor and executive in a variety of successful healthcare businesses (including managed care companies), his financial and
marketing expertise, as well as his experience as a member of the Board of Trustees of the University of Miami. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Paul G.
Gabos</I> was elected as a Director in November 2002. Mr.&nbsp;Gabos, who is presently retired, served as Chief Financial Officer of Lincare Holdings Inc. (&#147;Lincare&#148;) from June 1997 until December 2012, after its merger with a subsidiary
of Linde AG, and prior thereto served as Vice President &#151; Administration for Lincare. Prior to joining Lincare in 1993, Mr.&nbsp;Gabos worked for Coopers&nbsp;&amp; Lybrand and for Dean Witter Reynolds, Inc. Mr.&nbsp;Gabos currently serves on
the Board of Directors of Health Insurance Innovations, Inc. The Board of Directors has concluded that Mr.&nbsp;Gabos&#146; qualifications to serve on the Board include his management experience as a senior executive and financial expertise as Chief
Financial Officer of a publicly traded healthcare services company and prior thereto as an investment banker with a large national firm.<I> </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Pascal J. Goldschmidt, M.D.</I>, was elected as a Director in March 2006. Dr.&nbsp;Goldschmidt currently serves as a Director and Chief Executive Officer of European Care Global QHCI, Ltd.
Dr.&nbsp;Goldschmidt previously served </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
as the Director of Strategic International Projects and Dean Emeritus at the University of Miami. Dr.&nbsp;Goldschmidt served as the Senior Vice President for Medical Affairs and Dean of the
University of Miami Leonard M. Miller School of Medicine from April 2006 until May 2016. Dr.&nbsp;Goldschmidt also served as the Chief Executive Officer of the University of Miami Health System from November 2007 until January 2016. Previously,
Dr.&nbsp;Goldschmidt was a faculty member with the Department of Medicine at Duke University Medical Center where he served as Chairman from 2003 to 2006 and as Chief of the Division of Cardiology from 2000 to 2003. Dr.&nbsp;Goldschmidt served on
the Board of Directors of Health Management Associates from June 2011 until August 2013 and previously served as a director for Opko Health, Inc. from 2007 until 2011. The Board of Directors has concluded that Dr.&nbsp;Goldschmidt&#146;s
qualifications to serve on the Board include his experience as a Chief Executive Officer of a healthcare and hospital system, as Dean of a premier medical school managing physicians and other healthcare professionals, as a physician trained in
cardiology, as well as his experience performing scientific research and developing and implementing educational programs for physicians. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Enrique J. Sosa, Ph.D.</I>, was elected as a Director in May 2004. Dr.&nbsp;Sosa, who is presently retired, served as President of BP Amoco Chemicals from January 1999 to April 1999. From 1995 to 1998,
he was Executive Vice President of Amoco Corporation. Prior to joining Amoco, Dr.&nbsp;Sosa served as Senior Vice President of The Dow Chemical Company, President of Dow North America and a member of its Board of Directors. Dr.&nbsp;Sosa was a
director of FMC Corporation from June 1999 until April 2012 and a director of Northern Trust Corporation from April 2007 until April 2012. The Board of Directors has concluded that Dr.&nbsp;Sosa&#146;s qualifications to serve on the Board include
his management and financial expertise as a former executive officer of large international industrial businesses, his many years of experience with corporate governance, and his service on the Boards of Directors of other publicly traded companies.
<I> </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Joseph M. Calabro</I> joined the Company in January 1996 as Chief Information Officer. In January 2000,
Mr.&nbsp;Calabro was appointed Executive Vice President, Management, in May 2000, he was appointed Chief Operating Officer, and in May 2004, he was appointed President. Prior to joining the Company, Mr.&nbsp;Calabro served as Director of Information
Technology for the Ambulatory Surgery Group of Columbia/HCA. He served in various operational and technology positions for various healthcare companies from 1987 to 1994.<I> </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vivian Lopez-Blanco</I> joined the Company in May 2008 as Vice President and Treasurer and was appointed Chief Financial Officer in
January 2010. Prior to joining the Company, from 2003 to 2008, Ms.&nbsp;Lopez-Blanco served as Chief Financial Officer of Carrols Corporation&#146;s Hispanic Restaurants Division, which includes the Pollo Tropical and Taco Cabana concepts.
Ms.&nbsp;Lopez-Blanco joined Pollo Tropical in 1997 as Controller, was promoted to Chief Financial Officer in 1998 and led the Company through its acquisition by Carrols. Prior to Pollo Tropical, Ms.&nbsp;Lopez-Blanco served in a variety of
positions with an international accounting firm. Ms.&nbsp;Lopez-Blanco is a certified public accountant.<I> </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>David A.
Clark</I> joined the Company in May 2001 and became President of our Mednax National Medical Group in January 2017. Prior to his appointment, Mr.&nbsp;Clark served as President of our Western Division since June 2015. Mr.&nbsp;Clark previously
served as Chief Operating Officer of our Pediatrix Division from August 2008 until April 2015, with executive officer responsibilities beginning January&nbsp;1, 2009. Mr.&nbsp;Clark served as Senior Vice President, Operations from December 2003
until August 2008, and as Vice President of Operations, South Central Region from November 2001 to November 2003. From June 2000 to October 2001, Mr.&nbsp;Clark was Vice President of Operations for Magella Healthcare, which we acquired in 2001, and
prior thereto he was Vice President of Business Development for Magella Healthcare. Mr.&nbsp;Clark is a certified public accountant.<I> </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Dominic J. Andreano</I> joined the Company in September 2001 and was appointed Senior Vice President, General Counsel and Secretary in May 2012. Prior to his appointment, Mr.&nbsp;Andreano previously
served as Deputy General Counsel for the Company from January 2009 until May 2012, as Associate General Counsel for the Company from January 2004 until December 2008, and prior thereto as Director, Business Development.<I> </I>Prior to joining the
Company, Mr.&nbsp;Andreano was an associate in the corporate securities department of<I> </I>Holland&nbsp;&amp; Knight, LLP in Miami from June 2000 until September 2001, and an associate in the healthcare corporate department of Greenberg Traurig,
P.A. in Miami from September 1997 until June 2000.<I> </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>John C. Pepia</I> joined the Company in February 2002 and served as Vice President,
Accounting and Finance until May 2016, at which time Mr.&nbsp;Pepia was appointed Senior Vice President and Chief Accounting Officer. The Board of Directors appointed Mr.&nbsp;Pepia Principal Accounting Officer in August 2016. Prior to joining the
Company, from 1996 to 2002, Mr.&nbsp;Pepia held several Vice President of Accounting&nbsp;&amp; Finance positions at ANC Rental Corporation.&nbsp;He served in various financial positions in several public and private companies from 1985 to 1996.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_33"></A>Committees of the Board of Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_34"></A>Audit Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Audit Committee held seven meetings in 2017. Messrs. Gabos and Kadre, Dr.&nbsp;Sosa and Ms.&nbsp;Barker were members of the committee throughout 2017. Mr.&nbsp;Gabos acted as chair of the
committee throughout 2017. MEDNAX&#146;s Board of Directors has determined that each of Messrs. Gabos and Kadre, Dr.&nbsp;Sosa and Ms.&nbsp;Barker qualify as &#147;audit committee financial experts&#148; as defined by the rules and regulations of
the SEC and that each of Messrs. Gabos and Kadre, and Dr.&nbsp;Sosa and Ms.&nbsp;Barker meet the independence requirements under such rules and regulations and for a New York Stock Exchange listed company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Board of Directors has adopted a written charter for the Audit Committee setting out the functions that it is to perform. A
copy of the Audit Committee Charter is available on our Website at <U>www.mednax.com</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please refer to the Report of the
Audit Committee, which is set forth above, for a further description of our Audit Committee&#146;s responsibilities and its recommendation with respect to our audited consolidated financial statements for the year ended December&nbsp;31, 2017.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_35"></A>Compensation Committee </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Compensation Committee held six meetings in 2017, and took various other actions via unanimous written consent. Messrs.
Kadre and Fernandez and Dr.&nbsp;Carlo were members of the committee throughout 2017. Mr.&nbsp;Kadre acted as chair of the committee throughout 2017. MEDNAX&#146;s Board of Directors has determined that each of Messrs. Kadre and Fernandez and
Dr.&nbsp;Carlo meet the independence requirements for a New York Stock Exchange listed company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Board of
Directors has adopted a written charter for the Compensation Committee setting out the functions that it is to perform. A copy of the Compensation Committee Charter is available on our Website at <U>www.mednax.com</U>. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The primary purpose of MEDNAX&#146;s Compensation Committee is to assist MEDNAX&#146;s Board of Directors in the discharge of the Board
of Directors&#146; responsibilities relating to compensation of executives. The scope of authority of MEDNAX&#146;s Compensation Committee includes the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Evaluating the performance of and setting the compensation for MEDNAX&#146;s Chief Executive Officer and other executive officers;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Supervising and making recommendations to MEDNAX&#146;s Board of Directors with respect to incentive compensation plans and equity-based plans for
executive officers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Overseeing the review of the Company&#146;s incentive compensation arrangements to determine whether they encourage excessive risk-taking, including
discussing at least annually the relationship between risk management policies and practices and compensation and considering, as appropriate, compensation policies and practices that could mitigate any such risk; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Evaluating whether or not to engage, retain, or terminate an outside consulting firm for the review and evaluation of MEDNAX&#146;s compensation plans
and approving such outside consulting firm&#146;s fees and other retention terms; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conducting an annual self-assessment of the Compensation Committee. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon a determination of MEDNAX&#146;s full Compensation Committee membership, matters
may be delegated to a subcommittee for evaluation and recommendation back to the full committee. For a description of the role performed by executive officers and compensation consultants in determining or recommending the amount or form of
executive and Director compensation, see &#147;Executive Compensation: Compensation Discussion and Analysis &#151; How Pay Decisions are Made.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_36"></A>Nominating and Corporate Governance Committee </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Nominating and Corporate Governance Committee held one meeting in 2017, and took various other actions via unanimous written
consent. Drs. Carlo and Sosa and Mr.&nbsp;Fernandez were members of the committee throughout 2017. Dr.&nbsp;Carlo served as chairman of the committee throughout 2017. MEDNAX&#146;s Board of Directors has determined that each of Drs. Carlo and Sosa
and Mr.&nbsp;Fernandez meet the independence requirements for a New York Stock Exchange listed company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s Board
of Directors has adopted a written charter for the Nominating and Corporate Governance Committee setting out the functions that it is to perform. A copy of the Nominating and Corporate Governance Committee Charter is available on our website at
<U>www.mednax.com</U>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee assists the Board of Directors with respect to
nominating new Directors and committee members and taking a leadership role in shaping the corporate governance of MEDNAX. To fulfill its responsibilities and duties, the committee, among other things, reviews the qualifications and independence of
existing Directors and new candidates; assesses the contributions of current Directors; identifies and recommends individuals qualified to be appointed to committees of the Board of Directors; considers rotation of committee members; reviews the
charters of the committees and makes recommendations to the full Board of Directors with respect thereto; develops and recommends to the Board of Directors corporate governance principles, including a code of business conduct; and evaluates and
recommends succession plans for MEDNAX&#146;s Chief Executive Officer and other senior executives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although the Nominating
and Corporate Governance Committee does not solicit director nominations, the committee will consider candidates suggested by shareholders in written submissions to MEDNAX&#146;s Secretary in accordance with the procedures described below in the
section entitled &#147;Information Concerning Shareholder Proposals.&#148; In evaluating nominees for Director, the committee does not differentiate between nominees recommended by shareholders and others. In identifying and evaluating candidates to
be nominated for Director, the committee reviews the desired experience, mix of skills and other qualities required for appropriate Board composition, taking into account the current Board members and the specific needs of MEDNAX and its Board of
Directors. Although the committee does not have a formal policy with regard to the consideration of diversity in identifying Director nominees, the committee&#146;s review process is designed so that the Board of Directors includes members with
diverse backgrounds, skills and experience, and represents appropriate financial, clinical and other expertise relevant to the business of MEDNAX. At a minimum, Director candidates must meet the following qualifications: high personal and
professional ethics, integrity and values and a commitment to the representation of the long-term interests of our shareholders. Although the committee&#146;s charter permits the committee to engage a search firm to identify Director candidates,
MEDNAX did not pay any fees to third parties to assist in the process of identifying or evaluating Director candidates in 2017. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_37">
</A>Risk Considerations in Our Compensation Programs </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has reviewed its compensation structures and policies as
they pertain to risk and has determined that its compensation programs do not create or encourage the taking of risks that are reasonably likely to have a material adverse effect on the Company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_38"></A>Certain Relationships and Related Person Transactions </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_39"></A>Review and Approval of Related Person Transactions </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MEDNAX has a written policy for the review and approval or ratification of transactions (i)&nbsp;between MEDNAX and any MEDNAX Director or
any other entity in which any MEDNAX Director is a director, officer or has a financial interest; and (ii)&nbsp;in which MEDNAX is or will be a participant and any related person has or will have a direct or indirect material interest. For purposes
of the policy, a related person includes any MEDNAX Director or Director nominee, executive officer or holder of more than 5% of the outstanding voting stock of MEDNAX or any of their respective immediate family members. The policy does not apply to
transactions pertaining to (i)&nbsp;director or officer compensation that is approved or recommended to MEDNAX&#146;s Board of Directors for approval by MEDNAX&#146;s Compensation Committee or (ii)&nbsp;the employment by MEDNAX of any immediate
family member of a related person in a non-officer position and at compensation levels commensurate with that paid to other similarly situated employees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of the policy, all covered transactions, if determined to be material by MEDNAX&#146;s General Counsel or if the transaction involves the participation of a member of the MEDNAX
Board of Directors, are required to be promptly referred to the disinterested members of the MEDNAX Audit Committee for their review or, if less than a majority of the members of MEDNAX Audit Committee are disinterested, to all the disinterested
members of the MEDNAX Board of Directors. Pursuant to the terms of the policy, materiality determinations must be based on the significance of the information to investors in light of all circumstances, including, but not limited to, the
(i)&nbsp;relationship of the related persons to the covered transaction, and with each other, (ii)&nbsp;importance to the person having the interest, and (iii)&nbsp;amount involved in the transaction. All transactions involving in excess of $120,000
are automatically deemed to be material pursuant to the terms of the policy. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The disinterested Directors of MEDNAX&#146;s
Audit Committee or Board of Directors, as applicable, are required to review such material covered transactions at their next regularly-scheduled meeting, or earlier if a special meeting is called by the Chairman of the Audit Committee and may only
approve such a material covered transaction if it has been entered into in good faith and on fair and reasonable terms that are no less favorable to MEDNAX than those that would be available to MEDNAX in a comparable transaction in arm&#146;s length
dealings with an unrelated third party at the time it is considered by the disinterested Directors of MEDNAX&#146;s Audit Committee or Board of Directors, as applicable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">All of the transactions described in &#147;Transactions with Related Persons&#148; below were covered transactions under our policy and the policies and procedures required by the policy were followed in
connection with the review and approval or ratification of all of such transactions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_40"></A>Transactions with Related Persons </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Alvarez has served on MEDNAX&#146;s Board of Directors since March 1997. Mr.&nbsp;Alvarez is the Senior Chairman of Greenberg
Traurig, P.A., which serves as one of MEDNAX&#146;s outside counsels and receives customary fees for legal services. In 2017, MEDNAX paid Greenberg Traurig, P.A. approximately $1,348,000 for such services and currently anticipates that this
relationship will continue. Mr.&nbsp;Alvarez does not personally provide legal services to MEDNAX and derives no direct personal benefit from MEDNAX&#146;s payment for legal services to Greenberg Traurig, P.A. Further, the fees derived from MEDNAX
represent an immaterial portion of the overall revenue generated by Greenberg Traurig, P.A. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_41"></A>Compensation Committee Interlocks and Insider Participation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2017, none of our executive officers or Directors was a member of the Board of Directors of any other company where the relationship
would be considered a compensation committee interlock under the SEC rules. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_42"></A>EXECUTIVE COMPENSATION: COMPENSATION DISCUSSION AND
ANALYSIS (&#147;CD&amp;A&#148;) </B></FONT></P><DIV STYLE="position:relative;float:left; width:65%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_43"></A>SECTION I: A MESSAGE TO OUR SHAREHOLDERS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear MEDNAX Shareholders, </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="1">The principal responsibility of the Compensation Committee of the Board of Directors (&#147;the Compensation Committee&#148;) is to ensure that we have an executive compensation program in place that
attracts and retains the best executive workforce in our industry. We believe that having the highest-quality, most-experienced leadership team in place is critical to our mission: &#147;<I>Take great care of the patient, every day and in every
way</I>.&#148;<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP> We also recognize that to best serve our patients and shareholders, we must also fulfill our responsibility to &#147;Take great care of the
business.&#148; Our executive officer compensation program is designed to ensure that we accomplish our mission while delivering value to our shareholders. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT
STYLE="font-family:Times New Roman" SIZE="1">The healthcare and economic landscapes continue to change, and we are extremely fortunate to have one of the longest-serving leadership teams in our industry navigating MEDNAX through these changes. In
2017, MEDNAX further expanded upon its diversified portfolio of services, which consists of neonatal and pediatric care, anesthesia solutions, radiology and telemedicine, as well as a management services organization and other consulting services.
During 2017, MEDNAX&#146;s financial results reflected a challenging healthcare environment, with earnings declining from the previous year due to unexpected changes in payor mix, reduced patient volumes and increased pressures on practitioner
compensation in critical markets. Company leadership responded to these challenges by introducing cost reduction initiatives while also maintaining a disciplined approach in executing our acquisition strategy. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1">Despite progress in many areas and continued service excellence, the Compensation Committee affirmed its pay-for-performance principles by
authorizing no bonus payment for the CEO, COO and CFO for 2017, which followed a 29% of target payout for 2016 results. Bonuses for other executive officers were approved at levels below target, consistent with bonuses paid to other bonus-eligible
salaried employees. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1">Recognizing the importance of retaining leadership and motivating them to continue execution of the
company&#146;s strategy, the Compensation Committee established performance goals for the 2017 performance share grants that were considered challenging but achievable in light of the uncertainty relating to various drivers of our financial results.
The Committee also eliminated the &#147;retesting&#148; feature that had been included in prior performance share grants. The establishment of goals for these 2017 performance share grants considered the low bonus payout for 2016, the anticipated
low payout (if any) for 2017 and the below target number of performance shares earned from the 2016 equity grants. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1">In
addition, the Compensation Committee updated its market-based evaluation of compensation for all executive officers, and responded to this analysis by authorizing supplemental grants of restricted stock to certain executive officers to ensure that
their total compensation was market competitive and to enhance retention of these key individuals. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1">Beginning on the next page
of this Proxy Statement, we present specific information about the compensation paid to our Chief Executive Officer (&#147;CEO&#148;) and other Named Executive Officers (&#147;NEOs&#148;) for 2017. We have provided information regarding how our
executive compensation program works and the decisions made about pay, as well as how those decisions were made. Making sure you understand the rationale for our decisions is a top priority, as ongoing support for the executive compensation program
is critical to our overall success. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1">Finally, we want to thank you for making MEDNAX part of your investment portfolio. You can
be confident in our commitment to deliver exceptional performance that drives shareholder value over the long-term and quality care for the patients that depend on MEDNAX. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">Sincerely, </FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px">


<IMG SRC="g463041g97f40.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Manuel Kadre </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Compensation Committee Chairman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Lead
Independent Director </FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:32%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;background-color:;;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Committee Report </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="1">The Compensation Committee determines the compensation for our CEO and other NEOs and oversees the administration of our
executive compensation program. The Compensation Committee is composed entirely of independent Directors and is advised as necessary by independent consultants and legal counsel. Our CEO provides advice and recommendations to the Compensation
Committee with respect to the compensation of other senior executive officers. Under the rules of the SEC, our NEOs for 2017 are: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="23" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Roger J. Medel, M.D., Chief Executive Officer </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="23" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Vivian Lopez-Blanco, Chief Financial Officer and Treasurer </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="23" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Joseph M. Calabro, President and Chief Operating Officer </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="23" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">David A. Clark, President, MEDNAX National Medical Group </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="23" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></TD>
<TD WIDTH="1" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dominic J. Andreano, Senior Vice President, General Counsel and Secretary </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="1">In fulfilling our role, we met and held discussions with the Company&#146;s management and reviewed and discussed this
CD&amp;A. Based on our review and such discussions, we recommended to the Board of Directors that the CD&amp;A be included in this Proxy Statement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="1">Submitted by the Compensation Committee of the Board of Directors: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="1">Manuel Kadre </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="1">Waldemar A. Carlo, M.D. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="1">Michael B. Fernandez </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>This Compensation Committee Report does not constitute soliciting material and should not be deemed
filed or incorporated by reference into any of MEDNAX&#146;s filings under the Securities Act or the Exchange Act, except to the extent that we specifically incorporate such report by reference.
</I></FONT></P></div></div><div style="clear:both; height:0px; font-size:0px">&nbsp;</div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_44"></A>SECTION II: EXECUTIVE SUMMARY </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_45"></A>2017 Business Highlights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Stability and building long-term value are at the core of everything we do. Our unique healthcare model has been in place for over 35 years, allowing us to focus on what is most important in our industry
&#151; taking great care of our patients and improving patient outcomes. In 2017, we continued to position ourselves for the future of healthcare by concentrating on our long-term growth strategy. We remained disciplined in our spending,
highly-selective in our acquisitions and responsive to the changing healthcare landscape. We were challenged in 2017 by unexpected changes in payor mix, reduced patient volumes and increased pressures on practitioner compensation in critical
markets. Key financial results for the last three fiscal years, including the impact of the challenges we faced in 2017, are highlighted below: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g463041g01p93.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings before interest, taxes and depreciation and amortization (&#147;EBITDA&#148;) is a non-GAAP
financial measure. For a description of the rationale for our presentation of EBITDA and a reconciliation of EBITDA to net income, the most directly comparable GAAP measure, for the years ended December&nbsp;31, 2017, 2016 and 2015, please see the
disclosure under the caption &#147;Non-GAAP Measures&#148; beginning on page 53 of our Annual Report on Form 10-K for the year ended December&nbsp;31, 2017, filed with the SEC on February&nbsp;14, 2018. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our proven track record is also validated by the growth of our diluted earnings per share and annual cash flow from operations over the
last 10 years. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g463041g93r44.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top">


<IMG SRC="g463041g77k04.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g463041g46q41.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top">


<IMG SRC="g463041g20j69.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Note:</B> All share and per share amounts for all periods presented and discussed in this Proxy
Statement reflect the two-for-one stock split effected in 2013. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:55%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_46"></A>Response to Say-on-Pay Vote and Shareholder Outreach
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each year, we provide our shareholders with the opportunity to approve, or vote against, the compensation of our NEOs
(&#147;say-on-pay&#148;). We are committed to ensuring that our investors fully understand our executive compensation program, including how it aligns the interests of our executives with our shareholders and how it rewards the achievement of our
strategic objectives. We believe that the continued delivery of sustainable long-term value to our shareholders requires regular dialogue. To this end, we regularly make efforts to engage in discussions with our shareholders in order to obtain a
deeper understanding of our investors&#146; views regarding our compensation program and other important topics, including company performance and operations, strategic direction, risk and operational oversight and leadership, among other matters.
Outside of formal engagement efforts, we interact throughout the year with our shareholders and make ourselves available to them at their request. During 2017, we met with over 45% of our active shareholders on over 70 occasions throughout the year
during industry conferences, in meetings at our offices or at the offices of our shareholders and through conference telephone calls. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In response to feedback from our shareholders, we made significant changes to our executive compensation program in 2014, including changes to our equity award program and the adoption of certain
corporate governance policies, which remained in effect since that time and for 2017. These changes are described in detail in this CD&amp;A. We are pleased that at our 2017 annual meeting of shareholders, the compensation of our NEOs was approved
by more than 88% of shares that voted on the matter. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_47"></A>CEO Pay At-A-Glance </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The significant majority (approximately 88%) of our CEO&#146;s target direct compensation (sum of base salary, target bonus and grant
value of stock awards, including performance shares at target) is variable and linked to financial performance results. Dr.&nbsp;Medel&#146;s target total compensation of $8,650,000 has not been increased since 2012. The chart shows the elements of
actual CEO total direct compensation awarded to Dr.&nbsp;Medel for 2016 performance, as compared to the prior year. The chart below also reflects the currently anticipated target total direct compensation for 2017; the actual value of the
June&nbsp;1, 2017 award of performance shares and restricted stock granted to Dr.&nbsp;Medel and our other NEOs is not known as of the date of this Proxy Statement because the performance period for such awards will initially be measured over a
one-year period from April&nbsp;1, 2017 through March&nbsp;31, 2018. For more information on the performance share awards and restricted stock awards for 2017, please see the section below entitled 2017 Equity-Based Awards. </FONT></P>
<p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;
</FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:42%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
<div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;background-color:;;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Measuring Pay-for-Performance at MEDNAX </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the healthcare services industry, company stock prices at any point in time can be significantly affected by changes
(actual or anticipated) in the regulatory environment. Additionally, regulatory changes affect different healthcare companies in varying ways. For MEDNAX specifically, factors such as timing, size and type of acquisitions, effects of the continued
diversification of our services, effects of same-unit volume and reimbursement-related factors, including payor mix shifts, are often unpredictable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For these reasons, we do not use relative total shareholder return as a key performance metric in our program. Instead, our performance goals are focused on internal key financial metrics that
<I>drive</I> long-term value creation, such as revenue and profitability. Our past financial performance demonstrates, and we fully expect, that meeting these metrics will over time translate into increased shareholder value. For equity-based
awards, our share price ultimately should reflect whether we have executed this strategy successfully and the three-year vesting schedule for equity grants ensures our officers maintain a long-term perspective. A look at our historical stock prices
over the last 10&nbsp;years shows a growth rate of 57%, from a stock price of $34.08 on December&nbsp;31, 2007, to $53.44 on December&nbsp;31, 2017, after giving effect to stock splits during this period. This growth demonstrates that the
achievement of the performance goals set over this period resulted in creation of long-term value for shareholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For many of these same reasons, we do not incorporate financial goals over a multi-year period (such as cumulative earnings over three years) into our officer compensation program. Our long-term strategy
emphasizes continued growth through a disciplined approach in acquiring established physician practices in our specialties, and any multi-year goals would necessarily need to reflect assumptions and projections about both the level and type of
acquisitions made during the measurement period. We believe, however, that the multi-year vesting of our equity awards effectively encourages long-term growth and performance. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee believes that this approach is in the best interests of all of
MEDNAX&#146;s constituents. Of course, we will continue to refine our approach as the healthcare landscape continues to evolve.
</FONT></P></div></div><div style="clear:both; height:0px; font-size:0px">&nbsp;</div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g463041g96o06.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents performance shares earned in excess of target due to achievement of performance conditions above target. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents performance shares earned below target due to achievement of performance conditions below target. Performance shares granted in 2016 were
earned at 62.75% of target. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the grant-date fair value of the target equity-based awards for which the underlying measurement period has not yet lapsed. See Note 1 to
the Summary Compensation Table. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">4</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Actual </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">Despite the company&#146;s continued growth, since 2011, Dr.&nbsp;Medel&#146;s salary has been $1,000,000 and his target bonus opportunity has been 150% of salary. His average bonus paid over the last ten
years has been approximately 135% of salary or 90% of target. Dr.&nbsp;Medel&#146;s bonus exceeded 170% of salary in only two out of those 10 years. The updated market analysis conducted during 2017 found that the median peer target bonus for chief
executive officers was 125% of salary. That same analysis found that over the 2011-2016 period, the actual peer CEO bonus was 130% of salary at the median and 176% of salary at the 75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile. In October 2017, Dr.&nbsp;Medel agreed to a three-year extension of his Employment Agreement, with no
changes to his compensation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_48"></A>SECTION III: OVERVIEW OF THE EXECUTIVE COMPENSATION PROGRAM </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_49"></A>The Guiding Principles of Our Pay Philosophy </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has designed our executive compensation program with the following guiding principles in mind: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Quality of Personnel and Competitiveness.</B> We are committed to employing the highest quality executive team in the healthcare services industry.
We expect our executives to be of the highest caliber in terms of business acumen and integrity. We closely analyze and understand compensation for executives at similarly situated companies to help ensure we can effectively compete for and retain
key talent. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Alignment of Interests. </B>We must offer a total executive compensation package that best supports our leadership talent and growth strategies and
focuses executives on financial and operational results. We use a mix of fixed and variable (at-risk) pay to support these objectives, by giving our executives a substantial equity stake in the business and rewarding them for performance that drives
shareholder value over the long term. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compliance with Regulatory Guidelines and Sensible Standards of Corporate Governance. </B>We comply with applicable laws, rules, statutes,
regulations and guidelines and monitor our compensation program on an ongoing basis to ensure it abides by applicable requirements. Specifically, we focus on relevant considerations in the areas of accounting cost, tax impact, cash flow constraints,
risk management and other sensible standards of good corporate governance. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_50"></A>Elements of Pay </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our pay philosophy is supported by the following pay elements in our executive compensation program: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Form</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Purpose</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Base Salary</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash (Fixed)</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provides a competitive level of pay that reflects the
executive&#146;s experience, role and responsibilities and performance</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Annual Bonus</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash (Variable)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rewards executives for achieving income from operations goals in the most recent performance year</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-Term Incentives</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity (Variable)</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provide meaningful incentives for management to execute on
longer-term financial and strategic growth goals that drive shareholder value creation and support the Company&#146;s retention strategy</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_51"></A>Pay Mix </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The charts below show that most of our NEOs&#146; total direct compensation is variable (86% for the CEO and an average of 81% for our
other NEOs) based upon actual awarded and anticipated 2017 compensation: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g463041g06p04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_52"></A>How Pay Decisions Are Made </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee, composed solely of independent Directors, is responsible for making pay decisions for the NEOs. The
Compensation Committee works very closely with its independent consultant, which for 2017 was Willis Towers Watson&nbsp;&amp; Co. (&#147;Willis Towers Watson&#148;), and management to examine pay and performance matters throughout the year. The
Compensation Committee held six meetings over the course of 2017, and took various other actions via unanimous written consent. The Compensation Committee&#146;s written charter can be accessed on the MEDNAX website at <U>www.mednax.com</U>.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The Role of the Compensation Committee and Management </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The primary role of the Compensation Committee is to assist MEDNAX&#146;s Board of Directors in the discharge of the Board&#146;s
responsibilities related to executive compensation matters. The Compensation Committee&#146;s responsibilities include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Evaluating the performance of and setting pay for the CEO and other NEOs; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Supervising and making recommendations to the Board of Directors about changes to the executive compensation program; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Overseeing the annual review of the Company&#146;s incentive compensation elements to determine whether they encourage excessive risk taking, including
discussing the relationship between risk management policies and practices and pay; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Evaluating whether or not to engage, retain, or terminate an outside consulting firm for the review and evaluation of MEDNAX&#146;s executive
compensation program and approving such outside consulting firm&#146;s fees and other retention terms; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conducting an annual self-assessment of the Compensation Committee&#146;s performance. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The CEO does not play any role in the Compensation Committee&#146;s determination of his own pay; however, the Compensation Committee
solicits input from the CEO concerning the performance and compensation of the other NEOs. The CEO bases his recommendations on his assessment of each individual&#146;s performance, tenure and experience in the role, external market pay practices,
retention risk and MEDNAX&#146;s overall pay philosophy. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The Role of Independent Consultants </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee continually reviews executive compensation to ensure that it reflects our pay philosophy and, as necessary,
retains the services of an independent consultant to assist in such review. During 2017, the Compensation Committee retained Willis Towers Watson to provide data and analysis with respect to the compensation paid to our NEOs. The Compensation
Committee has assessed the independence of Willis Towers Watson pursuant to applicable SEC rules, New York Stock Exchange listing standards and its own committee charter and concluded that no conflict of interest exists that would prevent Willis
Towers Watson from independently advising the Compensation Committee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Assessing External Market Practice </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As part of our pay philosophy, our executive compensation program is designed to attract, motivate and retain our executives in an
increasingly competitive and complex talent market. To this end, we regularly evaluate industry-specific and general market compensation practices and trends to ensure that our program features and NEO pay opportunities remain appropriately
competitive. The Compensation Committee considers publicly available data, provided by its independent compensation consultant, for informational purposes when making its pay decisions. However, market data are not the sole determinants of the
Company&#146;s practices or executive pay levels. When determining salaries, target bonus opportunities and annual equity grants for NEOs, the Compensation Committee also considers the performance of the Company and the individual, the nature of an
individual&#146;s role within the Company, internal comparisons to the compensation of other Company officers, tenure with the Company and experience in the officer&#146;s current role. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2016, the Compensation Committee reviewed CEO compensation information from a
group of 16&nbsp;publicly traded healthcare services companies. The companies included in the analysis were recommended by the Committee&#146;s consultant and approved by the Committee. During the fall of 2017, the consultant updated the peer
analysis for the CEO position as well as for the Company&#146;s other NEOs. The companies included in our peer group were as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="30%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Acadia Healthcare Company, Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Envision Healthcare Corporation</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Select Medical Corporation</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Amedisys, Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;HealthSouth
Corporation</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Team Health
Holdings, Inc.**</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;AmSurg Corp.*</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Kindred Healthcare,
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Tenet
Healthcare Corporation</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Brookdale Senior Living Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Laboratory Corporation of
America Holdings</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Universal
Health Services, Inc.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Chemed Corporation</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;LifePoint Hospitals,
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;DaVita Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8194;&#8202;Magellan Health Services,
Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>*</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>AmSurg and Envision Healthcare merged in late 2016. Both companies were included in the 2016 survey, but only the combined company (Envision Healthcare) was included
in the 2017 study. </I></FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>**</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Team Health was taken private in late 2016, and was therefore not included in the 2017 study. </I></FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In determining the peer group for the studies, the Compensation Committee considered a variety of factors including revenue, income from
operations, net income, market capitalization and enterprise value. Based on the advice of its consultant, the Compensation Committee established that top executive pay levels at publicly-traded companies in the healthcare services industry were
more closely correlated to factors other than revenue. As such, the peer group was determined with an objective of placing MEDNAX near the median for both income from operations and enterprise value. Given MEDNAX&#146;s profitability, this meant
that MEDNAX would rank in the lower quartile of its peers in terms of revenue and in the upper quartile of its peers in terms of net income and market capitalization. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">An updated analysis of the remaining peer companies showed that as of year-end 2016, MEDNAX ranked near the peer
25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;percentile in terms of revenue, at the peer
57</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;percentile in terms of operating income, near
the peer 80</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;percentile in terms of net income, near
the peer 60</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;percentile in terms of enterprise value
and near the peer 70</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;percentile in terms of market
capitalization. MEDNAX also ranked between the peer 35</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
and 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;percentiles for three-year growth rates in
revenues, income from operations and net income , and above the peer median for annualized total shareholder return over the past three and five year periods. Data from the updated peer analysis are summarized in the tables below: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Revenue</U></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Income From<BR><U>Operations(1)</U></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net<BR><U>Income(1)</U></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Market<BR><U>Capitalization(2)</U></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Enterprise<BR><U>Value(3)</U></B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>75th Percentile</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$8,283.4</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$964.8</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$291.6</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$7,345.0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$15,147.6</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Median</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$4,239.4</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$445.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$108.7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$3,547.7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$6,955.8</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>25th Percentile</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$3,414.6</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$292.9</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-$10.8</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$2,216.7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$4,473.7</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MEDNAX, Inc.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$3,183.2</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$571.7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$336.3</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$6,472.4</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$8,111.1</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MEDNAX, Inc.</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PERCENTILE RANK</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>21%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>57%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>79%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>71%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>57%</I></B></FONT></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(1)</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Peer companies with an operating loss or net loss in either the base year or the most current year were assumed to rank at the bottom. </I></FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(2)</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Market capitalization calculated as of February 2017. </I></FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(3)</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Enterprise value is equal to market capitalization value plus net debt as reported for year-end 2016. </I></FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><U><FONT STYLE="white-space:nowrap">3-Year&nbsp;Compound&nbsp;Annual&nbsp;Growth&nbsp;
Rates</FONT></U></I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><U>Annualized&nbsp;Total&nbsp;Shareholder</U></I></B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="5" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><U>Return</U></I></B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Revenue</U></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Income&nbsp;From<BR><U>Operations</U></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net<BR><U>Income</U></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>3-year</U></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>5-year</U></B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>75th Percentile</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19.3%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23.9%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.7%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.8%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22.3%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Median</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14.8%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12.2%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.3%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.8%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12.1%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>25th Percentile</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.4%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.6%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-3.4%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-13.6%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.5%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MEDNAX, Inc.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.9%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.1%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.2%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.7%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.1%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MEDNAX, Inc.</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PERCENTILE RANK</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>43%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>36%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>45%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>57%</I></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>54%</I></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee reviews a variety of other areas including key incentive design features,
equity grant programs, historical CEO bonus payout levels, stock ownership policies, Board of Directors compensation and other policies relating to officer and Board member compensation from time to time relative to MEDNAX&#146;s peers. In addition,
the Compensation Committee periodically reviews information relating to NEO compensation practices as developed from companies considered to be MEDNAX peers by proxy advisory firms. However, since some of these advisory firms determine peers based
primarily on comparable revenue, the Compensation Committee has not used information from these companies in evaluating NEO salaries, bonus opportunities and annual equity-based award values. The Compensation Committee believes that information from
the peer group it has selected is more relevant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_53"></A>SECTION IV: THE EXECUTIVE COMPENSATION PROGRAM IN DETAIL
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_54"></A>Base Salary </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee reviews and approves base salary levels at the beginning of each year. Base salary decisions generally reflect the Compensation Committee&#146;s consideration of the external
market practices of our peer group for comparable positions, published survey data, and subjective factors including the individual&#146;s experience, role, responsibilities and performance. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>2017 Base Salary Decisions </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2017 base salaries for the NEOs were as
follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NEO</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017 Base Salary</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger J. Medel, M.D.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$1,000,000</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vivian Lopez-Blanco</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$475,000</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph M. Calabro</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$600,000</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David A. Clark</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$450,000</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dominic J. Andreano</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$350,000</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:54%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_55"></A>Annual Bonuses </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s NEOs participate in an annual bonus program, which is administered under the shareholder-approved
MEDNAX, Inc. Amended and Restated 2008 Incentive Compensation Plan, as amended. The annual bonus is designed to recognize performance achievements primarily focused on growth in our Company&#146;s results of operations during its fiscal year.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee uses guidelines and may apply either positive or negative discretion to adjust the
bonuses based on the actual level of income from operations achieved, as well as other performance goals established for individual NEOs. In addition, the Compensation Committee uses a performance range at the target bonus level to minimize the
variability of potential payouts. The bonus adjustment guidelines established for 2017 were as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Income From Operations:<BR>Performance
Goals</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>%&nbsp;of&nbsp;Target&nbsp;
Bonus<BR>Payout</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than $571,700,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">0%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$571,700,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">25%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$579,300,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">50%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$586,900,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">75%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$603,500,000-619,500,000</FONT></P></TD>

<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">100%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$626,500,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">125%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$633,000,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">150%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$639,500,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">175%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">$646,500,000</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">200%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Income&nbsp;from&nbsp;
operations&nbsp;in&nbsp;2017&nbsp;was&nbsp;$480,076,000</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Actual target bonus payout percentages increase proportionately between each percentage amount based on
the actual income from operations achieved by the Company. </FONT></P>
<p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;
</FONT></P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:43%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="font-size:30px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;background-color:;;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:8px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why We Use Income From Operations </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee uses income from operations as its primary performance measure for annual bonuses and has for
several years. This measure is used to encourage our NEOs to focus on efficiently managing our business and to execute on our acquisition growth strategy. Each year, the goal is set to exceed the prior year&#146;s results; we strive to set financial
targets that are both challenging and realistic. Since this approach was first implemented a decade ago, actual bonus payouts for NEOs have averaged slightly below target, while income from operations growth rates have consistently exceeded those of
our peer group. In the last 10 years, bonus payouts have been less than 100% of the targets four times and have exceeded 120% of the targets twice. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:8px; margin-left:1%;margin-right:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The income from operations goal and maximum bonus award opportunities are also designed to satisfy the
requirements of &#167;162(m) of the Internal Revenue Code. </FONT></P></div></div><div style="clear:both; height:0px; font-size:0px">&nbsp;</div>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2017 Annual Bonus Decisions </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:3%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee establishes each NEO&#146;s maximum annual bonus opportunity as a percentage of base salary in effect at the beginning of the year. The target bonus opportunity for each NEO is
equal to 50% of the NEO&#146;s maximum bonus opportunity. The Committee, consistent with historical practice, established the minimum income from operations goal at a level equal to the income from operations achieved by the Company in the prior
year. By the middle of the second quarter of 2017, it became clear that due to the various financial challenges the Company faced, the minimum income from operations level necessary for Dr.&nbsp;Medel, Mr.&nbsp;Calabro and Ms.&nbsp;Lopez-Blanco to
earn a bonus was unlikely to be achieved. The Compensation Committee considered the adoption of a supplemental bonus program designed to motivate and incentivize the executive team to achieve incrementally higher income from operations in the second
half of 2017. However, the Compensation Committee ultimately decided to maintain the original bonus plan for 2017. The Compensation Committee determined that the Company&#146;s 2017 income from operations corresponded to a payment of 0% of the
target bonus payment under the bonus guidelines for each of Dr.&nbsp;Medel, Ms.&nbsp;Lopez-Blanco and Mr.&nbsp;Calabro. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For
2017, the Chief Executive Officer and the President and Chief Operating Officer recommended and the Compensation Committee approved, the annual bonuses for Mr.&nbsp;Clark and Mr.&nbsp;Andreano that were consistent with those being paid to
bonus-eligible employees, other than Dr.&nbsp;Medel, Ms.&nbsp;Lopez-Blanco and Mr.&nbsp;Calabro. The recommendations considered the financial performance results of the Company in 2017, the operating performance of the Company&#146;s MEDNAX National
Medical Group (in the case of Mr.&nbsp;Clark), the performance of the Company&#146;s General Counsel&#146;s office and legal function (in the case of Mr.&nbsp;Andreano), and the individual contributions of Mr.&nbsp;Clark and Mr.&nbsp;Andreano to the
Company in 2017. The recommendations also took into account the updated market compensation references for Messrs. Clark&#146;s and Andreano&#146;s positions, noting that Messrs. Clark and Andreano&#146;s base salaries were below the market median.
In considering these factors, the Chief Executive Officer and the President and Chief Operating Officer recommended to the Compensation Committee that Mr.&nbsp;Clark and Mr.&nbsp;Andreano should each receive 75% of his target bonus opportunity,
similar </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
to other bonus-eligible employees who earned 75% of their target bonuses based on their individual, departmental and Company performance. The Compensation Committee agreed with the
recommendations and approved the bonuses for Messrs. Clark and Andreano. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="middle" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;Maximum&nbsp;Annual&nbsp;&nbsp;<BR>Bonus as a %
of <BR>Base Salary</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Target Annual<BR>&nbsp;&nbsp;Bonus as a % of&nbsp;&nbsp;<BR>Base Salary</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Actual Annual
<BR>&nbsp;&nbsp;Bonus&nbsp;as&nbsp;a&nbsp;%&nbsp;of&nbsp;&nbsp;&nbsp;<BR>&nbsp;&nbsp;Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Actual Bonus <BR>($)</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr. Medel</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">300%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">150%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">0%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms. Lopez-Blanco</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">200%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">100%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">0%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Calabro</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">200%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">100%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">0%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Clark</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">200%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">100%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">75%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">$337,500</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Andreano</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">150%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">75%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">75%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">$196,875</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_56"></A>Equity-Based Awards </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I><A NAME="toc463041_57"></A>2017 Equity-Based Awards </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee approved the June&nbsp;1, 2017 equity-based awards outlined below in May 2017. These equity-based awards were divided equally into performance share awards and time-based restricted stock awards for each of Dr.&nbsp;Medel,
Ms.&nbsp;Lopez-Blanco and Mr.&nbsp;Calabro. The equity grant values for Dr.&nbsp;Medel, Ms.&nbsp;Lopez-Blanco and Mr.&nbsp;Calabro remained the same in 2017 as they were in 2016. The actual number of shares earned from the June&nbsp;1, 2017 award of
restricted stock and performance shares granted to Dr.&nbsp;Medel, Ms.&nbsp;Lopez-Blanco and Mr.&nbsp;Calabro has not been determined as of the date of this Proxy Statement because the performance period for such awards will initially be measured
over a one-year period from April&nbsp;1, 2017 through March&nbsp;31, 2018. Messrs. Clark and Andreano&#146;s equity-based awards granted in 2017 are subject only to the 162(m) goal and time-based vesting requirements. In 2018, Messrs. Clark and
Andreano were awarded performance shares subject to the same performance metrics as our other NEOs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">50% of the equity-based
award is granted in performance shares that: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Use two metrics:</U></B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px" align="left"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares are earned based on
the achievement of net revenue <I>and</I> EBITDA goals, both of which we believe drive shareholder value creation. In particular, EBITDA is a key driver of market capitalization value and EBITDA is linked to shareholder returns.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Have rigorous performance goals:</U></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px" align="left"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">A target award for each metric will be earned if net revenue or EBITDA growth equals or exceeds 2% and
-12.9%, respectively. NEOs may receive an above-target award for each metric only if growth in net revenue or EBITDA exceeds 11% and 2.5%, respectively. These goals vary year-to-year, based on various factors that may have a direct impact on the
results for the performance period, including the effects of volume and reimbursement-related factors and acquisition-related activities.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The approach described in the table above reflects the Compensation Committee&#146;s desire to set
rigorous performance goals in a highly volatile and uncertain environment, while also rewarding NEOs when the Company achieves these goals and delivers sustained results for our shareholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In setting financial performance goals for these performance share awards, the Compensation Committee received recommendations from
management based on the Company&#146;s strategic plan for the performance measurement period. The Compensation Committee, working with its independent compensation consultant and Company management, evaluated the impact of various drivers on revenue
and EBITDA in determining the 2017 grants. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2017 performance goals were set to appropriately reflect specific factors that were
expected to have a direct impact on the results for this performance period. The growth rate targets for the 2017 performance period differ from the Company&#146;s historical 5-year average growth rates because of volatility in the various drivers
that impact results from year to year. Other drivers considered in setting the performance goals included, but were not necessarily limited to: acquisition-related activities, including size, type, timing and volume of acquisitions, the continued
diversification of our services, same-unit volume growth, expense-related initiatives and reimbursement-related factors, including payor mix. At the time the 2017 performance goals were being developed, the financial challenges faced by the Company
were becoming apparent, but their full impact on future net revenue and EBITDA results was still highly uncertain. The Compensation Committee established net revenue and EBITDA goals that reflected the financial challenges and uncertain operating
environment, particularly with regard to year-over-year changes in EBITDA, that the Compensation Committee felt were still rigorous yet achievable. At the time the goals were approved, the Company&#146;s internal forecast for the Performance Share
measurement period projected a significant decline in EBITDA and modest growth in net revenue. The Compensation Committee developed performance goals in light of these forecasts, noting that it would be extremely unlikely that an above-target award
would be earned based on the financial forecasts at the time of the goal. Consideration was also given to those factors that impacted previous year results (positively or negatively) but were not anticipated to impact 2017 results. The Compensation
Committee further elected to eliminate a retesting feature of the equity program that allowed an additional opportunity to earn performance shares if the performance criteria were not met during the initial performance period. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As the Company continues to grow, the base on which performance goals are set will continue to increase, and it will become increasingly
challenging to maintain historical growth rates for both revenue and EBITDA. This factor was also taken into account when setting growth rate targets for the 2017 performance period. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee believes the above approach used to establish financial performance goals for performance share awards results in goals
that are challenging yet realistic and achievable, adequately rigorous and effective in continuing to motivate the executive team to drive the strong shareholder returns historically generated by the Company. Accordingly, the Committee believes the
performance shares awarded appropriately align Company performance with executive compensation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While this discussion of 2017
equity awards relates to growth targets for the 2017 performance period, we believe our approach to granting performance shares also creates long-term alignment, given that the value of the award realized by the NEOs will depend on the value of our
stock when the shares vest over a multi-year period. As a result, we believe our NEOs are incentivized not only to execute the Company&#146;s growth strategy but also to maintain discipline in its acquisition-related activities and processes in
order to generate sustainable longer-term growth and increased shareholder value. We believe our approach also addresses our critical need to retain the highest-caliber executives in our industry &#151; especially as the challenges in the healthcare
sector grow increasingly more complex and competition for executive talent in the healthcare sector increases. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The table below outlines the 2017 equity award program: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Equity Component</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="11" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How It Works</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:0.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Performance Share Awards
(50%)</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:0.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Purpose:</I> To
have the percentage of shares earned vary with Company performance achievement compared to pre-established goals</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="11"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;50% of the performance share award is tied to net revenue
results and 50% is tied to EBITDA results; results for each metric are considered separately.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;Performance will initially be measured over a one-year period from April&nbsp;1, 2017 through
March 31, 2018.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;If shares are earned during this initial measurement period, they will vest over the first
three anniversaries of the grant date (June 1, 2018, 2019 and 2020) subject to continued employment.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;Shares earned may vary from 0% to 150% of target based on growth rates of net revenue and
EBITDA during the initial measurement period:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Net Revenue Growth Rate Achieved</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares Earned</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>EBITDA Growth Rate Achieved</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-3.0%&nbsp;or&nbsp;Below</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">0%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Below&nbsp;
-20.0%</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-3.0</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">25%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">-20.0%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-3.0%&nbsp;to&nbsp;1.99%</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">See Footnote (1) below</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">-20.0%&nbsp;to&nbsp;
-12.901%</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2% to 11%</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">100%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">-12.9 to 2.5%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.01%&nbsp;to&nbsp;15%</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">See Footnote (1) below</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.501%&nbsp;to&nbsp;7.5%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Over 15%</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">150%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Over 7.5%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:0.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1) <I>Actual percentage
of shares earned will be determined by linear interpolation based on the actual growth rate achieved. For example, for each 1% of net revenue growth achieved between -3.0% and 1.99%, 15% of the performance shares would be earned for that metric, and
for each 1% of net revenue growth achieved between 11.01% and 15%, 12.5% of the performance shares would be earned. In each case, any earned performance shares are subject to additional time-based vesting.</I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;Any shares not earned by March&nbsp;31, 2018 will be forfeited. The
&#147;retesting&#148; feature of the equity program that allowed an additional opportunity to earn performance shares if the performance criteria were not met during the initial performance period was eliminated for the 2017 performance share
awards.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:0.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Restricted Stock Awards (50%)</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:0.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Purpose:</I><B> </B>To encourage
the retention of executives, while providing a continuing incentive to increase shareholder value since the realized value of the award will depend on the Company&#146;s share price at the times an award vests<B></B></FONT></P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;Vesting will be contingent upon the Company achieving a performance goal established at the
time of the grant to preserve tax deductibility under &#167;162(m) of the Internal Revenue Code consisting of EBITDA for the 12&nbsp;months ended March&nbsp;31, 2018 of not less than $400 million. Once the performance goal is satisfied, shares will
vest at the rate of one-third per year beginning on the first anniversary of the grant date.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;If the performance goal is satisfied, shares will vest over the first three anniversaries of
the grant date (June 1, 2018, 2019 and 2020) subject to continued employment</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#149;&#8195;&#8202;If the performance goal is not achieved by March&nbsp;31, 2018, all shares will be forfeited.</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Actual Performance and Shares Earned in 2017 for 2016 Performance Share Awards
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the period from April&nbsp;1, 2016 to March&nbsp;31, 2017, the Company&#146;s net revenue and EBITDA, the metrics
on which the 2016 performance share awards were measured, grew by 13.1%, in the case of net revenue and 2%, in the case of EBITDA. In accordance with the pre-established target growth rates of 8% to 14% for each of net revenue and EBITDA, our NEOs
earned 100% and 25.5% of their target performance share awards for each metric, respectively, and 62.75% of their target performance share awards overall. The shares earned vest over the first three anniversaries of the grant date, subject to
continued employment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Restricted Stock Unit Awards </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Based on the results of the updated NEO market analysis conducted in 2017, in December 2017 the Compensation Committee made supplemental grants to Messrs. Clark and Andreano of 14,741 and 9,828
performance-based restricted stock units (&#147;RSUs&#148;) respectively. These grants were designed to ensure that the total compensation of Messrs. Clark and Andreano was competitive with market references, particularly after the market analysis
completed in the fall of 2017 indicated that the annual equity grants made in June 2017 to Messrs. Clark and Andreano were below the market median for each. The RSUs will vest on March&nbsp;1, 2020 if the Company achieves consolidated EBITDA for the
twelve months ended December&nbsp;31, 2018 equal to or exceeding $440,000,000, and is subject to each executive&#146;s continued employment. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_58"></A>Other Practices, Policies&nbsp;&amp; Guidelines </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><A NAME="toc463041_59"></A>Equity Grant Practices </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee determines the effective date of annual equity-based awards without regard to current or anticipated stock price levels. Although usually made around mid-year, the Compensation
Committee may also make, and in the past has made, grants during the course of the year, primarily for new hires, promotions, to retain valued employees or to reward exceptional performance. These grants may be subject to performance conditions
and/or time-based vesting, and are issued on the date of grant approval or upon a date certain following the grant approval date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We follow equity grant procedures designed to promote the proper authorization, documentation and accounting for all equity grants. Pursuant to these procedures the Compensation Committee or the Board of
Directors must formally approve all equity awards during an in person or telephonic meeting or by the unanimous written consent executed by all members of the Compensation Committee or the Board of Directors, as the case may be, it being understood
that no equity award granted pursuant to any such written consent may have an effective date earlier than the date that all executed counterparts of such unanimous written consent are delivered to the General Counsel of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The grant-date fair value of our equity-based awards will be the closing sales price for a share of our common stock as reported on the
New York Stock Exchange on the effective date of the grant as approved by the Compensation Committee or the Board of Directors, which date may not be prior to either the date such grant was approved or the commencement date of employment of the
employee to whom the equity award is being made. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our &#147;insiders&#148; can only buy or sell Company stock in accordance
with our Insider Trading Policy, and our employees generally can only buy or sell Company stock in accordance with our Policy Statement on Inside Information and Insider Trading for All Employees. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEOs are allowed to vote performance shares and restricted stock as a shareholder based on the number of shares held under restriction.
Any dividends declared with respect to any performance share or restricted stock awards would be held until the awards vest, at which time the dividends would be paid to the NEOs. If performance shares or restricted stock are forfeited, the
NEO&#146;s rights to receive the dividends declared with respect to those shares would be forfeited as well. At present, the Company does not pay dividends and it has no current intention to do so in the future. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><A NAME="toc463041_60"></A>Clawback Policy </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has adopted a &#147;clawback policy&#148; that permits the Company to seek to recover certain amounts of incentive
compensation, including both cash and equity, awarded to any executive officer (as defined in the Exchange Act ) on or after January&nbsp;1, 2014 if payment of such compensation was based on the achievement of financial results that were
subsequently the subject of a restatement of our financial statements due to misconduct, and if the executive officer engaged in improper conduct that materially contributed to the need for restatement, and a lower amount of incentive compensation
would have been earned based on the restated financial results. </FONT></P> <P STYLE="margin-top:14px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><A NAME="toc463041_61"></A>Stock Ownership and Retention
Policy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee believes that the Company&#146;s Board of Directors and NEOs should maintain a material
personal financial stake in the Company through the ownership of shares of the Company&#146;s common stock to promote a long-term perspective in managing the enterprise and to align shareholder, director and executive interests. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of our NEOs are required to own shares of MEDNAX common stock with a value of not less than a specified multiple of his or her base
salary. The policy also requires NEOs to retain 50% of net after-tax shares acquired during the year upon vesting (or exercise of stock options) unless his or her ownership level was satisfied as of the beginning of the year. These multiples were
determined in accordance with current market practice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below shows the multiple of base salary ownership
requirements and actual ownership levels as of December&nbsp;31, 2017: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" NOWRAP ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ownership<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;Requirement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ownership&nbsp;Level&nbsp;as&nbsp;of&nbsp;
December&nbsp;31,&nbsp;2017</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Medel</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">6x&nbsp;base&nbsp;salary</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">64.2x base salary</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Calabro</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">4x base salary</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">19.8x base salary</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Ms.&nbsp;Lopez-Blanco</FONT></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">2x base salary</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.5x base salary</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Clark</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">2x base salary</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.9x base salary</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Andreano</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">2x base salary</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.0x base salary</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As the table above reflects, our NEOs hold a significant investment in MEDNAX, which is a strong
reflection of our culture and aligns with our compensation philosophy. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares that count toward the ownership requirement are
as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Owned outright by the NEO or Director, or by spouse or dependent children; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Held in trust for economic benefit of the NEO or Director, or spouse or dependent children; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Held in the MEDNAX 401(k) plan or other Company-sponsored benefit plan; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Restricted shares/units for which the underlying performance conditions have been met and only remain subject to time-based vesting requirements or any
restricted shares/units only subject to time-based vesting requirements or the achievement of performance goals established at the time of the grant solely to preserve tax deductibility under Section&nbsp;162(m) of the Internal Revenue Code.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee will evaluate NEO ownership levels annually and will review this policy from
time to time and, following consultation with the Board of Directors, make modifications as necessary or appropriate. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><A NAME="toc463041_62"></A>Anti-Hedging and Anti-Pledging Policy </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All MEDNAX directors, management, financial and other insiders are prohibited from engaging in transactions in MEDNAX securities or
derivatives of MEDNAX securities that might be considered hedging, such as selling short or buying or selling options. In addition, it is against the policy for such persons to hold securities in margin accounts or pledge MEDNAX securities as
collateral for a loan, unless such person clearly demonstrates the financial capacity to repay the loan without resort to the pledged securities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I><A NAME="toc463041_63"></A>Retirement and Deferred Compensation Plans </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
maintain a Thrift and Profit Sharing Plan (the &#147;401(k) Plan&#148;), which is a 401(k) plan, to enable eligible employees to save for retirement through a tax-advantaged combination of elective employee contributions and our discretionary
matching contributions, and provide employees the opportunity to directly manage their retirement plan assets through a variety of investment options. The 401(k) Plan allows eligible employees to elect to contribute from 1% to 60% of their eligible
compensation to an investment trust on a pre-tax and/or Roth after-tax basis, up to the maximum dollar amounts permitted by law. The 401(k) Plan also offers employees the option to voluntarily contribute additional funds on a non-deductible
after-tax basis subject to certain limits. In 2017, the maximum employee pre-tax and/or Roth elective contribution to the 401(k) Plan was $18,000, plus an additional $6,000 for employees who were at least 50 years old in 2017. Eligible compensation
generally means all wages, salaries and fees for services from the Company, up to a maximum specified amount permitted by law. Matching contributions under the 401(k) Plan are discretionary. For 2017, the Company matched 100% of the first 4% of
eligible compensation that each eligible participant contributed to the 401(k) Plan on his or her behalf. The portion of an employee&#146;s account under the 401(k) Plan that is attributable to matching contributions vests as follows: 30% after one
year of service, 60% after two years of service, and 100% after three years of service. However, regardless of the number of years of service, an employee is fully vested in our matching contributions (and the earnings thereon) if the employee
retires at age 65 or later, or terminates employment by reason of death or total and permanent disability. The 401(k) Plan provides for a variety of different investment options, in which the employee&#146;s and the Company&#146;s contributions are
invested. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although the Company maintains a non-qualified deferred compensation plan, none of the NEOs participate in that
Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts of the Company&#146;s matching contributions under the 401(k) Plan for 2017 for each of the NEOs are
included in the &#147;All Other Compensation&#148; column of the Summary Compensation Table. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><A NAME="toc463041_64"></A>Benefits and Perquisites </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We provide our NEOs with certain benefits designed to protect them and their immediate families in the event of illness, disability, or death. We believe it is necessary to provide these benefits in order
for us to be successful in attracting and retaining executives in a competitive marketplace, and to provide financial security in these circumstances. NEOs are eligible for health and welfare benefits available to similarly situated eligible Company
employees during active employment under the same terms and conditions. These benefits include medical, dental, vision, short-term and long-term disability and group-term life insurance coverage. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of their Employment Agreements, each of the NEOs are entitled to 38 days paid time off each year for vacation,
illness, injury, personal days and other similar purposes in accordance with our policies in effect from time to time. Any paid time off not used during a calendar year may be carried over to the next year to the extent permitted under those
policies. Dr.&nbsp;Medel and Mr.&nbsp;Calabro each are entitled under their Employment Agreements to utilize, for personal travel, the aircraft that the Company leases. Dr.&nbsp;Medel&#146;s personal use of the aircraft may not exceed 95 hours of
flight in any calendar year and Mr.&nbsp;Calabro&#146;s personal use of the aircraft may not exceed 50 hours of flight in any calendar year without the consent of the Compensation Committee. The incremental cost to the Company of these benefits for
Dr.&nbsp;Medel and Mr.&nbsp;Calabro is included in the &#147;All Other Compensation&#148; column of the Summary Compensation Table. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has reviewed our perquisites expenditures, and believes they
continue to be an important element of the overall compensation package to retain current officers, and in fact command a higher perceived value than the actual cost. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I><A NAME="toc463041_65"></A>Termination of Employment and Change in Control Agreements </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As described in greater detail below, the Employment Agreements between the Company and each of the NEOs provide for the payment of certain compensation and benefits in the event of the termination of an
executive&#146;s employment, the amount of which varies depending upon the reason for such termination. The Compensation Committee has reviewed the essential terms of these termination provisions, and believes they are reasonable, appropriate, and
generally consistent with market practice. Those provisions include a reimbursement by the Company to Mr.&nbsp;Calabro of any excise tax imposed upon the executive pursuant to Section&nbsp;4999 of the Code with respect to any &#147;excess parachute
payments,&#148; as that term is defined in Section&nbsp;280G of the Code, that the executive receives as a result of a Change in Control. In the case of Dr.&nbsp;Medel, his current Employment Agreement provides that, if any amount payable to
Dr.&nbsp;Medel in connection with a Change in Control would be subject to excise tax under Section&nbsp;4999 of the Code, then the Company will reduce the payment to an amount equal to the largest portion of such payment that would result in no
portion of such payment being subject to excise tax (unless such reduction would result in Dr.&nbsp;Medel receiving, on an after tax basis, an amount lower than the unreduced payment after taking into account all applicable federal, state and local
employment taxes, income taxes and excise taxes, in which case the payment amount would not be reduced). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In certain
situations pursuant to the terms of the award agreement or an executive&#146;s Employment Agreement, the service requirement may be waived and vesting accelerated. However, in no situations except those involving a change-in-control of MEDNAX will
any shares vest unless the performance goal has first been achieved. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additionally, any unvested restricted stock is generally
forfeited upon termination of the employment of the NEOs. The Employment Agreements with our NEOs provide however, that their restricted stock may vest or continue to vest after termination of employment in certain circumstances. In the event of
termination of Dr.&nbsp;Medel and Mr.&nbsp;Calabro by the Company without Cause (as defined in his Employment Agreement) or due to the executive&#146;s Disability (as defined in his Employment Agreement) or by the executive for Good Reason (as
defined in his Employment Agreement), due to the executive&#146;s health becoming impaired to any extent that makes the continued performance of his duties hazardous to the executive&#146;s physical or mental health or life (&#147;Poor Health&#148;)
or due to death, all restricted stock granted prior to termination of employment will continue to vest until fully vested. Furthermore, in the event of a Change in Control (as defined in his Employment Agreement), for Dr.&nbsp;Medel and
Mr.&nbsp;Calabro, all unvested restricted stock will automatically vest. In the event that Ms.&nbsp;Lopez-Blanco&#146;s or Messrs. Clark or Andreano&#146;s employment is terminated due to Disability or death, all unvested restricted stock granted to
her or him by the Company will continue to vest until fully vested following the termination of her or his employment. In the event that, at any time following a Change in Control (as defined in her or his Employment Agreement),
Ms.&nbsp;Lopez-Blanco or Messrs. Clark and Andreano are terminated by the Company without Cause (as defined in her or his Employment Agreement) or by the executive for Good Reason (as defined in her or his Employment Agreement), provided that
termination by the executive for Good Reason related to a diminution in duties following a Change in Control must occur within the 24-month period of a Change in Control, any unvested restricted stock will automatically vest. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_66"></A>Summary Compensation Table </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth the 2017, 2016 and 2015 compensation for our principal executive officer, principal financial officer, and
our other NEOs for the time they were deemed to be NEOs. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity<BR>Incentive Plan<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Roger J. Medel, M.D.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1"></FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2017</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,000,000</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,000,000</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,000,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,150,000</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,150,035</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,150,045</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">444,000</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,687,500</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">215,508</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">230,750</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">172,868</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,365,508</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,824,785</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,010,413</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Vivian Lopez-Blanco.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Chief Financial Officer and Treasurer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1"></FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2017</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">475,000</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">454,167</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">425,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,300,029</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,300,037</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,150,040</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">140,600</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">478,125</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,088</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,301</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,816</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,786,117</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,908,105</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,065,981</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Joseph M. Calabro</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">President and Chief Operating Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1"></FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2017</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2015</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">600,000</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">600,000</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">600,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,750,025</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,750,056</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,750,057</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">177,600</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">675,000</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">90,766</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">142,749</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">60,517</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">$</FONT></P></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,440,791</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,670,405</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,085,574</FONT></P></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">David A. Clark</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">President, MEDNAX National Medical</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">450,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,600,034</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">337,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,266</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,405,800</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dominic J. Andreano</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Senior Vice President, General Counsel and</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Secretary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">350,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,000,085</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">196,875</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,088</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,558,048</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock awards consist of performance-based restricted stock awards, time-based restricted stock awards and time-based restricted stock unit awards. The amounts in this
column reflect the grant-date fair value of the awards, calculated in accordance with the accounting guidance for equity-based compensation, but excluding the impact of estimated forfeitures. The amounts included for any performance-based restricted
stock awards are calculated based on the most probable outcome of the performance conditions for such awards on the grant date. See the Grants of Plan-Based Awards in 2017 table for information on restricted stock awards granted in 2017. For
information regarding the assumptions made in calculating the amounts reflected in this column, see Note 13, &#147;Stock Incentive Plans and Stock Purchase Plans,&#148; to our Consolidated Financial Statements included in our 2017 Annual Report to
Shareholders. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The salary amount provided represents actual paid salary for 2016. Ms.&nbsp;Lopez-Blanco received an increase in base salary effective June&nbsp;1, 2016.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reflects incremental costs in 2017, 2016 and 2015 of $204,578, $217,870, and $159,863, respectively, for Dr.&nbsp;Medel&#146;s personal use of an aircraft, which MEDNAX
leases, in accordance with his Employment Agreement, additional compensation in 2017, 2016 and 2015 of $10,800, $10,600 and $10,600, respectively, for 401(k) thrift and profit sharing matching contributions, and costs incurred by MEDNAX of $130,
$141, and $156, respectively, for term life insurance coverage. Also includes costs incurred by MEDNAX in 2016 and 2015 for spousal travel to and entertainment (recreational activities) at MEDNAX&#146;s annual board retreat which do not exceed the
greater of $25,000 or 10% of the total amount of perquisites and personal benefits received in either year. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reflects additional compensation of $10,800, $10,600 and $10,600, for 401(k) thrift and profit sharing matching contributions in 2017, 2016 and 2015, respectively, and
other compensation of $288, $260, and $240, respectively, for term life insurance coverage in 2017, 2016 and 2015. Also includes costs incurred by MEDNAX in 2016 and 2015 for spousal travel to and entertainment (recreational activities) at
MEDNAX&#146;s annual board retreat which does not exceed the greater of $25,000 or 10% of the total amount of perquisites and personal benefits received in either year. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reflects incremental costs in 2017, 2016 and 2015 of $79,678, $129,726 and $49,677, respectively, for Mr.&nbsp;Calabro&#146;s personal use of an aircraft, which MEDNAX
leases, in accordance with his Employment Agreement, additional compensation in 2017, 2016 and 2015 of $10,800, $10,600 and $10,600, respectively, for 401(k) thrift and profit sharing matching contributions, and costs incurred by MEDNAX in 2017,
2016 and 2015 of $288, $260 and $240, respectively, for term life insurance coverage. Also includes costs incurred by MEDNAX in 2016 for guest travel to and entertainment (recreational activities) at MEDNAX&#146;s annual board retreat which does not
exceed the greater of $25,000 or 10% of the total amount of perquisites and personal benefits received in that year. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reflects additional compensation of $10,800 for 401(k) thrift and profit sharing matching contributions, costs incurred by MEDNAX of $288 for term life insurance
coverage and incremental costs of $7,178 for Mr.&nbsp;Clark&#146;s share of personal travel on an aircraft, which MEDNAX leases which use of such aircraft occurred during travel with either Dr.&nbsp;Medel or Mr.&nbsp;Calabro under the terms of each
executive&#146;s Employment Agreement. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reflects additional compensation of $10,800 for 401(k) thrift and profit sharing matching contributions and costs incurred by MEDNAX of $288 for term life insurance
coverage. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_67"></A>Grants of Plan-Based Awards in 2017 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Future&nbsp;
Payouts</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Under&nbsp;Non-Equity&nbsp;Incentive&nbsp;Plan</FONT><BR>Awards(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Future&nbsp;Payouts&nbsp;Under</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Equity Incentive Plan Awards<BR>(Shares)(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other&nbsp;Stock<BR>Awards<BR>(Shares)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant-<BR>Date Fair<BR>Value of<BR>Stock <BR>Awards(5)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Roger J. Medel, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual cash incentive</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,500,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Performance share award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">55,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">82,899</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,075,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">55,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,075,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Vivian Lopez-Blanco</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual cash incentive</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">475,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">950,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Performance share award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,682</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,523</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">650,014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,683</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">650,015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Joseph M. Calabro</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual cash incentive</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">600,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Performance share award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">33,698</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,547</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,875,012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">33,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,875,013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">David A. Clark</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual cash incentive</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">450,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">900,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,277</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">850,012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock unit award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/7/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,741</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">750,022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dominic J. Andreano</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual cash incentive</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">262,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,987</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">500,037</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock units award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/7/17</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,828</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">500,049</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These columns reflect the range of payouts for 2017 annual cash bonuses under the MEDNAX, Inc. Amended and Restated 2008 Incentive Compensation Plan, as amended (the
&#147;Plan&#148;). Amounts actually earned in 2017 are reported as Non-Equity Incentive Plan Compensation in the Summary Compensation Table. For a more detailed description of the annual cash awards, see the section entitled &#147;Annual
Bonuses&#148; in CD&amp;A. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents performance share awards granted under the Plan, for which shares earned may vary from 0% to 150% of target based on growth rates of net revenue and EBITDA
during the initial measurement period. Award amounts are divided equally into performance share awards (50%)&nbsp;and time-based restricted stock (50%). The performance share awards vest as follows: 50% of the performance share award is tied to the
Company&#146;s revenue results and 50% of the performance share award is tied to the Company&#146;s EBITDA results; results for each metric are considered separately. Performance will initially be measured over a one-year period from April&nbsp;1,
2017 through March&nbsp;31, 2018. If shares are earned during this initial measurement period, they will vest in three equal increments over the first three anniversaries of the grant date (June 1, 2018,&nbsp;June&nbsp;1, 2019 and June&nbsp;1, 2020)
subject to continued employment. Shares earned may vary from 0% to 150% of target based on growth rates of net revenue and EBITDA during the initial measurement period. Any shares not earned by March&nbsp;31, 2018 will be forfeited. For a more
detailed description of our performance share awards and equity-based award granting policies, see the section entitled &#147;2017 Equity-Based Awards&#148; in CD&amp;A. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents restricted stock awards granted under the Plan, for which the vesting is contingent upon the Company achieving a performance goal established at the time of
the grant to preserve tax deductibility under &#167;162(m) of the Internal Revenue Code. The restricted stock awards vest as follows: if the Company&#146;s EBITDA for the twelve months ended March&nbsp;31, 2018, equals or exceeds $400 million, then
the restricted stock will vest in three equal increments over the first three anniversaries of the grant date (June&nbsp;1, 2018, June&nbsp;1, 2019 and June&nbsp;1, 2020) subject to continued employment. If, however, EBITDA does not equal or exceed
$400 million for that period, then the restricted stock shall terminate and become null and void. For a more detailed description of our restricted stock and equity-based award granting policies, see the section entitled &#147;2017 Equity-Based
Awards&#148; in CD&amp;A. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents restricted stock unit awards granted under the Plan, for which the vesting is contingent upon the Company achieving a performance goal established at the
time of the grant to preserve tax deductibility under &#167;162(m) of the Internal Revenue Code. The restricted stock unit awards shall vest as follows: if achievement of consolidated Company EBITDA, a non-GAAP measure, for the twelve months ending
December&nbsp;31, 2018 equals or exceeds $440 million, then the restricted stock units will vest on March&nbsp;1, 2020. In the event the performance period terminates due to a Change in Control (as defined in the Plan), the Compensation Committee
may evaluate satisfaction of the performance criteria on a pro forma basis. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The grant-date fair value of the performance share awards, restricted stock awards and restricted stock unit awards is determined pursuant to the accounting guidance
for equity-based compensation and represents the total amount that will be expensed in our financial statements over the relevant vesting periods. For information regarding the assumptions made in calculating the amounts reflected in this column,
see Note 13, &#147;Stock Incentive Plans and Stock Purchase Plans,&#148; to our Consolidated Financial Statements included in our 2017 Annual Report to Shareholders. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_68"></A>Outstanding Equity Awards at 2017 Fiscal Year-End </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Options<BR>Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity&nbsp;Incentive<BR>Plan Awards:<BR>Number of<BR>Unearned<BR>Shares,&nbsp;Units&nbsp;or<BR>Other
Rights<BR>That Have Not<BR>Yet Vested</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity&nbsp;Incentive<BR>Plan&nbsp;Awards:<BR>Market
or<BR>Payout&nbsp;Value&nbsp;of<BR>Unearned<BR>Shares,&nbsp;Units or<BR>Other&nbsp;Rights<BR>That Have&nbsp;Not<BR>Yet Vested(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Roger J. Medel, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">31,082</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,661,022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">49,076</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,622,621</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">110,532</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,906,830</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Vivian Lopez-Blanco</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/27/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,812</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">310,593</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,374</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">554,387</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,365</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,248,626</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Joseph M. Calabro</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,012,848</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,925</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,599,192</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">67,398</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,601,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">David A. Clark</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,205</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">171,275</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,618</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">353,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,277</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">816,403</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,741</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">787,759</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dominic J. Andreano</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27.72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/2/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,374</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">126,867</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,903</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">262,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,987</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">480,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,828</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">525,208</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on a stock price of $53.44, which was the closing price of a share of our common stock on the New&nbsp;York Stock Exchange on December&nbsp;29, 2017 (as
December&nbsp;30 and 31, 2017 were not market trading days). </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These stock options vested in three equal increments on May&nbsp;27, 2010,&nbsp;May&nbsp;27, 2011 and May&nbsp;27, 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These performance share awards and restricted stock awards vest on June&nbsp;1, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These performance share awards and restricted stock awards vest in two equal increments on each of June&nbsp;1, 2018 and June&nbsp;1, 2019. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents performance share awards and restricted stock awards granted under the Plan. Award amounts are divided equally into performance share awards (50%)&nbsp;and
time-based restricted stock (50%). The performance share awards vest as follows: 50% of the performance share award is tied to the Company&#146;s net revenue results and 50% of the performance share award is tied to the Company&#146;s EBITDA
results; results for each metric are considered separately. Performance will initially be measured over a one-year period from April&nbsp;1, 2017 through March&nbsp;31, 2018. Shares earned may vary from 0% to 150% of target based on growth rates of
net revenue and EBITDA during the initial measurement period. If shares are earned during this initial measurement period, they will vest in three equal increments over the first three anniversaries of the grant date (June 1, 2018,&nbsp;June&nbsp;1,
2019 and June&nbsp;1, 2020) subject to continued employment. Any shares not earned by March&nbsp;31, 2018 will be forfeited. The restricted stock awards vest as follows: if the Company&#146;s EBITDA for the twelve months ended March&nbsp;31, 2018
equals or exceeds $400 million, then the restricted stock will vest in three equal increments over the first three anniversaries of the grant date (June 1, 2018,&nbsp;June&nbsp;1, 2019 and June&nbsp;1, 2020) subject to continued employment. If,
however, EBITDA does not equal or exceed $400 million for that period, then the restricted stock shall terminate and become null and void. For a more detailed description of our restricted stock and restricted stock granting policies, see the
section entitled &#147;2017 Equity-Based Awards&#148; in CD&amp;A. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents restricted stock awards granted under the Plan, for which the vesting is contingent upon the Company achieving a performance goal established at the time of
the grant to preserve tax deductibility under &#167;162(m) of the Internal Revenue Code. The restricted stock awards vest as follows: if the Company&#146;s EBITDA for the twelve months ended March&nbsp;31, 2018 equals or exceeds $400 million, then
the restricted stock will vest in three equal increments over the first three anniversaries of the grant date (June&nbsp;1, 2018, June&nbsp;1, 2019 and June&nbsp;1, 2020) subject to continued employment. If, however, EBITDA does not equal or exceed
$400 million for that period, then the restricted stock shall terminate and become null and void. For a more detailed description of our restricted stock and equity-based award granting policies, see the section entitled &#147;2017 Equity-Based
Awards&#148; in CD&amp;A. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents restricted stock unit awards granted under the Plan, for which the vesting is contingent upon the Company achieving a performance goal established at the
time of the grant to preserve tax deductibility under &#167;162(m) of the Internal Revenue Code. The restricted stock unit awards shall vest as follows: the Company&#146;s EBITDA, for the twelve months ended December&nbsp;31, 2018 equals or exceeds
$440 million, then the restricted stock units will vest on March&nbsp;1, 2020. In the event the performance period terminates due to a Change in Control (as defined in the Plan), the Compensation Committee may evaluate satisfaction of the
performance criteria on a pro forma basis. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These stock options vested in three equal increments on June&nbsp;1, 2009,&nbsp;June&nbsp;1, 2010 and June&nbsp;1, 2011. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_69"></A>Options Exercised and Stock Vested in Fiscal Year 2017 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of Shares<BR>Acquired<BR>Upon<BR>Exercise</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value<BR>Realized<BR>Upon<BR>Exercise(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Shares<BR>Acquired&nbsp;on<BR>Vesting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value of<BR>Shares<BR>Realized<BR>Upon<BR>Vesting(3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Roger J. Medel, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">91,193</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,951,780</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Vivian Lopez-Blanco</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">958,504</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Joseph M. Calabro</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">55,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,019,352</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">David A. Clark</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,202</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">553,969</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dominic J. Andreano</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">246,262</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,995</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">379,829</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These columns reflect performance shares and restricted stock previously awarded to the NEO that vested during 2017. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Calculated based on the sales price received by the NEO upon the sale of the shares of MEDNAX common stock acquired upon the exercise of such stock options less the
exercise price of such options. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Calculated based on the closing price of a share of our common stock on the New York Stock Exchange on the vesting date. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_70"></A>Potential Payments Upon Termination or Change in Control </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In August 2011, the Company entered into a new Employment Agreement with Dr.&nbsp;Medel that replaced his previous Employment Agreement
entered into in August 2008. In October 2017, the Company entered into an amendment to Dr.&nbsp;Medel&#146;s Employment Agreement to extend its term until August 2021. In August 2008, the Company entered into an Employment Agreement with
Mr.&nbsp;Calabro. The Company entered into new Employment Agreements with each of Ms.&nbsp;Lopez-Blanco and Messrs. Clark and Andreano, in February 2018 (the &#147;2018 Employment Agreements&#148;). Each of these Employment Agreements provides for
the Company to make certain payments and provide certain benefits to the executive upon termination of employment with the Company. Those provisions are summarized below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Termination by Company for Cause</I>. In the event that an executive&#146;s employment with the Company is terminated by the Company for Cause, then the Company will pay the executive his or her base
salary through the termination date at the rate in effect at the termination date and reimburse the executive for any reasonable business expenses incurred through the date of termination. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The term &#147;Cause&#148; is defined in each of the Employment Agreements for Dr.&nbsp;Medel and Mr.&nbsp;Calabro to mean the
executive&#146;s (i)&nbsp;engagement in (A)&nbsp;willful misconduct resulting in material harm to the Company, or (B)&nbsp;gross negligence; (ii)&nbsp;conviction of, or pleading <I>nolo contendere</I> to, a felony or any other crime involving fraud,
financial misconduct, or misappropriation of the Company&#146;s assets; (iii)&nbsp;willful and continual failure, after written notice, to (A)&nbsp;perform substantially his employment duties consistent with his position and authority, or
(B)&nbsp;follow, consistent with his position, duties, and authorities, the reasonable lawful mandates of his supervisor; or (iv)&nbsp;breach of the requirements of his employment agreement with respect to the Company&#146;s confidential
information. For purposes of this definition, acts or omissions taken by the executive in a good faith belief that they were in the best interests of the Company or if done at the express direction of the Company&#146;s Board of Directors will not
be deemed willful or grossly negligent. In each of the Employment Agreements for <FONT STYLE="white-space:nowrap">Ms.&nbsp;Lopez-Blanco</FONT> and Messrs. Clark and Andreano, the term &#147;Cause&#148; is defined to mean (i)&nbsp;any act or omission
of the executive which is materially contrary to the business interests, reputation or goodwill of the Company; (ii)&nbsp;a material breach by the executive of his or her obligations under the Employment Agreement, which breach is not promptly
remedied upon written notice from the Company; (iii)&nbsp;the executive&#146;s refusal to perform his or her duties as assigned pursuant to the Employment Agreement other than a refusal which is remedied by the executive promptly after receipt of
written notice thereof by the Company; or (iv)&nbsp;the executive&#146;s failure or refusal to comply with a reasonable policy, standard or regulation of the Company in any material respect. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Termination by Executive due to Poor Health or due to Executive&#146;s Death</I>. In the event that an executive terminates his or her
employment because of Poor Health or the executive&#146;s employment terminates because of his or her death, then the Company will pay to the executive (or his or her estate) his or her base salary to the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
termination date, pay the executive a pro rata portion of the bonus that the executive would have received had his or her employment not terminated (as determined in accordance with the
Employment Agreement) and reimburse the executive for any reasonable business expenses incurred through the date of termination. In addition, if the executive terminates his or her employment due to Poor Health, the executive will receive any
disability payments otherwise payable under any plans provided by the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Termination due to Disability</I>. If the
Company terminates the employment of Dr.&nbsp;Medel or Mr.&nbsp;Calabro by reason of his Disability, then the Company will continue to pay Dr.&nbsp;Medel and Mr.&nbsp;Calabro base salary for a period of 12 months after the termination date and the
actual performance bonus, on a pro rata basis, that would have been payable to the executive for the fiscal year if the executive had not been terminated. If the Company terminates the employment of Ms.&nbsp;Lopez-Blanco or Messrs. Clark or Andreano
by reason of his or her Disability, the Company will pay the executive 50% of his or her base salary for a period of six months after the termination date and the actual performance bonus, on a pro rata basis, that would have been payable to the
executive for the fiscal year if he or she had not been terminated. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Termination by Company without Cause or by Executive
for Good Reason or due to Change in Control</I>. If the Company terminates the employment of Dr.&nbsp;Medel or Mr.&nbsp;Calabro without Cause (which requires not less than 90 days&#146; notice), or Mr.&nbsp;Calabro terminates his employment for any
reason within one year after a Change in Control, the Company terminates the employment of Mr.&nbsp;Calabro within 24 months following a Change in Control, or Dr.&nbsp;Medel or Mr.&nbsp;Calabro terminates his employment for Good Reason, then the
Company will (a)&nbsp;pay that executive&#146;s base salary through the termination date plus any reimbursement owed to that executive for any reasonable business expenses incurred through the date of termination, (b)&nbsp;continue to pay the
executive&#146;s base salary for a period of 24 months after the termination date, (c)&nbsp;on the first and second anniversaries of the termination date, pay the executive an amount equal to the greater of his &#147;average annual performance
bonus&#148; or his bonus for the year immediately preceding his or her termination and (d)&nbsp;pay the executive a pro rata portion of the bonus he would have received for the year in which his employment terminates. If the termination is due to a
Change in Control, then the performance bonuses referred to in (c)&nbsp;above would be paid to the executive in a lump sum within 90 days of the termination date. If the Company terminates the employment of Dr.&nbsp;Medel without Cause or
Dr.&nbsp;Medel terminates his employment for Good Reason in either case within 24 months following a Change in Control, the Company will pay his base salary through the termination date plus any reimbursement owed to him for any reasonable business
expenses incurred through the date of termination and continue to pay Dr.&nbsp;Medel&#146;s base salary for 36 months after the termination date and, within 90 days following such termination date, an amount equal to three times the greater of his
&#147;average annual performance bonus&#148; or his bonus for the year immediately preceding his termination. For this purpose, &#147;average annual performance bonus&#148; means the average of the executive&#146;s earned performance bonus as a
percentage of base salary for the three years preceding such termination date, multiplied by the executive&#146;s base salary at the time of termination. If Ms.&nbsp;Lopez-Blanco or Messrs. Clark or Andreano terminates his or her employment for Good
Reason (other than a Change in Control Good Reason, as defined below), then the Company will (a)&nbsp;pay him or her base salary through the termination date plus any reimbursement owed to him or her for any reasonable business expenses incurred
through the date of termination, (b)&nbsp;continue to pay him or her base salary for a period of 12 months (18 months if termination is in connection with a Change in Control) after the termination date, (c)&nbsp;pay him or her a pro rata portion of
the performance bonus he or she would have received for the year in which his or her employment terminates, and (d)&nbsp;pay the executive an amount equal to the greater of his or her &#147;average annual performance bonus&#148; (as defined in his
or her Employment Agreement) or his or her bonus for the year immediately preceding his termination. If the Company terminates the employment of Ms.&nbsp;Lopez-Blanco or Messrs. Clark or Andreano without Cause, then the Company will (a)&nbsp;pay his
or her base salary through the termination date plus any reimbursement owed to him or her for any reasonable business expenses incurred through the date of termination, (b)&nbsp;continue to pay his or her base salary for a period of 18 months after
the termination date, (c)&nbsp;pay him or her a pro rata portion of the performance bonus he or she would have received for the year in which his or her employment terminates, and (d)&nbsp;within 30 days of the first anniversary of the termination
date, pay him or her an amount equal to his or her &#147;average annual performance bonus.&#148; For this purpose, &#147;average annual performance bonus&#148; means (i)&nbsp;the average of the percentage of the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
performance bonus target achieved by the executive for the three full calendar years prior to the termination date. If the termination is due to a Change in Control, then the performance bonuses
referred to in (d)&nbsp;above would be paid to the executive in a lump sum within 90 days of the termination date. In addition, in the case of <FONT STYLE="white-space:nowrap">Ms.&nbsp;Lopez-Blanco</FONT> and Messrs. Clark and Andreano, if, at any
time following a Change in Control, the executive&#146;s employment is terminated by the Company without Cause, or by Executive for Good Reason, any unvested equity will become fully vested and exercisable as of the effective date of such
termination. For purposes of this definition, &#147;Good Reason&#148; will not be deemed to exist unless the executive provides the Company with written notice of the existence of such condition within 90 days after the initial existence of the
condition and the Company fails to remedy the condition within 30 days after its receipt of such notice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Employment
Agreement for each of Dr.&nbsp;Medel and Mr.&nbsp;Calabro defines &#147;Good Reason&#148; to mean (i)&nbsp;a material diminution in the executive&#146;s base salary or performance bonus eligibility; (ii)&nbsp;a material diminution in the
executive&#146;s authority, duties, or responsibilities; (iii)&nbsp;a material diminution in the authority, duties or responsibilities of the supervisor to whom the executive is required to report, including, in the case of the Chief Executive
Officer, a requirement that Dr.&nbsp;Medel report to a corporate officer or employee instead of reporting directly to the Board of Directors of the Company; (iv)&nbsp;a material diminution in the budget over which the executive retains authority;
(v)&nbsp;a material change in the geographic location at which the executive must perform the services under his Employment Agreement; or (vi)&nbsp;any other action or inaction that constitutes a material breach by the Company under his Employment
Agreement. The 2018 Employment Agreements for <FONT STYLE="white-space:nowrap">Ms.&nbsp;Lopez-Blanco</FONT> and Messrs. Clark and Andreano defines &#147;Good Reason&#148; to mean (i)&nbsp;a decrease in the executive&#146;s base salary; (ii)&nbsp;a
decrease in the performance bonus potential utilized by the Company in determining a performance bonus for the executive; (iii)&nbsp;within a two year period after a Change in Control, the executive is either (a)&nbsp;assigned any position, duties,
responsibilities or compensation that is inconsistent with his or her position, duties, responsibilities or compensation prior to such Change in Control, or (b)&nbsp;required to report to any other person other than the President or Chief Executive
Officer of Employer in place just prior to the Change in Control (provided that the executive is not Chief Executive Officer of the Company or its equivalent and reports directly to the Board), or (c)&nbsp;forced to relocate to another location more
than 25 miles from the Company&#146;s location prior to the Change in Control (each of (iii)(a), (b)&nbsp;and (c)&nbsp;a &#147;Change in Control Good Reason&#148;); (iv)&nbsp;the assignment to the executive of any officer position inconsistent with
his or her present position or material diminution in authority, other than any isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of written notice; (v)&nbsp;the
requirement by the Company that the executive be based in any office or location outside of the metropolitan area where the Company&#146;s present corporate offices are located, except for travel reasonably required in the performance of
the&nbsp;executive&#146;s duties; or (vi)&nbsp;any other action or inaction that constitutes a material breach by the Company of the executive&#146;s Employment Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The term &#147;Change in Control&#148; is defined in each executive&#146;s Employment Agreement to mean (i)&nbsp;the acquisition by a person or an entity or a group of persons and entities, directly or
indirectly, of more than 50% of the Company&#146;s common stock in a single transaction or a series of transactions (hereinafter referred to as a &#147;50% Change in Control&#148;); (ii)&nbsp;a merger or other form of corporate reorganization
resulting in an actual or <I>de facto</I> 50% Change in Control; or (iii)&nbsp;the failure of Applicable Directors (as defined below) to constitute a majority of the Company&#146;s Board of Directors during any two (2)&nbsp;consecutive year period
after the date of each of the executive&#146;s Employment Agreement (the &#147;Two-Year Period&#148;). &#147;Applicable Directors&#148; means those individuals who are members of the Company&#146;s Board of Directors at the inception of the Two-Year
Period and any new Director whose election to the Board of Directors or nomination for election to the Board of Directors was approved (prior to any vote thereon by the shareholders) by a vote of at least two-thirds of the Directors then still in
office who either were Directors at the beginning of the Two-Year Period at issue or whose election or nomination for election during such Two-Year Period was previously approved as provided in this sentence. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Termination by Executive</I>. An executive may terminate his or her employment, other than for Good Reason or due to a Change in
Control, upon 90 days&#146; notice to the Company. In such event, the Company will continue to pay the executive his or her base salary through the termination date, and in the case of Dr.&nbsp;Medel and
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">
Mr.&nbsp;Calabro, if in connection with such termination the executive gives sufficient notice and executes a general release of the Company, then the Company will pay the executive a pro rata
portion of the bonus that the executive would have received had his employment not terminated (as determined in accordance with his Employment Agreement). In addition, the Company will reimburse each executive for any reasonable business expenses
incurred through the date of termination. If the Company specifies a termination date for the employment of any of the NEOs that is less than 90 days, as applicable after the Company&#146;s receipt of written notice of such termination from the
executive, then the Company will continue to pay to the executive his or her base salary for a period ending on such
90</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> day. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Employment Transition and Severance Agreement</I>. If the Company so requests within five business days following a termination of the
employment of Dr.&nbsp;Medel or, Mr.&nbsp;Calabro by reason of the executive&#146;s Disability, termination by the Company without Cause, termination by the executive due to Poor Health, or termination by the executive for Good Reason, then the
executive will continue to be employed by the Company on a part-time basis for a period (the &#147;transition period&#148;) to be determined by the Company of up to 90 days, unless extended by mutual agreement. During this transition period, the
executive is required to perform such services as may reasonably be required for the transition to others of matters previously within the executive&#146;s responsibilities. Unless otherwise mutually agreed, the executive will not be required to
serve more than five days per month during the transition period. For services during the transition period, the executive will be compensated at a daily rate equal to his base salary immediately prior to the termination of his employment divided by
365. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Continuation of Group Health Coverage</I>. The Employment Agreement for each of Dr.&nbsp;Medel and Mr.&nbsp;Calabro
also provides for the continuation in any self-insured, group health plan sponsored by the Company as if the executive were still an employee of the Company during any severance period or transition period. For this purpose, &#147;severance
period&#148; means the period after the termination date during which the executive continues to receive base salary payments following the termination of employment as described above. In addition, upon termination of the executive&#146;s
employment for any reason (in the case of Dr.&nbsp;Medel or, in the case of the other executives for any reason other than Cause) and only if the executive and his eligible dependents first irrevocably decline any continuation coverage provided
pursuant to the applicable provisions in the Employee Retirement Income Security Act of 1974, the executive and his eligible dependents will be entitled to elect to continue in any self-insured, group health plan sponsored by the Company as if the
executive were still an employee of the Company (the &#147;Enhanced Coverage&#148;), during a period of five years following the later of the termination date, the end of the severance period or the end of the transition period. In its sole
discretion, the Company may provide healthcare insurance to the executive and his eligible dependents through one or several insurance carriers selected by the Company in lieu of the Enhanced Coverage (the &#147;Alternate Enhanced Coverage&#148;),
provided the coverage is substantially comparable. The executive will pay the full cost of the Enhanced Coverage or the cost of the Alternate Enhanced Coverage, up to the cost of the plan for such period of coverage for similarly situated employees
and covered beneficiaries. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Payments in the Event of a Change in Control</I>. The Employment Agreement for Mr.&nbsp;Calabro
requires the Company to increase or &#147;gross-up&#148; any amounts payable to Mr.&nbsp;Calabro that are contingent upon a Change in Control by an amount that will reimburse the executive, on an after-tax basis, for any excise tax imposed under
Section&nbsp;4999 of the Code, on any amounts that are deemed to be &#147;excess parachute payments,&#148; and for any interest or penalties incurred by an executive with respect to any such excise tax. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vesting of Equity Awards.</I> The Employment Agreement for each of Dr.&nbsp;Medel and Mr.&nbsp;Calabro provides that all unvested
stock options, stock appreciation rights, restricted stock and other stock based awards granted to an executive by the Company will continue to vest until fully vested following the termination of an executive&#146;s employment due to Disability,
termination without Cause, Good Reason, Poor Health or death. In addition, in the event of a Change in Control, for each of Dr.&nbsp;Medel and Mr.&nbsp;Calabro, such awards will automatically vest and, in the case of stock options and stock
appreciation rights, become immediately exercisable. In the event <FONT STYLE="white-space:nowrap">Ms.&nbsp;Lopez-Blanco&#146;s</FONT> or Messrs. Clark or Andreano&#146;s employment is terminated due to Disability or death, all unvested stock
options, stock appreciation rights, restricted stock and other stock based awards granted to him or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
her by the Company will continue to vest until fully vested following the termination of his or her employment. In the event that, at any time following a Change in Control, Ms.&nbsp;Lopez-Blanco
or Messrs. Clark and Andreano are terminated by the Company without Cause or by the executive for Good Reason, provided that termination by the executive for Good Reason related to a diminution in duties following a Change in Control must occur
within the 24-month period following a Change in Control, any unvested stock options, unvested restricted stock, unvested stock appreciation rights and other unvested incentive compensation awards, held by the executive on the termination date will
automatically vest and, in the case of stock options, become immediately exercisable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of Ms.&nbsp;Lopez-Blanco
and Messrs. Clark and Andreano, their 2018 Employment Agreements also provide that unvested equity awards will vest in certain situations following a Change in Control absent a termination of the Executive&#146;s employment unless more favorable
provisions are included in a particular grant. If, prior to the one year anniversary of the effective date of a Change in Control, the employment by the Company or its affiliates or successors of both Dr.&nbsp;Medel and Mr.&nbsp;Calabro is
terminated for any reason, or they both no longer hold the positions they held just prior to the Change in Control (and neither holds the top executive position in the Company), then the unvested equity awards granted to each of
Ms.&nbsp;Lopez-Blanco and Messrs. Clark and Andreano will become fully vested and payable to the executive on the first anniversary of the effective date of the Change in Control; provided, however, that any portion of the unvested equity awards
that is scheduled to become vested and payable pursuant to its terms prior to the first anniversary of such Change in Control will become vested and payable to the executive pursuant to its terms. Further, if, after the one year anniversary of the
effective date of a Change in Control, the employment by the Company or its affiliates or successors of both Dr.&nbsp;Medel and Mr.&nbsp;Calabro is terminated for any reason, or they both no longer hold the positions they held just prior to the
Change in Control (provided that neither holds the top executive position in the Company), then the unvested equity awards granted to each of Ms.&nbsp;Lopez-Blanco and Messrs. Clark and Andreano will become fully vested and payable to the executive
on the one year anniversary of the termination date, or date of the change in position of Roger J. Medel, M.D. or Joseph M. Calabro, whichever termination date or date in change of position is later; provided, however, that any portion of the
unvested equity awards that is scheduled to become vested and payable pursuant to its terms prior to the one year anniversary of such termination date or date of change in position will become vested and payable to the executive pursuant to its
terms. In either case, the vesting of the unvested equity awards is subject to continued employment of Ms.&nbsp;Lopez-Blanco, or Messrs. Clark or Andreano through the date on which the unvested equity awards would vest in the situations described
above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Payments of Unused Leave Time</I><B></B>. In accordance with the Company&#146;s paid time off policies, an
executive officer will be paid any earned but unused paid time off upon termination. This payment will occur in all termination events. In addition to the leave time that the executive accrues in any year, such executive may carry<B> </B>forward 15
days of leave time from the prior year; therefore, the maximum payout upon termination for each executive would be the value of such executive&#146;s contracted annual leave time plus 15 carry-over days.<B> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Restrictive Covenants</I>. Pursuant to his or her Employment Agreement, each executive officer is subject to certain restrictive
covenants that survive termination of employment. If the executive fails to comply with any of those restrictive covenants, he or she will not be entitled to receive any further payments or benefits as a result of the termination of his or her
employment (other than his or her base salary through the date of termination and reimbursement of any reasonable business expenses incurred through the date of termination). In addition, the Company then will have the right to terminate without
advance notice any future payments and benefits of every kind that otherwise would be due to the executive on account of his or her termination of employment. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following tables illustrate the payments and benefits that each of Dr.&nbsp;Medel,
Ms.&nbsp;Lopez-Blanco, Messrs. Calabro, Clark and Andreano would have received under his or her Employment Agreement if his or her employment with the Company had terminated for any of the reasons described above on December&nbsp;31, 2017. The
amounts presented in the tables, reflect compensation (including equity ownership) at such year end, are estimates only and do not necessarily reflect the actual value of the payments and other benefits that would be received by the NEOs, which
would only be known at the time that employment actually terminates. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>TRIGGERING EVENT</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:33pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation<BR>Components</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Change in<BR>Control</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>By<BR>Executive<BR>without<BR>Good<BR>Reason</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>By<BR>Company<BR>for Cause</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>By<BR>Company<BR>without<BR>Cause</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>By<BR>Executive<BR>for&nbsp;Good<BR>Reason</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>By the<BR>Company<BR>by&nbsp;Reason<BR>of<BR>Executive&#146;s<BR>Disability</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>By<BR>Executive<BR>Due to<BR>Poor<BR>Health or<BR>Due to<BR>Executive&#146;s<BR>Death</B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Roger J. Medel, M.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Severance(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,050,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,700,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,700,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Long-term Incentives(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,190,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,190,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,190,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,190,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,190,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Other Compensation(7)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">198,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">198,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">198,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">198,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">198,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">198,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">198,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total&nbsp;Benefit&nbsp;to&nbsp;Employee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>17,438,474</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>198,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>198,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>15,088,474</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>15,088,474</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>11,388,474</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>10,388,474</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Vivian Lopez-Blanco</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Severance(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">712,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,125,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">888,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">237,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Long-term Incentives(6)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,113,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,113,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,113,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Benefit to Employee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,826,105</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,125,750</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>888,250</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,351,105</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,113,605</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Joseph M. Calabro</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Severance(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,280,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,280,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,280,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">600,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Long-term Incentives(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,213,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,213,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,213,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,213,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,213,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Section 280G Gross-up(5)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Benefit to Employee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8,493,789</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8,493,789</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8,493,789</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>6,813,789</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>6,213,789</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">David A. Clark</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Severance(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,012,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,305,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,012,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">562,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">337,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Long-term Incentives(6)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,129,103</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,129,103</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,129,103</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Benefit to Employee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>3,141,603</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,305,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,012,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,691,603</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,466,603</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dominic Andreano</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Severance(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">721,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">952,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">777,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">371,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">196,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Long-term Incentives(6)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,394,356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,394,356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,394,356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Benefit to Employee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,116,231</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>952,875</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>777,875</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,766,231</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,591,231</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash severance includes: (i)&nbsp;in the case of a termination by the executive without Good Reason, base salary through the date of termination, the actual performance
bonus, on a pro rata basis, that would have been payable to the executive for the fiscal year, as set forth in the Summary Compensation Table, if the executive had not been terminated so long as the executive gives sufficient notice and executes a
general release of Company plus any reimbursement owed to the executive for reasonable business expenses incurred through the date of termination, (ii)&nbsp;in the case of termination by the Company without Cause or by the executive for Good Reason,
(a)&nbsp;continuation of base salary through the termination date, plus any reimbursement owed to the executive for any reasonable business expenses incurred through the date of termination, (b)&nbsp;continuation of base salary for 24 months after
the termination date, (c)&nbsp;on the first and second anniversaries of the termination date, the greater of the executive&#146;s &#147;average annual performance bonus&#148; (as defined in the executive&#146;s Employment Agreement) or his prior
year&#146;s bonus (this amount is paid as a lump sum within 90 days of the termination date if the termination is in connection with a Change in Control) and (d)&nbsp;the actual performance bonus, on a pro rata basis, that would have been payable to
the executive for the fiscal year if the executive had not been terminated, (iii)&nbsp;in the case of termination by the Company without Cause or Dr.&nbsp;Medel for Good Reason, in either case within 24 months following a Change in Control:
(a)&nbsp;continuation of base salary through the termination date, plus any reimbursement owed to the executive for any reasonable business expenses incurred through the date of termination, (b)&nbsp;continuation of base salary for 36 months after
the termination date, (c)&nbsp;within 90 days following such termination, an amount equal to three times the greater of the executive&#146;s &#147;average annual performance bonus&#148; (as defined in the executive&#146;s Employment Agreement) or
his prior year&#146;s bonus, and (iv)&nbsp;in the case of termination by the Company on account of the executive&#146;s Disability, continuation of base salary for a period of 12 months after the termination date and the actual performance bonus, on
a pro rata basis, that would have been payable to executive for the fiscal year if executive had not been terminated, and (v)&nbsp;in the case of termination by the executive due to executive&#146;s Poor Health or Death, the executive&#146;s base
salary through the termination date, the actual performance bonus, on a pro rata basis, that would have been payable to the executive for the fiscal year if the executive had not been terminated plus any reimbursement owed to the executive for
reasonable business expenses incurred through the date of termination. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash severance includes: (i)&nbsp;in the case of a termination by the executive without Good Reason, base salary through the date of termination, the
actual performance bonus, on a pro rata basis, that would have been payable to the executive for the fiscal year, as set forth in the Summary Compensation Table, if executive had not been terminated so long as the executive gives sufficient notice
and executes a general release of Company plus any reimbursement owed to the executive for reasonable business expenses incurred through the date of termination, (ii)&nbsp;in the case of termination by the Company without Cause or by the executive
for Good Reason or due to Change in Control, (a)&nbsp;continuation of base salary through the termination date, plus any reimbursement owed to the executive for any reasonable business expenses incurred through the date of termination,
(b)&nbsp;continuation of base salary for 24 months after the termination date, (c)&nbsp;on the first and second anniversaries of the termination date, the greater of the executive&#146;s &#147;average annual performance bonus&#148; (as defined in
the executive&#146;s Employment Agreement) or his prior year&#146;s bonus (this amount is paid as a lump sum within 90 days of the </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">
termination date if the termination is in connection with a Change in Control) and (d)&nbsp;the actual performance bonus, on a pro rata basis, that would have been payable to the executive for
the fiscal year if the executive had not been terminated, (iii)&nbsp;in the case of termination by the Company on account of the executive&#146;s Disability, continuation of base salary for a period of 12 months after the termination date and the
actual performance bonus, on a pro rata basis, that would have been payable to the executive for the fiscal year if the executive had not been terminated, and (iv)&nbsp;in the case of termination by the executive due to the executive&#146;s Poor
Health or Death, the executive&#146;s base salary through the termination date, plus any reimbursement owed to the executive for reasonable business expenses incurred through the date of termination , and the actual performance bonus, on a pro rata
basis, that would have been payable to the executive for the fiscal year if the executive had not been terminated. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash severance includes: (i)&nbsp;in the case of termination by the Company without Cause, (a)&nbsp;continuation of base salary through the termination date, plus any
reimbursement owed to the executive for any reasonable business expenses incurred through the date of termination, (b)&nbsp;continuation of base salary for 18 months after the termination date, (c)&nbsp;the actual performance bonus, on a pro rata
basis, that would have been payable to the executive for the fiscal year if the executive had not been terminated, and (d)&nbsp;the executive&#146;s &#147;average annual performance bonus&#148; (as defined in the executive&#146;s Employment
Agreement), (ii)&nbsp;in the case of termination by the Executive for Good Reason, (a)&nbsp;continuation of base salary through the termination date, plus any reimbursement owed to the executive for any reasonable business expenses incurred through
the date of termination, (b)&nbsp;continuation of base salary for 12 months after the termination date (18 months in the case of Good Reason Change in Control as defined in the Executive&#146;s Employment Agreement), (c)&nbsp;the greater of the
executive&#146;s &#147;average annual performance bonus&#148; (as defined in the executive&#146;s Employment Agreement) or his or her prior year&#146;s performance bonus, on a pro rata basis, that would have been payable to the executive for the
fiscal year if the executive had not been terminated, and (d)&nbsp;the actual performance bonus, on a pro rata basis, that would have been payable to the executive for the fiscal year if the executive had not been terminated, and (iii)&nbsp;in the
case of termination by the Company on account of the executive&#146;s Disability, the Company will pay the executive 50% of his or her base salary for a period of six months after the termination date and the actual performance bonus, on a pro rata
basis, that would have been payable to the executive for the fiscal year if the executive had not been terminated, and (iv)&nbsp;in the case of termination by the executive due to the executive&#146;s Poor Health or Death, the executive&#146;s base
salary through the termination date, plus any reimbursement owed to the executive for reasonable business expenses incurred through the date of termination and the actual performance bonus, on a pro rata basis, that would have been payable to the
executive for the fiscal year if the executive had not been terminated. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">This amount reflects the value of each of the executive&#146;s unvested restricted stock as of December&nbsp;31, 2017, that would continue to vest until fully vested if
a specified termination event had occurred on December&nbsp;31, 2017. In the case of a Change in Control, the vesting of such unvested restricted stock is immediate whether or not the executive&#146;s employment is terminated.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">If both a Change in Control occurred and the executive&#146;s employment terminated on December&nbsp;31, 2017, and the executive received the estimated payments shown
in the Change in Control column of this table on that date, those payments would not have resulted in any excess parachute payment under Section&nbsp;280G of the Code and thus no gross-up payments would have been required with respect to those
payments. Whether or not a payment will constitute an &#147;excess parachute payment,&#148; however, depends not only upon the value of the payments that are contingent upon a Change in Control but also upon the average of an executive&#146;s W-2
compensation for the five years immediately prior to the year in which the Change in Control occurs. Thus, facts and circumstances at the time of any Change in Control and termination thereafter, as well as changes in the executive&#146;s
compensation history preceding the Change in Control, could materially impact whether and to what extent any excise tax would be imposed and therefore the amount of any gross-up payment. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">This amount reflects the value of each of the executive&#146;s unvested restricted stock as of December&nbsp;31, 2017, that would continue to vest until fully vested if
a specified termination event had occurred on December&nbsp;31, 2017. Other than as determined by the Compensation Committee for any particular grant, in the case of a Change in Control, the vesting of such unvested restricted stock is immediate in
the case of termination by the Company without Cause or by the executive for Good Reason following a Change in Control, or in the event that termination by the executive for Good Reason related to a diminution in duties following a Change in Control
occurs within the <FONT STYLE="white-space:nowrap">24-month</FONT> period of a Change in Control, any unvested restricted stock will automatically vest. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">If Dr.&nbsp;Medel&#146;s employment is terminated for any reason, the Company will reimburse Dr.&nbsp;Medel for mutually agreed upon lease space and reasonable wages to
an administrative assistant for two years from his date of termination. This amount represents the approximate cost of lease space and reasonable wages to an administrative assistant for two years. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">If the executive is terminated for Cause, then the Company will continue to pay the executive his or her base salary through the termination date plus any reimbursement
owed to the executive for any reasonable business expenses incurred through the date of termination. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_71"></A>CHIEF EXECUTIVE OFFICER PAY RATIO </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our CEO&#146;s annual total compensation for 2017 was $7,365,508, as reflected in the Summary Compensation Table included in this Proxy
Statement. The calculation of annual total compensation of all employees, excluding our CEO, as of December&nbsp;31, 2017 was determined using 2017 W-2 compensation, on an annualized basis for full-time employees who were not employed by us for all
of 2017.&nbsp;Our median employee&#146;s annual total compensation for 2017 was $91,192. As a result, we estimate that our CEO&#146;s 2017 annual total compensation was approximately 81 times that of our median employee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_72"></A>DIRECTOR COMPENSATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each non-employee Director receives the following compensation for their service: (i)&nbsp;an annual retainer fee of $65,000, payable
quarterly, (ii)&nbsp;an annual fee of $7,500 for attendance at meetings, payable quarterly, (iii)&nbsp;an additional annual retainer fee of $50,000, payable quarterly, for the Chairman of the Board of Directors and an additional annual retainer fee
of $25,000, payable quarterly, for the Lead Independent Director, (iv)&nbsp;an additional annual retainer fee of $20,000, payable quarterly, for the chair of the Audit Committee, and (v)&nbsp;an additional annual retainer fee of $10,000 per
committee, payable quarterly, for the chair of any committee of the Board of Directors other than the Audit Committee. In addition, each year, each non-employee Director is granted restricted stock with a grant date fair value of $127,500, vesting
in equal annual increments over a three-year period commencing on the anniversary of the date of grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of
Directors&#146; policy for awarding restricted stock also applies to each non-employee Director upon his or her initial election or appointment to the Board of Directors. The grant date fair value of the award will be $200,000 with a three-year
vesting period. We provide grants of equity to our Directors because we believe that it helps foster a long-term perspective and aligns our Directors&#146; interests with that of our shareholders. All non-management members of our Board of Directors
are required to own MEDNAX common stock worth three times their annual base cash retainer fee. MEDNAX also reimburses all of its Directors for out-of-pocket expenses incurred in connection with the rendering of services as a Director. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table includes all non-employee Directors who served in 2017. Dr.&nbsp;Medel does not earn additional income for his
service as a Director. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned&nbsp;or<BR>Paid&nbsp;in&nbsp;Cash(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cesar L. Alvarez</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Manuel Kadre</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">107,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">235,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karey D. Barker</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Waldemar A. Carlo, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">82,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael B. Fernandez</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul G. Gabos</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">220,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pascal J. Goldschmidt, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">82,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Donna E. Shalala, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enrique J. Sosa, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">This column reports the amount of cash compensation earned in 2017 for Board and committee service. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The amounts in this column reflect the grant-date fair value of the restricted stock awards, calculated in accordance with the accounting guidance for equity-based
compensation, but excluding the impact of estimated forfeitures. The following Directors had outstanding stock option awards and restricted stock awards, respectively, at the end of fiscal year 2017: Mr.&nbsp;Alvarez (28,870 and 4,147),
Mr.&nbsp;Kadre (-0- and 4,147), Ms.&nbsp;Barker (-0- and 4,490), Dr.&nbsp;Carlo (35,786 and 4,147), Mr.&nbsp;Fernandez (-0- and 4,147), Mr.&nbsp;Gabos (18,202 and 4,147), Dr.&nbsp;Goldschmidt (-0- and 4,147), Dr.&nbsp;Shalala (28,634 and 4,147) and
Dr.&nbsp;Sosa (46,454 and 4,147). </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_73"></A>SHARE OWNERSHIP INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_74"></A>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Exchange Act requires MEDNAX&#146;s Directors and executive officers, and persons who own more than 10% of our
common stock, to file with the SEC reports of ownership and changes in ownership of our common stock. Our Directors, executive officers and greater than 10% shareholders are also required by rules promulgated by the SEC to furnish MEDNAX with copies
of all Section&nbsp;16(a) forms they file. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on a review of the copies of such reports furnished to MEDNAX, the
absence of a Form 3, 4 or 5, or representations from certain reporting persons that no Forms 5 were required, MEDNAX believes that all Section&nbsp;16(a) filing requirements applicable to its Directors, officers and greater than 10% beneficial
owners were complied with during the fiscal year ended December&nbsp;31, 2017. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_75"></A>Security Ownership of Certain
Beneficial Owners and Management </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information concerning the beneficial ownership of common
stock of MEDNAX as of March&nbsp;12, 2018, for the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each person known to us to be a beneficial owner of more than 5% of our outstanding shares of common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of our Directors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Chief Executive Officer and our other NEOs; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">All of our Directors and executive officers as a group. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:101pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name of Beneficial Owner&nbsp;(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Common&nbsp;Stock&nbsp;Beneficially&nbsp;Owned&nbsp;(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;&nbsp;&nbsp;Shares&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;&nbsp;&nbsp;Percent&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">T. Rowe Price Associates, Inc. (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,907,689</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Vanguard Group (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,862,177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc. (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,740,542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger J. Medel, M.D. (6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,441,829</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cesar L. Alvarez (7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">64,767</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karey D. Barker (8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,362</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Waldemar A. Carlo, M.D. (9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,683</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael B. Fernandez (10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">96,589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul G. Gabos (11)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34,099</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pascal J. Goldschmidt, M.D. (12).</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,422</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Manuel Kadre (13)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,897</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enrique J. Sosa, Ph.D. (14)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,351</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph M. Calabro (15)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">354,933</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vivian Lopez-Blanco (16)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">147,985</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David A. Clark (17)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,452</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dominic J. Andreano (18)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47,039</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Directors and executive officers as a group (14 persons) (19)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,534,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than one percent </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise specified, the address of each of the beneficial owners identified is c/o MEDNAX, Inc., 1301 Concord Terrace, Sunrise, Florida 33323. Each holder is a
beneficial owner of common stock of MEDNAX. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on 94,382,958 shares of common stock issued and outstanding as of March&nbsp;12, 2018. The number and percentage of shares beneficially owned is
determined in accordance with Rule 13d-3 of the Exchange Act and the information is not necessarily indicative of beneficial ownership for any other purpose. Under that rule, beneficial ownership includes any shares as to which the individual or
entity has voting power or investment power and any shares that the individual or entity has the right to acquire within 60 days of March&nbsp;12, 2018, through the exercise of any stock option or other
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
right. Unless otherwise indicated in the footnotes or table, each individual or entity has sole voting and investment power, or shares such powers with his or her spouse, with respect to the
shares shown as beneficially owned. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on a Schedule 13G/A filed with the SEC on February&nbsp;14, 2018. T. Rowe Price Associates, Inc.&#146;s address is 100&nbsp;E. Pratt Street, Baltimore, Maryland
21202. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on a Schedule 13G/A filed with the SEC on February&nbsp;9, 2018. The Vanguard Group&#146;s address is 100 Vanguard Boulevard, Malvern, Pennsylvania 19355.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on a Schedule 13G/A filed with the SEC on January&nbsp;25, 2018. BlackRock, Inc.&#146;s address is 55 East 52</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">nd</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Street, New York, New York 10055. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;1,103,700 shares of common stock directly owned; and (ii)&nbsp;338,129 shares of unvested performance shares and restricted stock which Dr.&nbsp;Medel
presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;29,400 shares of common stock directly owned; (ii)&nbsp;28,870 shares of common stock subject to options exercisable within 60 days of March&nbsp;12,
2018; and (iii)&nbsp;6,497 shares of unvested restricted stock which Mr.&nbsp;Alvarez presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;2,522 shares of common stock directly owned; and (ii)&nbsp;6,840 shares of unvested restricted stock which Ms.&nbsp;Barker presently has the power to
vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;9,400 shares of common stock directly owned; (ii)&nbsp;35,786 shares of common stock subject to options exercisable within 60 days of March&nbsp;12,
2018; and (iii)&nbsp;6,497 shares of unvested restricted stock which Dr.&nbsp;Carlo presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;67,772 shares of common stock directly owned; (ii)&nbsp;22,320 shares of common stock beneficially owned through a self-directed IRA; and
(iii)&nbsp;6,497 shares of unvested restricted stock which Mr.&nbsp;Fernandez presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;9,400 shares of common stock directly owned; (ii)&nbsp;18,202 shares of common stock subject to options exercisable within 60 days of March&nbsp;12,
2018; and (iii)&nbsp;6,497 shares of unvested restricted stock which Mr.&nbsp;Gabos presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;13,925 shares of common stock directly owned; and (ii)&nbsp;6,497 shares of unvested restricted stock which Dr.&nbsp;Goldschmidt presently has the
power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;109,400 shares of common stock directly owned; and (ii)&nbsp;6,497 shares of unvested restricted stock which Mr.&nbsp;Kadre presently has the power to
vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;9,400 shares of common stock directly owned; (ii)&nbsp;46,454 shares of common stock subject to options exercisable within 60 days of March&nbsp;12,
2018; and (iii)&nbsp;6,497 shares of unvested restricted stock which Dr.&nbsp;Sosa presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;146,508 shares of common stock directly owned; and (ii)&nbsp;208,425 shares of unvested performance shares and restricted stock which Mr.&nbsp;Calabro
presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;27,948 shares of common stock directly owned; (ii)&nbsp;3,626 shares of common stock directly owned that were acquired through the Company&#146;s
Employee Stock Purchase Plan; (iii)&nbsp;40,000 shares of common stock subject to options exercisable within 60 days of March&nbsp;12, 2018; and (iv)&nbsp;76,411 shares of unvested performance shares and restricted stock which Ms.&nbsp;Lopez-Blanco
presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;44,452 shares of unvested performance shares and restricted stock which Mr.&nbsp;Clark presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;9,610 shares of common stock directly owned; (ii)&nbsp;1,342 shares of common stock directly owned that were acquired through the Company&#146;s
Employee Stock Purchase Plan; (iii)&nbsp;6,000 shares of common stock subject to options exercisable within 60 days of March&nbsp;12, 2018; and (iv)&nbsp;30,087 shares of unvested performance shares and restricted stock which Mr.&nbsp;Andreano
presently has the power to vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(19)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;1,554,713 shares of common stock directly owned; (ii)&nbsp;181,312 shares of common stock subject to options exercisable within 60 days of
March&nbsp;12, 2018; and (iii)&nbsp;761,140 shares of unvested performance shares and restricted stock which certain executive officers presently have the power to vote. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_76"></A>INDEPENDENT AUDITORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_77"></A>Independent Auditors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">MEDNAX&#146;s independent auditor for the year ended December&nbsp;31, 2017, was the firm of PricewaterhouseCoopers LLP. Subject to shareholder ratification, the Audit Committee has reappointed
PricewaterhouseCoopers LLP as the independent registered public accounting firm to perform audit services for MEDNAX in 2018. MEDNAX expects that representatives of PricewaterhouseCoopers LLP will attend the annual meeting. They will have an
opportunity to make a statement if they desire to do so and will be available to respond to appropriate questions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_78"></A>Fees Paid to Independent Auditors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The aggregate fees billed by PricewaterhouseCoopers LLP for the indicated services rendered during fiscal years 2017 and 2016 were as follows: </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_79"></A>Audit Fees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">PricewaterhouseCoopers LLP billed MEDNAX $1,570,750, in the aggregate, for professional services for the audit of the Company&#146;s consolidated financial statements and internal control over financial
reporting for the year ended December&nbsp;31, 2017, reviews of MEDNAX&#146;s interim consolidated financial statements, which are included in each of MEDNAX&#146;s Quarterly Reports on Form 10-Q for the year ended December&nbsp;31, 2017, the
statutory audit of MEDNAX&#146;s wholly owned captive insurance subsidiary and the review of certain SEC filings. During 2016, PricewaterhouseCoopers LLP billed MEDNAX $1,545,879, in the aggregate, for professional services for the audit of the
Company&#146;s consolidated financial statements and internal control over financial reporting for the year ended December&nbsp;31, 2016, reviews of MEDNAX&#146;s interim consolidated financial statements, which are included in each of MEDNAX&#146;s
Quarterly Reports on Form 10-Q for the year ended December&nbsp;31, 2016 and the statutory audit of MEDNAX&#146;s wholly owned captive insurance subsidiary. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_80"></A>Audit-Related Fees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">PricewaterhouseCoopers LLP
did not bill MEDNAX for any audit-related fees in 2017 or 2016. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_81"></A>Tax Fees </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">PricewaterhouseCoopers LLP did not bill MEDNAX for any tax services in 2017 or 2016. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_82"></A>All Other Fees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">PricewaterhouseCoopers LLP did not bill MEDNAX for any other services in 2017 or 2016. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_83"></A>Pre-Approval Policies and Procedures </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit
Committee is required to review and approve the proposed retention of independent auditors to perform any proposed auditing and non-auditing services as outlined in its charter. The Audit Committee has not established policies and procedures
separate from its charter concerning the pre-approval of auditing and non-auditing related services. As required by Section&nbsp;10A of the Exchange Act, our Audit Committee has authorized all auditing and non-auditing services provided by
PricewaterhouseCoopers LLP during 2017 and the fees paid for such services. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_84"></A>PROPOSAL 2: RATIFICATION OF THE APPOINTMENT OF INDEPENDENT
AUDITORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has selected and appointed the firm of PricewaterhouseCoopers LLP to act as our independent
registered public accounting firm for the 2018 fiscal year. PricewaterhouseCoopers LLP was our independent auditor for the fiscal year ended December&nbsp;31, 2017. Although ratification is not required by our bylaws or otherwise, the Board of
Directors is submitting the appointment of PricewaterhouseCoopers LLP to our shareholders for ratification as a matter of good corporate practice. If the appointment is not ratified, the Audit Committee will re-evaluate its appointment, taking into
consideration our shareholders&#146; vote. However, the Audit Committee is solely responsible for the appointment and termination of our auditors and may do so at any time in its discretion. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proxies will be voted &#147;FOR&#148; ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public
accounting firm for the 2018 fiscal year absent contrary instructions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>MEDNAX&#146;s Board of Directors recommends a
vote &#147;FOR&#148; ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2018 fiscal year. </I></B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_85"></A>PROPOSAL 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required by Section&nbsp;14A of the Exchange Act, MEDNAX is providing its shareholders the opportunity to cast a
non-binding advisory vote &#147;FOR&#148; or &#147;AGAINST&#148; the compensation paid to named executive officers in 2017 as disclosed and described in the &#147;Executive Compensation: Compensation Discussion and Analysis&#148; section of this
Proxy Statement, including the section entitled &#147;Overview of the Executive Compensation Program,&#148; the compensation tables and the narrative disclosures that accompany the compensation tables. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As described in detail in our &#147;Executive Compensation: Compensation Discussion and Analysis&#148; section of this Proxy Statement,
the compensation tables and related narrative discussion, the compensation of executive officers is designed to have strong links to performance achievements, both in terms of operational and financial results as well as in optimizing shareholder
value. We evaluate the relationship between compensation cost, shareholder value and company performance on a regular basis. At-risk elements such as performance-based cash incentives and equity-based compensation comprise a significant portion of
our overall executive remuneration. For incentive plans, we establish performance goals so that the level of compensation received appropriately corresponds to the level of performance achieved. In addition, the vesting of equity-based compensation
is designed to encourage ownership that results in business decisions that build long-term shareholder value and thus stock price appreciation, and retention of our named executive officers. We believe that the compensation paid to our named
executive officers for 2017 appropriately considers our demonstrated ability to increase revenue and profitability over the long-term as a result of the continued leadership of these named executive officers. The introduction of performance shares
with rigorous financial goals in 2014 and the continued use of such awards since that time and in 2017 further aligns executive pay with Company performance and our clawback policy, required minimum share ownership for our executive officers and
enhanced anti-hedging policies further align executive compensation with our shareholders&#146; long-term interests. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shareholders are urged to read the section entitled &#147;Executive Compensation: Compensation Discussion and Analysis,&#148; which
discusses our executive compensation programs in detail, as well as the section entitled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; appearing in our 2017 Annual Report that accompanies this
Proxy Statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accordingly, MEDNAX requests your approval of the following resolution: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RESOLVED, that the compensation paid to the Company&#146;s named executive officers, as disclosed pursuant to the compensation disclosure
rules of the SEC, including the section entitled &#147;Executive Compensation: Compensation Discussion and Analysis,&#148; compensation tables and related narrative discussion, is hereby APPROVED. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>MEDNAX&#146;s Board of Directors recommends a vote &#147;FOR&#148; the approval of the compensation paid to its named executive
officers as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission and described in the section entitled &#147;Executive Compensation: Compensation Discussion and Analysis,&#148; including the compensation
tables and the related narrative discussion. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>Although the vote is non-binding and advisory, the Board
of Directors and the Compensation Committee will review the voting results in connection with their ongoing evaluation of the Company&#146;s compensation program.<B><I> </I></B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_86"></A>OTHER BUSINESS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors knows of no other business to be brought before the annual meeting. If, however, any other business should
properly come before the annual meeting, it is the intention of the persons named in the accompanying proxy card to vote the shares they represent in accordance with the recommendation of MEDNAX&#146;s Board of Directors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_87"></A>AVAILABILITY OF ANNUAL REPORT ON FORM 10-K </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Copies of our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2017 (without exhibits or documents incorporated
by reference therein) are available without charge to shareholders upon written request to Investor Relations at 1301 Concord Terrace, Sunrise, Florida 33323, by calling (954)&nbsp;384-0175 or via the Internet at <U>www.mednax.com</U>.
</B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc463041_88"></A>INFORMATION CONCERNING SHAREHOLDER PROPOSALS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As more specifically provided in our Articles of Incorporation, no business may be brought before an annual meeting unless it is
specified in the notice of the meeting or is otherwise properly brought before the meeting by or at the direction of our Board of Directors or by a shareholder entitled to vote who has delivered proper notice to us, together with the information
required by our Articles of Incorporation, not less than 120 days nor more than 180 days prior to the first anniversary of the preceding year&#146;s notice of annual meeting. Accordingly, any shareholder proposal to be considered at the 2019 Annual
Meeting of Shareholders must be properly submitted to us on or before November&nbsp;23, 2018, but not earlier than September&nbsp;24, 2018, or such proposal will be considered untimely. A copy of the provision of MEDNAX&#146;s Articles of
Incorporation relating to shareholder nominations is available upon request from MEDNAX&#146;s Secretary at 1301 Concord Terrace, Sunrise, Florida 33323. These requirements are separate from the SEC&#146;s requirements that a shareholder must meet
in order to have a shareholder proposal included in our Proxy Statement for the 2019 Annual Meeting of Shareholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shareholders interested in submitting a proposal for inclusion in our proxy materials for the 2019 Annual Shareholders&#146; Meeting may
do so by following the procedures set forth in Rule 14a-8 under the Exchange Act and MEDNAX&#146;s Articles of Incorporation. To be eligible for inclusion in such proxy materials, shareholder proposals must be received by our Secretary, at the
address noted above, not later than November&nbsp;23, 2018. No shareholder proposal was properly received for inclusion in this Proxy Statement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>


</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:24px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g463041g38o41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1301 Concord Terrace </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sunrise, Florida 33323-2825 </FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:2.00em">


<IMG SRC="g463041pc1.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:8pt; font-family:Times New Roman"><B><I>MEDNAX, INC.</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:8pt; font-family:Times New Roman"><B><I>1301 CONCORD TERRACE</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:8pt; font-family:Times New Roman"><B><I>SUNRISE, FL 33323-2825</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY INTERNET <FONT STYLE="white-space:nowrap">-</FONT>
<U>www.proxyvote.com</U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. EDT on May
15, 2018. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">If you would
like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery,
please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY PHONE - 1-800-690-6903</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. EDT on May 15, 2018. Have your proxy card in hand when you call and then follow the instructions.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY MAIL</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.</TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px dashed #000000; font-size:8pt; font-family:Times New Roman" ALIGN="right">E39185-P04396-Z71948&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KEEP THIS PORTION FOR YOUR RECORDS</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">DETACH AND RETURN THIS PORTION ONLY</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.</B></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="9" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-TOP:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="9" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>MEDNAX, INC.</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; font-size:8pt; font-family:Times New Roman"><B>The Board of Directors recommends you vote FOR the
following:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>For All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;Withhold&nbsp; All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For&nbsp;All&nbsp;&nbsp; Except&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top">To withhold authority to vote for any individual nominee(s), mark "For All Except" and write the number(s) of the nominee(s) on the line below.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="6"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">1.&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"><FONT STYLE="font-size:8pt">Election of Directors</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Nominees:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">01)&nbsp;&nbsp;&nbsp;&nbsp;Cesar&nbsp;L.&nbsp;Alvarez</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;06)&nbsp;&nbsp;&nbsp;&nbsp;P.&nbsp;J.&nbsp;Goldschmidt,&nbsp;M.D.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">02)&nbsp;&nbsp;&nbsp;&nbsp;Karey&nbsp;D.&nbsp;Barker</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;07)&nbsp;&nbsp;&nbsp;&nbsp;Manuel&nbsp;Kadre</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">03)&nbsp;&nbsp;&nbsp;&nbsp;Waldemar&nbsp;A.&nbsp;Carlo,&nbsp;M.D.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;08)&nbsp;&nbsp;&nbsp;&nbsp;Roger&nbsp;J.&nbsp;Medel,&nbsp;M.D.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">04)&nbsp;&nbsp;&nbsp;&nbsp;Michael&nbsp;B.&nbsp;Fernandez</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;09)&nbsp;&nbsp;&nbsp;&nbsp;Enrique&nbsp;J.&nbsp;Sosa,&nbsp;Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">05)&nbsp;&nbsp;&nbsp;&nbsp;Paul&nbsp;G.&nbsp;Gabos</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="15"><B>The Board of Directors recommends you vote FOR proposals 2 and 3.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>&nbsp;Against</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>&nbsp;Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="18"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="16"><FONT STYLE="font-size:8pt">Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered certified public accounting firm for the 2018 fiscal year.</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="18"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">3.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="16"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Proposal to approve, by non-binding advisory vote, the compensation of our named executive officers.</P></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="15" VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7"><FONT STYLE="font-size:8pt">For Address Changes/Comments, please check this box and write them on the back where indicated.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Please indicate if you plan to attend this
meeting.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Yes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="13">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must
sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="11" VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:2.00pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;Signature [PLEASE SIGN WITHIN BOX]</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">Date</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">Signature&nbsp;(Joint&nbsp;Owners)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">Date</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:1pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for the
Annual Meeting: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com. </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt dashed #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">E39186-P04396-Z71948 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="32" STYLE="BORDER-LEFT:1.50pt solid #000000; BORDER-TOP:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="32" COLSPAN="4" STYLE="BORDER-TOP:1.50pt solid #000000">&nbsp;</TD>
<TD HEIGHT="32" COLSPAN="2" STYLE="BORDER-TOP:1.50pt solid #000000">&nbsp;</TD>
<TD HEIGHT="32" COLSPAN="2" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Annual Meeting of Shareholders</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>May 16, 2018 9:30 AM EDT</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is solicited by the Board of Directors</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shareholder(s) hereby appoint(s) Roger J. Medel, M.D., Dominic J.
Andreano and Vivian Lopez-Blanco, or any of them, as proxies, each with the power to appoint his or her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot and upon such other business
as may properly come before the meeting, all of the shares of Common Stock of MEDNAX, Inc. that the shareholder(s) is/are entitled to vote at the Annual Meeting of Shareholders to be held at 9:30 AM, EDT, on Wednesday, May 16, 2018, at the
DoubleTree Sunrise, 13400 W. Sunrise Blvd., Sunrise, Florida 33323, and any adjournment or postponement thereof.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with
the Board of Directors' recommendations.</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" NOWRAP><B>Address&nbsp;Changes/Comments:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" ALIGN="center">(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side.)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1.50pt solid #000000"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Continued and to be signed on reverse side</B></P> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-right:2pt">&nbsp;</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g463041g01p93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g01p93.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E )A P$1  (1 0,1 ?_$ *T  0 !! ,! 0$
M       (!PD*"P,%!@0" 0$! 0$! 0                $# @00   % P$!
M!1$.!0($!@,   (#! 4&  $'" D1$K5V=R$3<Y/3%!4V5K87)S<X:*@YLS1T
MM#5UE=46EM97MPHQ(K(8&4%1@2,D)C(S)558F*9G*!$!  $"!@$% 0 #
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MY24AZ,EATR*'(IE3J,7GO!ZXEK):29,T&N1SFI">-.W%(0.HE1BX\"8RX";
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M:+]XTM24\QP8L>:/6-T:2=^$@+XX+KG7&F,3E)0O5,3,ACK(T,#87<IN9&Q
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M,CK\0/JQB+.-:,EUK$7:H[<I^;OUHGU9[L?B/II&'S/VJ?44H% H% H% H%
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M<RY74_QSX3NKET4'Y'<5@#N$(ABL 5PA#<%A"%:U[V"&YE[ L*]^9;?7W/\
M>@M>(4FT<5L-DZ1^<65:0V9\9K.+]%L&/R]P<G1<>NP;.P( RUC*1&1B^XVG
ML!AIB90EW%Y[B:*X6^P5M.:M7C-$I&J0R-]EDT>2\?F-32[ PDG9HLXL\6"9
MD1"Q.S;&8R<3&Y9(C@EHU;HG?W @PDV]DJ=.(O="7L:+?R8XP%2L]N52DID:
MBY*J: F@:5+^!"0%X/:P'EDG@;CG&Q@B+# $=BKAW;6OS*#NZ!0*!04.RWJ8
MT^X%5M*#-.9,>8O6/R<Y6RI9M)VR/G.B9.9<D\]$6O/)$H**-MO1"#NVM?F5
M8B9P%J9BF6S];9HZ2E=KRT^J$1TLR%)F%B121L3)&%/D!)=,XQ7K9?/W6/OD
M,4*;A6GMCFVKB2' %CVL35<1@1WCN\"IS3GG9^,Y61FHC69I85Q?),:A49<V
M%Q-B"HM"1#X>=%>ODF]EI+48O<C59RS?&(A )&.P=Z/<N(3CN\":F&]6&DG(
M3A'L4X;U!8JR!(D+$4D9XS%YFQ/+X>TQ]"20,\*%L-M<84J0H(C+@+" -N;:
MUK<RTI,"5%0*!0*!0*!0*!0*",&8?+9@SB?J![UXK5])153#WDWC/0G'AAPI
M.)&$>RI=14:-9OFD:EN0[)O>@ZU8Q&M@K="@4&R$T(>9IIEY&8-P*FK"<9]U
M2RJ!0*"B6I?S<=0'(EE;O$?J#6>*/?!_1C?ZQ5Z$<- H-BALT/,(TI<B\+X*
M)K'=VE4YJY"@4'P.J\#4V.+F86(TMN0+%XR@7L$9@$:<Q0(L-Q?RV$,)>Y:]
M^9NWH,9">;?G2_D+L4EF>E3*CP&-NPW1JN7/VIKN0NL0>B'<T;.J;S%J0PHW
M=$F/N:G$8 LRY=S"BQ TX2E7DD6W%T8-[L4^IM&>0KNY:98F,7J9NT+E"T;D
M]7D+LXNHERM19Y?GIT$,2YR5V.<%Q)AA!YQA!@RQ.$E7O&[]PIIP:GE3(4NE
MS*HWQ42M2B=5\Z8W9<G0N+J>]K6UN4.IJTQJ:E#H?SVZ1+<E-;G90; L DD(
M'"2J_7I6U!L^JC >/,^,$><XHT9"0NBY&P/"I*M<FX#6_.K",M2I16"E-$::
MU",M<%MRP1VM_&UZXF*314A*@Z22]KD@^9'7X@?5C$6<:T9+K6(NU1VY3\W?
MK1/JSW8_$?32,/F?M4^HI003R[C+40\Y2R<[1!SD2C'TJQY#&6/HFC+CY"G>
M.S1%("BU$BBIC6L;&YF3-#(<O6N"%8A7]E%Q3:"RTU$I<VY,'QYMQ!J5ECL3
M-\(SF18UD3R\P5:]1Z4Y$DT@BB5.U1O*+6_(+1!%)111F;5CDXQ01QS-8H81
M(5"XQ&Z' ,1.8=W&,<:H4Q6*4CO-;$)V!QZ\E8Q2]U?5!A:G)L-D"M"YKU@"
M%DM1EXVB+XTDF*N>7 LF"?>D%EM=E5@F[0*!0*#JGWY$>?FIP^*'4&K^EG;5
M)N,#SPBIKT(\_0*#/ZV-/LUM,_P'*'ZV9)K'=VE5SRN0H%!P*O>RCH!ON8J#
M68:A?+[G'E@R7WZ/5>B,$4?H%!GA[#_V>^->,LUX6#6._LJ[G7(4$$<"_(NG
MKC/FKAS+E=3_ !SX3NKET4&+)M]M0F?,.9FP6UXASAE_%;8[X\D2UV;L;Y+F
MD'0.:TA^2DDJW%)&'IK3K51)(K@"88$0PAON6ON5ILB)BZ+!?]\^MK_YB:I_
M_L'EK\75W2/ ?WSZVO\ YB:I_P#[!Y:_%U*1X%W?8FZG=2F5M:[3%,HZA<XY
M)BYD$FRPR-S[+,]F+ 8K2,QYJ54-GD3^XMPU"8VUA%CN7O@"MNVO:]<[XB(&
M8Q62E H%!B7_ +D3RBZ<>)4EX='6GY^J2QF:T"@O"["SVA4#XCY#X%#7._J,
M[&L5*!0*!04Z!E_%(RW0WPE00LMDE2B#/ SY8Q)PMDS2DJ%*B*K1'KB[)Y 6
MF1FF]:"W#[EE#'8-PAO>P?<BR9C=R3."QNR#"'!(T1Q+,754BE;"J3-D16IE
M"Q'*G \A>84BCBM(D--*7&7"E,+*&(([A#>]@]@E5)EJ9.L1J"%:-604J2*T
MII9Z94F/+":0H3GE"&4<0<4.P@##>X1!O:]K[E!ST"@C!F'RV8,XGZ@>]>*U
M?2454P]Y-XST)QX8<*3B1A'LJ745&C6;YI&I;D.R;WH.M6,1K8*W0H%!LA-"
M'F::9>1F#<"IJPG&?=4LJ@4"@HEJ7\W'4!R)96[Q'Z@UGBCWP?T8W^L5>A'#
M0*#8H;-#S"-*7(O"^"B:QW=I5.:N0H%!YV7]J<HXNO?!JF@U>:OWTI^$'>Z"
MKT(^>@4&P)V/OLX],W%Z6_J+,*QW=I5<MKD=))>UR0?,CK\0/JQB+.-:,EUK
M$7:H[<I^;OUHGU9[L?B/II&'S/VJ?45X[(?:#-^*4BX(5U8Q&KZK="@4&Q'V
M8GF!:5N2IK^.N%8[NTJG?7(4"@ZI]^1'GYJ</BAU!J_I9VU2;C \\(J:]"//
MT"@S^MC3[-;3/\!RA^MF2:QW=I5<\KD*!0<"KWLHZ ;[F*@UF&H7R^YQY8,E
M]^CU7HC!%'Z!09X>P_\ 9[XUXRS7A8-8[^RKN=<A001P+\BZ>N,^:N',N5U/
M\<^$[JY=%!B"_N/O+KI[Y,I-WQHZUV8)+'#KL*"];L#_ #]F7D[GO :BN=_4
M9Q-8J4"@4&)?^Y$\HNG'B5)>'1UI^?JDL9FM H+PNPL]H5 ^(^0^!0USOZC.
MQK%2@4"@B=JEULZ>=&B&(N.?96Z1=).%;DBCIC9%9%)[JE#22G4+@G C[<O&
MD"66J!N7,L&PKWYG\+U8B9P%F1ZUQ;(R2+90X/NH3.YZB3Y2=LL"(;H=D!E9
M&M^?(V\15X3M\5;H*5%1$/K6]FW<E!Z(Y>Y'A -0>/<$$77#<$%UR;)/'44=
M8;&M2.?0-#KCM1C(1CECYY=G%%'W!F<F5Y/1+U^(SS@N;R4O+--$9ST@DQ&0
M%,403SXHYPW"XCISVIFAK+\KQ[@+$F3Y7))>X(4,9C*=ZQY,6@UR["M8"0&N
M#FJC;4SD*34R.XS!6"05<>[O0AMN!M)VS%Q<[KD*",&8?+9@SB?J![UXK5])
M153#WDWC/0G'AAPI.)&$>RI=14:-9OFD:EN0[)O>@ZU8Q&M@K="@4&R$T(>9
MIIEY&8-P*FK"<9]U2RJ!0*"B6I?S<=0'(EE;O$?J#6>*/?!_1C?ZQ5Z$<- H
M-BALT/,(TI<B\+X*)K'=VE4YJY"@4'G9?VIRCBZ]\&J:#5YJ_?2GX0=[H*O0
MCYZ!0; G8^^SCTS<7I;^HLPK'=VE5RVN1TDE[7)!\R.OQ ^K&(LXUHR76L1=
MJCMRGYN_6B?5GNQ^(^FD8?,_:I]17CLA]H,WXI2+@A75C$:OJMT*!0;$?9B>
M8%I6Y*FOXZX5CN[2J=]<A0*#JGWY$>?FIP^*'4&K^EG;5)N,#SPBIKT(\_0*
M#/ZV-/LUM,_P'*'ZV9)K'=VE5SRN0H%!P*O>RCH!ON8J#68:A?+[G'E@R7WZ
M/5>B,$4?H%!GA[#_ -GOC7C+->%@UCO[*NYUR%!!' OR+IZXSYJX<RY74_QS
MX3NKET4&(+^X^\NNGODRDW?&CK79@DL<.NPH+UNP/\_9EY.Y[P&HKG?U&<36
M*E H%!B7_N1/*+IQXE27AT=:?GZI+&9K0*"\+L+/:%0/B/D/@4-<[^HSL:Q4
MH% H,8K]R5VFZ7^,V0."F*M/S]4EB?5H%!<JV0OM"=/'&-?P.NKG?U&P,K%2
M@C!F'RV8,XGZ@>]>*U?2454P]Y-XST)QX8<*3B1A'LJ745&C6;YI&I;D.R;W
MH.M6,1K8*W0H%!LA-"'F::9>1F#<"IJPG&?=4LJ@4"@HEJ7\W'4!R)96[Q'Z
M@UGBCWP?T8W^L5>A'#0*#8H;-#S"-*7(O"^"B:QW=I5.:N0H%!YV7]J<HXNO
M?!JF@U>:OWTI^$'>Z"KT(^>@4&P)V/OLX],W%Z6_J+,*QW=I5<MKD=))>UR0
M?,CK\0/JQB+.-:,EUK$7:H[<I^;OUHGU9[L?B/II&'S/VJ?45X[(?:#-^*4B
MX(5U8Q&KZK="@4&Q'V8GF!:5N2IK^.N%8[NTJG?7(4"@ZI]^1'GYJ</BAU!J
M_I9VU2;C \\(J:]"//T"@S^MC3[-;3/\!RA^MF2:QW=I5<\KD*!0<"KWLHZ
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MQK%2@4"@QBOW)7:;I?XS9 X*8JT_/U26)]6@4%RK9"^T)T\<8U_ ZZN=_4;
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M>]@AM:^[?^&[SNF)BD2K)L\)*[\KLH?1$=_%-9TS@J_!F35919AIF,,G@+*
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MA2V6I?/0\:WI/^IA2V6I?/0\:WI/^IA2V6I?/0\:WI/^IA2V6I?/0\:WI/\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g463041g06p04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g06p04.jpg
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MZOA:G"[\TI/FB(.RPYI\F.:%'UJTO'(?8@;O-L?=%VL;9QHS7$%I&UZ(T#R
MU9K2UTL+,UTI&^=WBQU/89U&2]"V#\*URPM6SVR,XJ)?L&SH6*%0OE):S:US
M7?$K#2G-SE%RYX9\^><>N]E-]3(:1O7(:,XTZC)2*+/4Y_4N-560L3);=+ZQ
MUV1O4K.;8DT)..M9*?<::UJ<,M'EK!4Y-HYDWXC23A5;H>+--WN4KKD[JWEQ
MO#SM>-/<JXC0=<94VT-=W[6TKI?;-JU_#/Z0DE5V^U+'9*7+2%<C[?=JS>M@
MT^AS]/G)BYSU$J-I^*-+=P,U/%16=O6K (H'"WDFUTD_=>M#+I@\# & , 8
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MEG$C-A)RG\Q\,K]ARSX]2<RA ,=C-%Y5S)Q4$DA\ VM)+XP3%FH],:5M1ZM
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MJ\A&=.[/'7%N!N %1=632%'O1#]SU%.H]VU8IF5.8?G\19NHJ(^LWRO7GO\
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M  >\F9X^\=:I%;][5C94)8Y-L5L_0T)5;$]B]<Q#P2 Z1B+A;HDS6V;,GR=
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M>H^F.X$(4QT3N'=JCD*6V=(*J-7L%0X:1;=P7[COCKL890SQBVPZU,E?DK/
M&$<2.RNTRW/'-FM6U<G8J!H9Q-(@5DWGD8<RNV-II^,0H@C5JV\"EP<BEYPT
M4=S=Y()4I*OM5$QXMXI2A]67Y\G-ZRW(;;UCOSTSA&%\48>FQ*QAZ0U3CU52
MQ;84^\8I';SQ%I64[AC%-*/W?AF\ J)"=L$/!#+'%\_E#@;FY]-"W[/9!@#
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M 'J #A*LP"-=/>S6I?1ZOXYUE=7J]P5S,?HF4^CGOX97("F-8^S;7OU'J?\
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M;JK\'4]H@<?#;H ' ?0L(JP_^RV?L6F>2H<AUM5]H]*:7>OA2K_)K3MOJR+
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M0L Q39,D ZF[OREW*P@ *.GBX_XCARKT#OJJ"/0H%33 B)$TR:I)*2!4&4#
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MN<EM]_HC>QK#_NO;Y^#FQ0$R\KD["V&..*4A RT=,L%0$0%-Y%O$7S4X"'K
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MA<FGDU[/$Y[?[HO]?;'Y0LTSO.,8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MG*OY4_F.:3N*HRD& , 8 P!@# & , 8 P"<.-NL%=Q[RUOK[P#+L)BR-'$^
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M\^CRC&N?"FDO&%=[&LVRK-5SZABFVGA2OB["[UY+RU=/=2TQ_!)&>B# & ,
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M&:HH]X_@IHB0J0G.*8%$YNLDLD)O.M3Z&,+#QBJR\=%1S!=P"97"[-DV;+.
M111;I NJBF11;PT&[=$GBF-W4D$4PZ$3(!225Z20F\ST\H& , 8 P!@# & ,
M 8 P"8=#Z:L>^MH5K6];(=,\JY!>:E?"%5O7ZZT,0\Q-N@^23N,VYNXV24.F
M#V1791Z:A5G:77S%$H5-],]"I-N2+>O*@N>%8U+JO6W94Z%D4V2?P54[ER )
M&.@,I$4V%\"1UAK6551$05E+1*MV^S+2DY*@_!M%TI^8SAI:'11X6YMMXWG=
M80?NE<KH=<>F^AKI=C+P+>]H1SPU7JB4BEGNH:4[2VQOEYX9Q9):QIL@Q7=U
MUPN  ";C8$VO#T1J"9_.D4Y]W+))G0B71DQK:1<,+S=R]?".LZBBBW12;MTD
MT$$$R(H((D*DBBBD4")I))D I$TTR%*0A"% I"@!2@   8.,_3 (UTY[*M??
M5.%_!IY75ZO<BHM%L25D*, 8 P!@# & , C?3?LAU5^[>C?RQ%Y75ZO<BHM%
ML21D*6@\[^'.N^>G%?:_&+9)4VL=?H,QJU9BM2.G]$OT0;X1I5WBR"9-0SBO
MSJ+99XT1<-OAF%4E:^Y7(PEG93"POA::P.1KO;2>V^)&^K[I/9\9(4C;>F;H
MO"2Q6;ARV6:2L0ND]A[)791,&JZ\5+,S1UEJD^T\(LA$/HR79'!-PB?!W)J)
M3N::U]'[G1F['[M$-<]L/PPF-&;Y?,C<F]65R,@-O1W>:M9BU,FGA,ZER!J"
M'=!,%7[PC4EL39(^:P=V*Z:.V#2MV>O-9"IN%S53CM;/A<OVNC^8HLVWOH^Y
M<?MARVO[BW$5&QA=0<VBD=.-LT"LH<K&:C3&$P>&N4ADG3;Q#JQ[Y)RQ7$54
M#&-VPQ*-37]'*TTY,AK/1!@# & , 8 P!@# & , 8 P#VZW7)VWST15ZQ%O)
MNP3K]O&1$4P2%9V^>NC@FBBD0.@!U$>\HH<Q$D4BG664323.<IM)3=R0,N>\
M-U:7[$'@O:MT['4B;1O&X(DBZM5$G14GVS-JN&#A6N42&4+W7C>BU IUY6V3
MQ2?[-%(R\JFD>5DX"!6XK2-QODJ:?DZ+.S;:2KB\E\ZG,?W3N+9G)'<-_P!U
M[6GGURV?M>VR-JM,PJ0QE9"9F7/4C2/9I]XC*-8)>;Q,##,RE9Q,2T81,<@D
MS:-T2>#O24*25$=+;R?KLQ%.SWXD)6W9L$6/Y-\CTH6[[41>(%"3H=90;+*T
M+4YC& #MW5=8R+N:MR)2D.%RG92*75?,Z[#N"CDM(^**[[53S\P,]F#,8!&N
MGO9K4OH]7\<ZRNKU>X*YF/T3*?1SW\,KD!3&L?9MKWZCU/\ @+#*ZO5[D5%H
MMBN,A3&UVKG9^UCM(>&^P="/O@^-V(P*%[T=;GQ  E5VQ76;P($[IR4BBJ$#
M9FKN0IUI,1)P9&!GWL@V;*R4?'F2'J"+@B3Z\T<FBSUK8FD=ES=3LL?8-=;4
MU5<WL/,1ZIW$/9Z9>*=,';N4@7;*$<1\O!S+ 3(.FBP'1<MTW#5<>B:HCM33
M4\&=*;LG^?NM.V=X2RFH]U/H]IR>U9"Q4)MZ-1*T;2S]\T3%G4.0%-9@"28L
M[ LGTLC1BFBUA;2>9KSMHVKDY &EK#$X6FL._(XK6SDY8.^%^WIWJ6-;GT[<
M]%; F=>W=D+>2C%/%8OTB*?!L_#K'.$?.Q"YRE\XCWQ"&Z?,LT<IN&#PB+YH
MY03[88E&IKU61S-2<B*L]$& , 8 P!@# & , 8 P!@# /2AX>5L,M&P4%'O)
M:9F'K:-BXQ@@HY>OW[Q4J#5HU;I%,HLNNL<B:9" (F,8,3E>[D#*EO'=NH^P
M^X-VC>>R@A;/R0V,V&$H='%V0SNY[$59*.(*DQYT% <HT2D^,$]L2Q-3%3,@
MDN#==>3?T^*7XK2/CBY*Y>[]?".BRLVW)5=[>2_'<YH6V-I[*Y#[;N^W-ESD
MG>-I;7N$E:+/+K$.N_FK'87QE3(LV;<HE0;D452CX:'8(D:1S!%E%1K9%HV;
MH$\'>DH4DJ(Z;W8(]F6/9V</F3S8<*FRY+<@_@;8.Z172)\(5%FFS6&C:F%8
MOS?$:,DGKF?3**A?CO8+0DDZ>1K2*4(.2TCXHKJ*Y<^?J9R\&8P"-=.>RK7W
MU3A?P:>5U>KW(J+1;$E9"C & , 8 P!@# (WTW[(=5?NWHW\L1>5U>KW(J+1
M;$D9"C -9GRA[L=%><NK"\HN/5;*XY7Z6KBR,G78ML7S[>FKHWSA^O4R))@!
MGM_J(JO).AJ%[SJ;:K2=,.1ZX>U<8<:V5IPN3^U]GXS.?SQ<Y.[LX4[\I/(#
M1]B=5#9>N9<ZA$G22YHR:CCF%K8*7<(<5&PRM:L#(%XJ=B5SH+>&<'#-=A*M
M&+YH.F*%1*3QH\N:.F%Q/Y7\4>W*XGHST$JWINWZ:W:HWRB*NFSR^:.OKQJ)
M/.FO?!HK9];V=5JJI#3)$F\;9XQN=F\+!W&#>LX'U#$X'->JS.*TLVG)ZIKY
MU7X9B]WAHC8?'ZYN:;L"),V4$55H6<:@HK V:-(IW"2<*^,0A5TA Q/.6JA4
MGT>J<&[]LW5$"F[(8E$IKIBCG::<F0WGH@P!@# & , 8 P!@# & 5%4JC9KW
M8HJI4^$D+#8YMT1G%Q$8@9=TZ6-U,(@ ="(H(IE.NZ=+G2:M&R:KETLBW244
M+&U"INY S-1T1QM[)#CO:>6'+&W13:TL8P6GBM00D)568D6RRL;JS4T2NJW6
ML5SL1T%&[EZD9LF9LB]>/7<+48R:E1Y+2T<;DKH5WYLVL[-MJZ<3[?,7\?.N
M[3/M(-S=IER+E=T;,44@*=#%>0&F]4,WRCNOZOHQG0+)1Z!Q(@G*6B;,DA)7
M2TJ-D',_*D2211CX"*K\)$9G?! H%SQ?S SZ^36]C:[VW;ZWVAO):JF3U-1)
M?X0XV4B>9"!-DWV&="5/:DBS<DZ*TFA2:!AJ11();'=V820*)Q55%"PC*UM*
MP+U?MYZ&_A@YQ@# (UT][-:E]'J_CG65U>KW!7,Q^B93Z.>_AE<@*8UC[-M>
M_4>I_P !8975ZO<BHM%L5QD*, T\/*6.QQ>;D@Y?M#>,]5,\VC3(-(>2E#@F
M0J/M@4:OL2H--K0[-L057ENHD.U28VUH0BJLY1V+.3;BB]J2Z$^-[*TE]+HZ
M/+^V:57$?ECNCA+ONB\B]"V0U>OE(?=\6[@%EZ_;*\[$B<]2KA%I+-PF*K9&
M1!9RC$5D7")@;2D4[CIN.C)-F-XH5%"T\>SP9TN.-?)3BAVY?%!G=:4\;TS<
M%,;MVMQISIPV>WS1U\>MA%1B^3 &BMGUO9U6:RT'.(I-HVSQK8P@6#M\')QD
M%Z@C<#FJ8K/YG[7'%:6;3D_2)?.J_#,6&XM,; T5<WM(V%#*1DBW$ZL>^2[Z
MT//QO?$B,O!2 IIIOF"_3UB!4W+1;OLW[=H]17;)]D,2C4UZK(YVFG)D59Z(
M, 8 P!@# & , 8 P!@'LUZO3MLFXRMUF)D)V>F7:;&+B(MLJ\?OG:H]"(MVZ
M)3'.;H G.;H!$TRG54,1,AS ;24W<D#+VRBN.?9)<?+%S!YB6>,;W)C'G9P<
M,Q,TE)D)V29KFCM::PBU%T0LVPK$5-9O(RJ*J,;&1R<BX6D8NI1U@L+ODM+3
MCN5T*[\_P;6=FVY2^I]OGX.>+VDG:)[I[2OD9-[QVLN:&KS$KF U)JU@^6=U
MO5E#*Z,LT@XXQR(%D9V1,"<C<+0JU;N['-"*A6\?#,H2$B,CO@@4"ECB\V;#
MODTO8XN]CVFM]HOR5JITM<4R3^$.,%(G68A\>[K%.3IEW#),G).AJG29!$Y:
M(!R&&=N38;$F9O'5:/-81E:VG[%ZOV\]#?9P<XP!@$:Z<]E6OOJG"_@T\KJ]
M7N146BV)*R%& , 8 P!@# & 1OIOV0ZJ_=O1OY8B\KJ]7N146BV)(R%& , T
MU.W^[ IUM=S<.<W!ZF^/LQ4'MDW_ *%K;+HKL8Y0,YE-GZTB6I.BFP# "KNY
MU!FGW[V8%9^"1/=S2+&Y#:SM9?3$[L'E^-M#2_XN<J-]\*-UUS>?'V[RNOMC
MU-PHV5,0IE8J>B%%TAEZ?=*^X$&=AK$MYLFE*PDDD8@+(-GS0[*7CX]^T'0X
M5$I-37R],Z*G9X]KQPP[8W6S/1>Z8>O:PY,E8 >7TY/R8-4;'+,VAQ<7+0%L
M=J)NY4I4RKO5JUYP%TK[0K]I)L;#6VRMBE+"W"YJYHY+2R<-5.'!Y:Y;/L4O
MR6[._:.G%9"RZ^1?;.URF*KCSB-:^+;Z\U#J?N3T&T()WS=NGU\2:A4E6PD2
M5=/V,,EW"&Z8+5.Z*YYX/Q\O.9PM4O7SY,QWB @(@(" @/00'U" A\X"'ZA#
M-CR?S & , 8 P!@# & 75\>N'>X^1+QNZKT.:NTCQ@(^O]B07:P2:9#]U<D.
MGW2NK&^(!3D*VBRG;)+@1*2?QI% 6#..TA@YO+Y0]*%O3,OAY)<K^ O8>:@5
MEKO,%NN^;3"**5B@13B->;FVDY*)B(F*VZJM]<ZU)(H&!Y/R)&\*@1FHDW^-
M]K;MHY_RQ1Q1N^F"P1O9V;;DEK%A\Y'/.[1+M)^2':5[D5VCO2>*RKL*=\SU
M?J.O.'25 U=7W:I#'8P;%8XFD9V1(@V/9KA)E4F["Y;MR*G9PT?"PL3Y.R"!
M0*ZN+,KO88=A';.=EE@.2W)J"F*EPWKDH1Y#Q+H'<1/<C):,==#P-=4**#Z/
MUDU=(G;6^ZM3HK2ITW%5ISCX4&:GJB/%I:<-T/W8\OSEW.D#7Z_!5.!A:M5X
M:+KE:K<3'P->K\&P:Q<+!PD0T18141$QC))!G'QL:Q;H,V+)HBDV:MD4D$$R
M)D*4!RGKX P!@$:Z>]FM2^CU?QSK*ZO5[@KF8_1,I]'/?PRN0%,:Q]FVO?J/
M4_X"PRNKU>Y%1:+8KC(48!_#% P"4P 8I@$IBF ! P"'00$!]0@(>H0'U"&
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M (^Q:=MORP#CM M%V?'OA[MV[*IIF08+[5N-*U-'("'4J:XQU-)MU==N0?\
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MI#H'[<4_[S0O];B3R?1B:S75#TAT#]N*?]YH7^MQ)Y/HQ-9KJAZ0Z!^W%/\
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M"*];7ZB(ZZH**UUJ22J5*JJ:J2ECAR*)J$@F!3IJ$,\ Q#D, E,4P 8I@$!
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M"_9;'\C DLET1ZR222"2:*"::**1"II))$*FDFF0 *4B:9  I"%   I2@
3    8*?I@# & , 8 P!@# /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g463041g10m40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g10m40.jpg
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M8X*VUN$E)CB#HJ.RQO%WAL+B)T9'9__:  P# 0 "$0,1 #\ W^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                  ?GN27Q41?O
MGT_Z#^!@#CKG0FU=JY<9*O[%3S9*^Z7P-77[A@#PE:UYF9)E-K,BZF2"6OH1
M_ _F)5\>GI]\-_9[0?D[:'UZ$<A77[J(4M1?'I\28Z?_ , #\G<0R^)2_P!_
MV";T_P"GR !_/?,#KT-;Y?#U.'+(O7[_ -H] !_%WM2V?1R:VV?7I]L0ZWZ_
M^>VD ?U%Y3N?J;.#\>A$<EI!F?WB):DF?[GIZAN#GMR&'DDMIYIQ!_!2'$J2
M?[QD9D8 \W4OO@
M
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M? TH2DR_>,B( >3H7W@       'X6VVXGM<0AQ)].J5I)23Z?#T41EZ?< '
M>IJA\R-ZL@N*3Z)4J*SW)^[Z*)!*+U]?0P!PU8Y (U''<L(*E'W&<.QF-)Z]
M3/T94\N.1$9GT+RC(ON=/N@>/W7<,=51,@DN'W)/R[.+"DM=J>IF@CC,PWB[
MNI$:S=4KH7W/B ^T<94W+(9_;ZBNM&R275==,<A.F?577MC34O(]"Z?&7U,_
M@1? !^7Y=S^)S&L:,D6K%A2.&:4_^4HCB6.Y1]I$4R/[1$^)&?53R2))=RNT
MC(!^7Y>T[%$G0K!HGX,N-,9/T\V,^V^CK][N;4HB/]PSZ@#E
M
M
M    !\ !Q5S8Z%FUYGF.ETZLLD;KA=2(RZI01FGJ1ET-70O4CZ]# 'Y[YB_U
M#+;*3^"GU]RR^'^Y->A^G7]4\DR470TF7J /R41Q?],27G3/K\UL_9VD_N))
MKHZ9? ^BW5'UZ_.Z'V@#SMQ8[1]S;+:%>OSB27?\X^JNJSZJ/J?J?KZF /.
M                         /&XRTZDTNMH<2?H:5I)23+_ ()]2_[ !U27
MA%&^Z<J&R[4S>O<4RJ><A/&KX_/4RI!K(S(NI*/H9%VF73J0#?V'KSCYU2=5
M19D/*8:/7V:Q;*#9]I?UC4Z,DVE&9$9D;\60LS,BZE\ /O;Y/D_ OX3DP,[I
MWGTP;9$G'+(^U/LMRW[.PXXH^TD1K'^DGS4KH32%.LR7"-)E'(S,B'S;[?R'
M=@
M
M           ?A;C;:36XM*$E\5*,B(O^D <7VAYWI[,PHTF?JZ_W,M]O3KW(
M0:3=<ZF9$1=J"/UZ+( "BJ<]93SCI_V".K+!'UZET0@^]70RZ_;7'/@1]/NF
M!R6VFV4DAIM#:2^"4)))%^\1>@ \@
M     X,^M@6;*H\^*S*:41D:74$KT/X]#/YR?WR,C^\ .CGBUWCR_/Q"U7[)
MZFK'K9;DNL,NO7MB+-1/P#]5&DHSC31K5W/-O=.@?E^7Y?@/N^_G]U/W_C_Y
MGLJS-83\I%7=QW<=N5&2$19ZB]DF+/T(JZQ[4,R>X_FH:=3'E+5U\N.M)=YA
MM^7Y?EY'= /@
M
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M66GVUMI [$
M        &?3U/T(O4S/[@ X!REO&:(2"=Z&9*D+,RCHZ=>O;T,E/&1]$]&S)
M/4SZN)-/0 >1J*E)^8ZM3[IF9][G0R1]XFT$78V1=?BDNX_Z]2S]0!RP
M                                              !CC),)==E?*#%9
M:J3(V4]">8Z%&G-D?<J-.CJ(V9++A_JFW4*3U)+B.QY"'4C[OVV\T_+R_+[1
M_,3V U;358YD45-#EK!*(X#BC*':I;(S7)IGG#ZND24FX[!<,Y<=!+47M,=M
M4HP5/:GE^7G^'R,D ?
M            U7] <G=E<<<H>L<2G>\<:GS?,R3"+-YTZ&\;2HD+>0E/>JJN
M$,I),6YA(*0V:&FI;4^"ER"Z!L1:!Y(ZUY$XU[ZPJR\BXA,M'D>'V2VFLAQY
M]SHG^B8Z5&F96NN=2A7$+S(,HOM:U1YK<F%' S\
M                                 #COR6HY))9]5K/HTTGYSCBOO(27
MJ?\ OE?J4%\Y1DDC, <<F'9?SI1]C?H:8B5=4_</^B%H5T=,O4C0DR9^XHG#
M(U&!SR(B(B(B(B(B(B+H1$7H1$1>A$1? @!_0
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MCTAQ7NZY>5T)6/RWEJD.*2JHE3#<<A0@+$
M                         !P'9BE.G&AI)Y\NGFN'_L$;K\#>,C(UKZ?.
M2PV?>9=#4;:%$L >2/$2RI3JEJ??671;[G3O,O0^U!%T2VV1D1I;01$1^I]R
MC-1@<L
M     '2,ZP>JSBF?K9[*#>-"CC2.TN]MPB/M+N(NXD]WK\>J3^<0'U%5/W/W
M.YB77FQK3'<@:U;L>0LK(W/9L0R:6OH5ZVDC\JFM'UF76[0V1% EK,_?+9>2
M\KWJA*[,?53VIW3][Y?R_?)(@<0
M                #34?_P!G>_XUS_OF /$ /TE2D*2M"E)6E1*2I)FE25)/
MJE25%T,E$9$9&1]2/U( 6R<3/$5LL5]V:]W[-F7>-)\F%3[%4EV;>439=&VH
M^4(03DJ]JFR[>VU;2]=PR)7M*+9I:%0@+NJFVJ[ZL@W5)8P;>HM(K,VMM*V4
MS-@3X;Z"6S)B2XZW&)##J#)2'6EJ0HC]# 'L
M                      !ZM3STY2FH:C:CH7V/3.A=7#2?1QJ'U)1&9=#0
MN0:>QM75+?>X1FV!SF6&H[:6VD)0DNI^A>IJ,^JE*,^JE+4KYRE*,U*4?4S,
M_4 >8
M       !AS<>LX.P<<DM^7V6L5LW8<EE1M2$K:^V-J:>1T<;?9<)+C#J%I6V
MM)&D^O0#DU=E^+V_E^7V_(Z%H/<-AD$F=J_8#OE;%QB,IV-->[6RS/'V%I83
M<,IZ)25Q 4IJ/?14%T<4XQ:1R\J5)CP <FWR=_W_ "]I* #B
M                                    &FH__L[W_&N?]\P!X@    2[
MXQ<P]B<<+-NO86YE6MYDKS;C!Y\I:&6%.KZOV6-2UD[[DM3ZFMU*&W*ZR]4V
M$1Q\HTR(!L/:>W7KO>F)L9?KR\:LX9^6U9UK_9'O,?G+1WJK;VM\QQR%*3T5
MY:R4[#F(0<BOERXIH?4!E<
M   ?PS(B,S,B(BZF9^A$1?$S/[A$ /4&IRU4:6S4U6%TZO(5VN6']D3)EU4F
M']PW2[5R#_V,R8,G'0/;(2E"20E*4I21)2E)="2DB(B(B_<(NA?>+T^X /T
M
M    9$9=#]2, 08Y/ZUNH+M9L[ )"JG+L8FHN:BPCI(S9GQR<[F)#?PDP)\=
M;L*PAN=6)D20_&>2IIU:0.2;*FWM\T7\O/XO/[1(?1FWJC=>OJW,*]DJ^S;=
M=I\JH5.=[^.Y17I;39U;IGT4MD_,:FUSZB2<JKF0I*DMK=6T@<?+LIF
M                                           !IJ/_ .SO?\:Y_P!\
MP!X@     !D;5NV,]TSED/,]>W\JCN(W1M]*#\VNMH1K2MVKNJ]9^S65<^:2
M-<>0DS:<2W)BN1YC+$AH#84XL\U<"Y$0XU!9'%P[:;$?K-Q.3(_H.[-EOND6
M&(S'S)4^/VI6^]4NJ.WKFR=[TS8<<[-T":P
M              .K+(\F=[$J_P#<XRM27C29E[]>0?:;25$?4Z9I?<ET^A>\
MGD&A)G7H4<X/W_WOR_+OY=H2E*4DE)$E*2(DI(NA$1>A$1%Z$1%\" ']
M
M    >JNJJ-=5LNNE-I<:D,K1T41'T-23(CZ'U+T, 5@4-Y*XN\CT*L%JC:VV
MM+A8WDY*5V0ZF^4\IO&\E47HAM+3[ZZV>Z9$7L4U;RS/V5KH.2]TW_!Y_:[_
M  )Y? O9.Q:H!Q
M TU'_P#9WO\ C7/^^8 \0       #E0ILVMF1;&NERH%A!D,RX4Z$^[%F0Y4
M=Q+K$F+)86AZ/(8=2EQEYI:'&W$I6A1*(C &;OJHN1_[>>U/QWR#^? !]5'R
M/_;SVI^.^0?SX /JH^1_[>>U/QWR#^? !]5'R/\ V\]J?COD'\^ #ZJ/D?\
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M]@
M            "'/+S5$3/,%L7BCDM],5U*EDGYR%D@S:<(R+J2D+[5$KJ73I
MU_= Y-^#?;?_ )]O+[?[GW/=\.=J2MG::K&+R0;N9X#,?P7+D.J/VER;3(:]
MVV3B5F;BDVE,] DJ>ZJ0Y+]L0E7<RXA ^+V7\OR_ 2K ^
M                              %$^]/#!SG'%3K[2=XG/*@E.R/DI>.0
MZK+XK?4U^7#G_P!"T5\:$DI2C5[BE*^8S&@S'3ZJ K!R'&\@Q*WF4&4TEMCM
MY7N>5-J+NOE5EC%7]PGH<QIE]!*+YR%&CM<09+0:DF1F!Z4
M                               $_>"W&!W<F9LYIE$ UX)BTQ+K3,ED
MG(M[<QE(<0VZTZA34FKK5FAR0RZ2F+&><>O6U+A-7;4<#8G@PHU?%8B16R;8
M8;)"$_$S_KE+6H_5;CBS4XXXKJMQQ2EK-2E&8 Y@
M                                                    #U-[5LW-
M5-KGD)6B2PXWT,NOJI)D7_;T_P#Y %.L.]G\7>6-+=ON.QL"V%*3B>8L&;A0
MV#GR&VJ^[-I)^6EVND^SOO/J)2BA(E-]>BB[1S5%5$7;S^#X?M)[?+[FZ[ES
MY&1D1D9&1EU(R]2,C^!D?W2,#@?T
M              8NVAI;5^YJCW-LG#:C)F&VUHAS9+*H]S5]_4U+J;R&J/;5
MJC5T6M,26TT\9$F0V\CJ@P*C-X^%SD]-[9>:*R$LLKT^8\6%Y2_$KLD92751
M,U=\28M+;GU/HANQ:H7&VTDGVF<\KJH"K;*L0RG!KJ5CN98]<8Q>PCZ2:J\K
MY-;-;29J)#I,RFVU.1W>TU,26N^/(1T<9=<;,E&!UP
M                     &4=.:LO=QY_28/1MNDJ<\3]I-;:-TJNG9<;3-FJ
M3Z(-W[8W%@M.K;;DV,J'%6ZREXW4 ;2.HM94.IL&I,.H(C<2+6PVFE(;Z*ZK
M))=>YPTI6ZKN[ENON%YLJ2Y(F2#<DR'G%@9.
M                                                    %>/.+4;.
M5XI(M8\;O?;:-Y)I(NXGF4*/H1D74E++J@E=?3NZ_OCFU>W*OM_+MY;=^_P?
M\\Y\0=FN[2T-AUK82//R+'6G\*RGN6:WBNL84F#YT@U%W&]8UGNVU69FHS]O
M]5K42C X$FP
M8[V/J;7&W*55!L?#Z;*Z[M<*/[QC=)]<MTB);]3:QU,6E1)41$2I%;,BO*3\
MQ2S09I,"I7>/A;6D+VR]T+DA6\<O,>+!<PDL1;-!>JO(I<F2ABOF&:C)N/&N
MV*SRFD=TBZENGU,"JG,\$S/75Y(QO.L9NL4O(W4W*Z[@/P7EM]QI3)C*=234
MR&Z:3-B;$<?B/I^>R\X@R4 .I@
M$77T+U,_0B+[H V"/#XXZGKC"G,XR.$;.4Y.3+[C;[9D["CH0LH\+HM*5-JA
M(><0\1))13WIWVQ^.F&I ^^7V]OP_@7\E+* /@
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M7Q&TM1XC#<=IM!$220TDDET(B+[A?^S[@'PYP
M                                                      #QNMDZ
MTXVHNI.(4@R_X1&0 J%VPM6J>6VF<X9,XL9W.(6-6SO>AEOW5EJE4$WSW#-*
M"9:1-.0OO42>K1&9D9=0.2[JB+\O?X_C^/MYEOP'$
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MU!+RL]Q]02Q013S.V3DQV6W;0N\SE1D44CJEZ9R^I1V[EC8ITV'
M                             #^*422-2C)*4D:E&9]"(B+J9F9_ B+U
M,P!C[%%GD5G99<Z9JBNJ764#:B^:W5QW#)4I'7^NL'B5)4HNA^6IIL^I,I,#
MZOP?=^7X/M?A,A ?
M                                    "J7Q$L>-%$=]&(VY5<Y&LX[B
M"Z*;>A/-R$*2:>BB42D'T41]2_>^(Y)MLOP]]E[;]N_R_(O<LNP/(F\OP?#\
MK:,E(R3&*&\(R^X=I5Q9JD]/N&A3QI,ON&1D!Q.V
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M*BHBHJ*BHBHJ+NBHO=%14[*BIY*?H?#Z
M     '0=@V;K%7&HX2O_ "EE$HJE@B,N]J&LB]YRB+X]K497D$KIT0]*94?W
MC'U/WN_Y=E]I!_Q+^8&1^'EPZM]]8-A6/9W;8UE.#8K'QS))MC75+[&3VQ5L
MF4Y)JNDLG8R3-UA*?F+7Z+]!)=)8*'468BQD\\E>-\$\JRQ-:]Z+"SF1-G^K
MZWM4PN?RLF(QTEZ.)DSVRQ,Z;W.:U>H[E5=V[KV]AK0_95O(C\%;2_XVYQ_I
M"U?>AQOV7O?,UR!^^%<^QU;YZ7\ ^RK>1'X*VE_QMSC_ $@]Z'&_9>]\S7'O
MA7/L=6^>E_ 7>^$)XP]5XDI[-P3/,-QO56[< *-DM=B5!<3[.JR_6\OV.O?R
M"H7;$F>5CC>0O(K\DB*[V&(UYC4N*XZ<N<U"@6M-%/TOX2Q7GEN4+.\3II&-
M8Z&TW=R1/Y/5Y98DYHE\U6.5%VY6JZ5:;U,W.>(BEB97M0[2-C8]7-D@79JO
M:KD1>9C_ %7IY(CXU3?==KOQ B5@  !0#XN7C;Q/#PV+@FE=58%BFWMK6E*[
MENQJ[([JSKJG L=G]K6)0GE4A*D.Y)D9MS[54"0XPJLH8]9/=8?:R*O>;L;1
MF@W:EJV+]RQ-2ILD2&JZ*-CWV)6[K.Y.IV2*+U6<R(O/(KVHJ+$Y%AVH]5-P
ML\-6O#'9L.9U)VO>K6PL7M&B\J*O4?W=RKMRL1KME21JE0/V5;R(_!6TO^-N
M<?Z0FGO0XW[+WOF:Y&_?"N?8ZM\]+^ ?95O(C\%;2_XVYQ_I![T.-^R][YFN
M/?"N?8ZM\]+^ ?95O(C\%;2_XVYQ_I![T.-^R][YFN/?"N?8ZM\]+^ ?95O(
MC\%;2_XVYQ_I![T.-^R][YFN/?"N?8ZM\]+^ ?95O(C\%;2_XVYQ_I![T.-^
MR][YFN/?"N?8ZM\]+^ ?95O(C\%;2_XVYQ_I![T.-^R][YFN/?"N?8ZM\]+^
M ?95O(C\%;2_XVYQ_I![T.-^R][YFN/?"N?8ZM\]+^ ?95O(C\%;2_XVYQ_I
M![T.-^R][YFN/?"N?8ZM\]+^ ?95O(C\%;2_XVYQ_I![T.-^R][YFN/?"N?8
MZM\]+^ ?95O(C\%;2_XVYQ_I![T.-^R][YFN/?"N?8ZM\]+^ ]C7?166\6GT
MJM^)&J)T8C+O:KMA9?5OJ3U]23(DU-PV@S+T(SC+(C]>T_@.+N$%!4]3,W&K
M\+JT+T^XCV+_ /$?4XAVM_6QM=4^*>1J_=5COWB4^KOHK#3%K)C,;GXF;+P>
M,I2&Y-EK;8&,[-4DC,B5(35Y+3:J4ALO5:F"LI#B$D9(<?5T[L1;X0WF(JT<
MQ5L+[&VJTM3[7/$^YO\ +RHGR>S(5^(55RHEK'3Q)[7031V/M\LC:^WR<R_;
M+KN+/BO\"^84NOH=0;\QMC.[$VVH^L]@MRM=Y](FN].VOJ*;*6X$;+)B2,E+
M1A=ADC2$]QF]]K<[()E]'ZAPC727<=*M=O=;594LUT:GZ)[X5<L+?\NV)?B[
MIO*<?J+#Y-6LK7(TF=V2";>"95_2M;)LDB_Y)S_E[*6+",F;(N\UM^7/%OBE
MO7D+CU!693=:EP*RR^MQZYD2HE7;28+L9M$.=)A=);+"R?,U+8^V$:2Z?=&6
MP6/9ELOC\;+(^*.[99 Z1B(KV(_?UFH[LJI\"G0REQV/Q]NZQC9'5H72M8Y5
M1KE;MV54[HGR&I+]E6\B/P5M+_C;G'^D+D]Z'&_9>]\S7*Y]\*Y]CJWSTOX!
M]E6\B/P5M+_C;G'^D'O0XW[+WOF:X]\*Y]CJWSTOX#8Z\++Q,\ \232D[*XM
M?78/N; YJ*G;6K(]BN>5&N:Y)5CV48_(E):FV.(9-#CN^QRI#*9%=<P;BCEF
M_P"P1K&RK'5NE;.E[[87.=8HV&J^G;5G+U$;MU(9$3=K9XE5.9$79S',D3;F
M5K9MI_/0YRJLB-;#:A7ELUT=S<FZKR2,54171R(G953=KT<Q=^5'.M"$3,^
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M2-I41>A*)B T:OW3]3,P.'_E_P"?[I*(
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MJ+L>0?#D                              8H@$YD>R[>P4:E5F)0V*2
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M5E6;UJT^G5HTY%+F);/H1=/M<Q#GKZ_;.O4#B3E
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M^#!9?E>B_P"K8/S*UC]>\/[7G_TT/S=-/^]G9_;;%_X='U^BG_!@LORO1?\
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MFR2H^I-[1S5"/W$FBG<,C^Z?SW%GU/J?SNGP(#XOL_+VK]S\E+ P/@
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MF0EET/KZD?WP.*[>SX_9M[5_+]PGT!\
M             ^>/+_IJ3_"'O\8H>NS/J&_XK?WD/Y^7_5N_QG?OJ<<<CB
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MF1(]ZHC6\R[*Y=U3?9-U1J+S/79C=W.1#ZH/&?CMK7B?HS7/'_4M7[KPG7%
MQ3PENI:]XW=BXI<R]RB\>90VW*R#*+J1.O;J2AMMI=A/?3&9CQ4,1VM1LKD[
M68R%G(W'\\]J17NVWY8VIZL<4:*J\L<4:-CC3=51K4W55W5=@J%*#'5(*=9O
M+% Q&IY;N=YOD?MYOD<JO>OM<J^PSL,>=L      "$O-FT1!UU*0M73K#?/X
M].G<E?\ H_\ :!R;[=_+M\J;;KO^_O[?@/-X?-<[ XK:_==Z=;6=EULCI]UN
M3E=NVDS_ '3\CJ!Q)J
M /GCR_Z:D_PA[_&*'KLSZAO^*W]Y#^?E_P!6[_&=^^IQQR.(
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M&2DOVK2K:1W$?J1F_.</U^_\"^ '$S^
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MU^H95RE.W7:O^%'D<;:L/:GP);8O;ZHC%EO@.H/S7L%Y'*3\?)KLMUR2NO\
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M /% B,Q6_P#[C1 ?F>U
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MLR-"7+%J&RAQ9D@W'4$?7J23'-?)$]B)OW[^W;MV^/LOM3Y$+M0.
M
M                8JW@M3>I<\4GX^X7TG_P5NLH7_\ <4H GFG_ "\_M'L-
M4$E.!8^22Z%[&C_IZ%U__;]\OO ?5VW7;\OB^T9% ^%$/T1W^M@9[_=4U!_E
M2D6%PP_/77_S.[_!$1UO_:";_.*W\(?.U&RQ2H 'U5?#=_6]N#?_ #2./'^:
M?%!J)JC\\F?_ -,Y+^.3&PF#_M-B?]&T?XM&33&",H   %/WCW?K3'+3^#:5
M_P#$7J(37AW^?'#?+?\ ^&72-:P_.YD?DJ_QVL?-8&T91@
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MA-M;>4OKU2IB/$@(<+MZ&F87J1D?4%7=?N?N)_S^3[A;D!\
M                              "NC6?BX>&OME;3.)\Q],P9+ZR::A[
MO96I9BWC/M*.B+M6!ACZY"E_:T,H0I;J^B6B6:D]9-;T;JFFBK-A+SD3S=6C
M2XW;X=Z;ITV^/R3VF$@U'@[.W3R=5%7MM,]:SM_@Y;"1+^X3RQ;,\/SFL1=X
M3E>-9C3.]/+M\6O:O(:QSN+N3V3ZF5+BK[B]2[73ZEZEZ"/303UW].>&6!Z>
M;)HWQO\ O7HU?W#+QRQ3-YXI(Y6+Y.C>U[>_=/6:JIY?&=E'Y'Z
M                          &+=W*2G4FP5++JE.,V!_WR;+M/^\KH?]X#
MZGFGRH<C43B7< Q]23ZE[*GUZ]?ZU)_^T [S4R4!\(>\Z.&>"<]./USQWV-E
M.6X=C%UD6,9(_=X2JG3?-2L6L2LH;#)WM9;U_L\ATNR3WPE.>7_L2VU?.&;T
M_G+&G<BS)58H9YF12Q)'8YUC5)F\KE7IO8[=$\O6VW\]S&9;%PY>D^E/))%&
M]\;^>+EYT6-W,B>NUR;+[>Q2#]BO</OPAN2G^&U?^@ GGON9O[&XK[VW_.B*
M>]]C?KV]_N_\B/L5[A]^$-R4_P -J_\ 0 /?<S?V-Q7WMO\ G0][[&_7M[_=
M_P"1-BK1.I:70>D]1:.QNRM+G'M/:UPC6-';W9Q#N;.IP7&ZW&:^PM3@1H<(
M[&9$K&I$TX<2-&]H<<\AAIOM0FM,A<DR-^[?E:QDMVU8MR,CYNFQ]B5TKFLY
ME<[E:KU1O,Y5V1-U52;5*S:=6M48YSF5H(J['.VYG-AC;&U7;(B<RHU%79$3
M?R1$[&5ATSL   !&/F3Q;Q#FGQMV3QFSW(<DQ7$]FMXHW;7^(JJTY% +$LXQ
MG.X1UQW,"TK2.38XO$ARO:8+_P#04B237EO^4\WE<)EY\%E*N5K1Q335>MR1
MS\ZQ.ZU>6N[FZ;F/[-F<Y-G)ZR)ONFZ+T,GCXLI1GH3/DCCGZ?,^/EYV].6.
M9.7F:YO=T:(NZ+V5=ME[E#?V*]P^_"&Y*?X;5_Z "PO?<S?V-Q7WMO\ G1$/
M>^QOU[>_W?\ D1]BO</OPAN2G^&U?^@ >^YF_L;BOO;?\Z'O?8WZ]O?[O_(C
M[%>X??A#<E/\-J_]  ]]S-_8W%?>V_YT/>^QOU[>_P!W_D1]BO</OPAN2G^&
MU?\ H 'ON9O[&XK[VW_.A[WV-^O;W^[_ ,B/L5[A]^$-R4_PVK_T #WW,W]C
M<5][;_G0][[&_7M[_=_Y$?8KW#[\(;DI_AM7_H 'ON9O[&XK[VW_ #H>]]C?
MKV]_N_\ (C[%>X??A#<E/\-J_P#0 /?<S?V-Q7WMO^=#WOL;]>WO]W_D1]BO
M</OPAN2G^&U?^@ >^YF_L;BOO;?\Z'O?8WZ]O?[O_(C[%>X??A#<E/\ #:O_
M $ #WW,W]C<5][;_ )T/>^QOU[>_W?\ D1]BO</OPAN2G^&U?^@ >^YF_L;B
MOO;?\Z'O?8WZ]O?[O_(GMJOZ%EX1,/(7<;TY36+*5$:F(%_J>J-PB]>U3KVI
MK4R2?P5VI2KIU[5)/HHN#^+>?5/4Q^(:OPNCN/\ W$N,.3>'^*3ZJWD')_@O
MKM_?KN);:I^A[?#!UC)C3['4&5;9L8:D.1Y6UMD93:QO,1T^?)H,5DX?BUBE
M70R7'LZ*9$/N/^AR,DFG#W.)&K+:*UMV&FUWFE.K"Q=OBDE2:9ORMD:[MYF2
MKZ,P%=4<ZM)9<GDMB>1R;_&R-8HW?(YBIW\BV_6.H=4Z5QIG#=/:UP/5N*,&
ME;>.Z^Q.BQ"F-U*";]H=KZ&# C/REI+[;+?;<DO*-2WG5K4I1PRW=N7I5GNV
MK%N9?.6S-),_;??9'2.<J)\")LB>Q"1UZU>K&D5:"&O&GDR&-D;=_AY6(B*O
MPJO=?:ID4=8_<P7R9T+CG*'0>U./F77%WC^,[8Q.;B-S=8V<!-[6PIKC+CDF
ML.SASZ\I2#822/:X<AKH9]S9GTZ=_%Y"7%9&GDH61R2TYFSQLEYNFYS-]D?R
M.:[E[]^5R+\9U+]-E^G8IR.<R.S&Z)SV;<[4=[6\R*F_RHJ&OG]BO</OPAN2
MG^&U?^@ LCWW,W]C<5][;_G1#/>^QOU[>_W?^1'V*]P^_"&Y*?X;5_Z ![[F
M;^QN*^]M_P Z'O?8WZ]O?[O_ ")>9PBXA83P7X[8GQOUYDV59=BV(6F5VL*]
MS-50K()+V6Y'8Y+-;E'1UM37>5&EV3K$7R8+:_9VV_-4XYW+5 ,]FK&?R<V4
MLQ0PS3MA8Z.!'I$B0Q,B;MU'O=NK6(J[N7NJ[;(2S%8V+$THZ,,DDL<;I'(^
M7EYU61[GKOR-:WLKMD[>1+08<R0 '5,[P7$-G87E.N]@8]699A&;4-GC&5XU
M<QRE5EW0W,1V#95TQDS(S:DQGG$=[:FWFE&EYAUIYMMQ/[5[$]2>&S6E?#8@
MD9+#+&NSXY&*CFN:OPHJ?(ODJ*BJA^<T44\4D$S&R12L=')&Y-VO8Y-G-5/@
M5%^7X.YK;6/T++PSE6$Z3!WSR2K(4B9)?AUJ)VMI:*^*\\MR/!1*E8$N3)3$
M:4AA,B0M3[Q-DXZI3BE&=H-XMYU&M1V/Q;G(U$5RLM(KE1.[E1+*(FZ]]D1$
M3V=B#.X?XQ7*J7+S4555&[P+RHJ]DW6'==D[;KW7VG#^Q7N'WX0W)3_#:O\
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M</N4?VFE9K&B29ET4E9]J34H@.*_O=B7H'P
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MAUS]G>?R_DO[NYFH#B
M                                      <2?,:@0Y,UXR2W&9<=49_#
MHA)GT/[W4RZ?WP!2!N/VKD1R8P35$=;TBLLLC9>OSC]ZR8H*Y:K"Z=6IOKY1
M'"8=90XHT(2\XT@UI-23(?HY-D1/E_<\ON[]_P#\;7AQ8S$*-'AQ6TLQHC#4
M:.R@NB&F&&TM--I+[B4-I2DOW" _,\X
M               /CP3/Z<E_PE__ !JANNGDGR)^\:T+YK\J_OG&'T^
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M):ZZM8&1Q=)/VT:_A6$N+<Q[4L5;DE9,6;#R)K4\I!F^4MM],@GC-SS.\^H
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M@5=_9Y]_M>7X?_PB%JP'$
M      ^/!,_IR7_"7_\ &J&ZZ>2?(G[QK0OFORK^^<8?3X
M                        'TF_" VNC8_&G3URJ4E^1<ZWQI4[HKN)NWBU
M46+;1R4?0UJC6D29&4LR(U*;,^A=>@U U%3]S\]EZ>VS8<A:2-/^I=*Y\*_;
MB<Q?MFQ.(L)<Q..L[[NEIU^?XGMC1DB;^W:1KT_ 7&C#'?(6\_Z6YR3B_FM5
MCM1:7UH]<8<IFMIJ^79V#J6,IJGGU-0X3+\AQ++*5.NJ0VI+;:5+49)29D!C
MKEEHK"&>).5/8-IS%6<Z*IUV<%W$]>U#>6D^K+\13;'%<IZ@K@G50%3RL?)/
MO.(<LI/VDW@!G?;]5:3>(&:4L.MGR[A_1K\!BIC0Y#]D]//$VV2A-0&FURG)
M9O?:BC(:-XW/F=G=Z "'_'_>&K]:85K.EL>*>YFMBXWC]72VF9U.AZ1,ERW5
M#.MLK!G(WK*#=K9E-OOMR9;[;$A^*Z\E]HTN+0H"1O.>PS6?J:OU9KVFNK/)
M-R95380]+JZVPF1:/'7YD=V[L;:9#8>9KH#YG!J);DQ332J^RL'2628SBD@1
M6V3IGD+HN=H+;YW5'LF'HRRH<'BXWKC [.NR(M=SXIU=JQ*3'DV#UNR=>P]7
M]ZFO.8EW;M@XI:3?4D"0WB'5-SE?'6 WB])=Y')<S[#K-$"DJ+"RL5041[5U
M<@Z^-'<EMH0EQLG#=91Y2EI0[V*/H ,@8%R]Q[8&7T6'1--<AL=DWTI<1JZR
MW6\>FQRO4B,_)\ZULT9#+5$843!M)<*,[U?<:;[2[^X@,N;]AR['1.ZJ^OBR
M9T^=J78\.%"AL.RI<R7*PZY8C18L9A*WI$F0\M#+##*%NNNK2VVE2U$1@='X
M@5=E2\:=05=Q73JFSA8OY4RNLXDB!/B.^\[!?E28DIMJ0PYVJ2KL=;0KM4D^
MG0R, 8,W1K_Y9\X^/3M[A'RKP9C76;1[UVVQOW[B;,HJS,GJ]BV7,A2J=N04
MTX3L-N89.>U'%<83YIM& .+G&J:C%N:O%RUP#6U=CF-QJ/9BLDLL/PZ-44C$
MIW$[^- 5=S*6NCP&I#JGDQX9SW$N+-TFF>IK))@6'@  .KYMDCV'XCDF4QZ&
MYRB104T^TCXYCL-V?>7DB)'6ZQ5UD1AMUUV7,=2AAOM;7Y?>;JDFE"B %5OM
M=1NKDKI#8/'W2^S-9Y+1Y85ENG*KW$$83C\O$5/1%7-;<JBS9-?9W\^"5Q7^
M9T9FV7MC33RK#RFEU@$E.9N!YS(G:3WEKK')F97VB,U?O+/$:Q"W;6]Q:X74
M+N45K#3;TB5+9]R,1TL1F)$E#%C)F-,/>RK:6!@_=>S<EYHT>.Z,U3JO:..U
M5YD]'9;'S?/\7^3E-BM%4O\ M3L5#OMDQB79)DDB63/M#3TA4!$*!&G+F..P
M0)'<YL:L;'B5L/&L7I[.XF);P&+6U%1!E6EB\Q7YYB:U)8APVGI+_L\.,X\\
M;;2NQEEQY?1"%*(#T&JN75'.1KG7CFD^1M992F\1PYRYMM9,P<;@3745]*NR
MLK)>0J>B4L9\SDRIJH:G&82%O'&-2?* 'BYNXIFCQ:)VOAV*6N<)TKM:KS+(
M<8H&5RKR91MR:V9(D5\1I#K\CR7*AN,][.R^Y'3.3-=9.'%ENL@8CRS/+CES
MN;CG'UWK#9F/XKJ;8D'8^;9=G^,GC5;#142ZN>S315^USF94^25<]%)E#_M"
MY,AA;+"X3$V8P!:0 ()\ <?OL=UQMF-D%);T4F9R"S^RB1[FMF5C\JOD4V'H
MCSXS4UEAQ^$^MEY#,II*F'5-.I0M1MK(@/USHH+Z_J./Z**DM[I==R*P2SL$
MU-;,LE0*Z/&N"D6$Q,-EXXL)@UH)Z6^2&&C6DEN)[BZ@=PYLZCRC;^DGX&#L
M>VYGA>44FP<:K4FA+EI.H6K")(@1S<4E!RW*NVGNPF5&12IK,>)U2;Y+2!'+
M:/)W,M[ZKM=,Z\T)N"%M78%4WBF21\CQ5VFQ;#FK VXV2R)E[*?(_9"8.7$@
MR+*+5-MMOIESE1WV$UTD"55_KB1@'#S*M75Q/75CCO'S+,6;]WQWGW[BY;P*
MSBOJ@1&T*D.KLK1;JX<5#:WU&^TPE*W.G4"&=YQ4NMI</-0W>-0+'&=XX%K>
M=6PF7&9%-;9!CUDU;1<@P&W0\F/)0=E7SYR*QJ:DFD2)DJO>\F#=3WT 3,XR
MKL,2XIZS?L*.Z<LL>UR<N3CK%=*._D2*YJ;).JC52FDRUVDE311HL+R?/=DN
M-M)0:E$0 @?L2]K.0NS=09%HW1.U]=[TI-B4=KFF9W.&EB%358U&\[W^C+K:
M++4Q;NI>]F2P_8QD3)M8B;4FEQR>U4N@7&@  .#9I4JML$I(U*5!EI2E)&:E
M*-APB(B+U,S/T(B]3/T( 56\*.'>H<AU)CV;;:U+)D;!;OKY#S&7.97 0<6#
M9K16',Q*9/BT\A@XZ4DE,RH>8E-_/=2\9FHP)][YS.VUIIG.<DQ*EL;;(ZW'
MW8&)4]#5R;*6=Y8^74TJV*VO8>=<B5<J4S82T-M$ANOA2#,T)3U("K>PXC<C
M*[BQ4Q8^6XTMK&/(WE!PN'A]@G8L?-?=SMM)C%D12UR)61PHLN17)CIA+.3(
MB1X+2%.I9< %@N4Y-=[4X;9KD+N/7$#*<KT/FK<[&'JB?&N&<H7B%O7653'J
M'HZ+!:U734ABN:*-YLQA49UEM1/M]0(&5''>\P#0_'SDGJ_ '&-QZM;3=YUA
MLBDE(L\XHW[.;%LT3*F1&<F)R"M@J[XTAB(U8HK9$J7&4NPKZE) 6[X=D\3-
M,6H,K@P[.NC7U7%LD5UU D5EO7+D-D;U?9P)2&WXLZ"^3D64TI)I)YI9M+<:
M-#B@(;:%Q^^K^7_+VZGTEO!I[GZ7/N>VF5LR-66OLU.XB3[MGO,HBSO9UF2'
M_977?*5\USM/T '=^=-/;W_%;:M1155E=6LMO#2B5E3!DV5A*-C8.)R7BCPH
M;3TE[R8[+K[OEM*\MEIQU?1"%*(")?,+BM<Y;J2AVWK:#81<ZKM<8K3;,QBN
M:?9E9QBE5!I9[:I,!I*7)UWC$ZI@2CAO-+?FPJZ.A/=-I*N,\!,'=E5:6/#O
M,J>OK9\ZVDZ89AQZN'#D2K%^6=!#045F"PVN2[)-9&CR$-*=[B-/;U+H (H:
M WCJ[76(:OHYG%3<L78F/XY18[:YG5Z(I&7G+DZYJIMK).2.64*Z7&F&[)]J
MFR&V9,B(\][2S]L<;,#,/B/8]?Y-QT*LQNCN,ALOE[C$CW?1UDVVF^SM1K@G
M7_9(#$A_R6S6@G'?+[$&M)*47<74#IF2:P+B3R$Q?;NK,$DS-/[*CL8%LO&,
M4H)5Q,P:89MNP,JIXE?&EV,6G<.*B99,1FUQS<BVC#B3E6M*W& LBD2F(T9V
M6ZXE+#32GEN&?S?+2GNZ]?W2^'W^I "E/EKG&0[EV7C^GL+4J3;91<Q:IIMK
MJXU&1(<\MR4_Y?52(D",3DN8X:2)##+CBO0C YKZK=O:OG_Y?+Y+\.WD6]:R
MP&GU=@.*X!0H[:S%Z>-6,KZ$2Y#J$FY,F.D70O.FS''Y;Q_=<>48' [T
M                                          /CP3/Z<E_PE_\ QJAN
MNGDGR)^\:T+YK\J_OG&'T^
M!N=?0Z>[CM=,?(!Y\U3-99S<U'D*,UN%29&^C*:Z0I74^C+LZUO(3"%>J2KE
MI3]K)M):X\4\?X74C;B-]3)4X)E=MV6>NBU9&I\:110.7_*?&7/H.VEC".K*
MN[Z-B:-&]]^G-M88OR+(^5J(OZ3Y#;L2?<1']_H?W_B74O\ L,5J3$_0
M
M             "+'*';T#76%6*/:6T2G(ZS4GO22C4:3\MLBZ]?C\]7I]Q('
M)J>WR1")_A_:EL,BN<CY+9C&<]IN%S:+ &I2.IE7&YV7%^R2C,R]I=0JKB.$
M1=669QEW(=0H#XJ[_P#EO_S[K\/<M7 ^
M                   ?'@F?TY+_ (2__C5#==/)/D3]XUH7S7Y5_?.,/I\
M                                     "Z[P,-Z/:RY5VVNGI/DU^WL
M4=3#;[S3WY3@13,BK3(C,D=/DV]F"3_W0W#9)!GZI.K^*N,\7@H,BQN\F+M(
MKUV[I6N<L,GQ_P!?2JOP(B*JDZT#>\/E9:;EV9>KKRI[5GK<TC-NZ><*V$^'
M=6[? OT/];Y(WE.(U5DE9+<]G0R_T,C/S&TD74^AG^J2:3_?ZC7<M]4V7;S.
M]@?
M                  #K669+"Q6EF6LUUMLF&7%-DM9)[EDDSZ^IE\U/3N4?
MPZ%T^Z 1-RE3(_E-S&WY!UY3.RODA63$V&97#!J-FNHF)!>V+-WM6TB7-Z'"
MK4*+Y\AQ/^YMN*(<U[=M_AW^W[//?;MWV]B_=NVQW'ZC%**IQNAA,UU-20(U
M;6P8Z"0S&B16DM,MI2DB+T2DNY73JM1FH_4S X'N@
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M/+Y5^,F8!P
M                       #Q/OM1F7'WW$M,M(4MQQ9D24I274S,S %2O,K
MD#87$YC6V#(D65[<2&JJ#7UR%2)4A^6YY+3#3+/<XM]]Q:2)))Z^I%\$F8'Z
M)ZJ?X2_;_+X_^>Q,KB;Q^AZ%UO'@SD,R<YR4VKG-+4OMBG+!QLO)JX[JDI64
M&I;/R&T=.BY*I,GKU?Z$/S)2@
M              ^1GK_1FZ]U7<JJT[J'9VU;+VYYE4'7.!Y3FLEMU3AF276L
M<J[);/1*B4HW20E"#[UFE'4QN99R%"@Q'WKM2FWEWYK5B&!%3XEE>W?[1KA#
M4M6GJVM6L6'<RIM!#)*OW&-=L6=Z>\ KQ/MN^RR7M$0M44TOL[;K<.;XQB?D
M]_0S]JQBOG7^>QO+29*63N(I/U-*"6XE2$Q.[Q%TG2W1,@ZX]-_I=*O+-OM\
M$KVQ5UW]FTWQKLG<S];1V?L[*M1M9J_H[,L<>WRQM5\R?-_\RU33WT*=FLKV
M69O[EIB]'V]AS<>T_@-ME7GD?3S&XV89I98>40T^I(==P><2_0S91TZ'$;O%
MZ!-VX[#32>?+)=L,AV^!5A@;/O\ &B6&_*I(*W#R5=EN9*-GPLK0NDW^265T
M>WRK$OR(6J:>^APO#4UG[+(R_%MH[TL8_8ZI[9VR;*OKU24]%=Z*C5\77<5R
M*2_U$*R5:-*;Z-RE2R[U+B%WB?JFUND,U3'M7MM4JM<[;XWVUM*B_"YG)\6Q
M(:VB,%!LLD=BVY/;/.YJ;_XM=($V^)W,GP[EJFG^&G$WC^49>EN-^E=;3HA(
M\N[Q;7.+U^3.*01$AR7E)5J\CGO)(B)+\ZTD/$7H2Q$+N<S&1W\=E+UIKO..
M6U,Z)/B;#S=)J?$UB)\1(*V+QU/9:M&K Y/T<<$:2?;DY>=?MN4DJ,6=\
M                              (3[GJY&N-K4FQZU)MU>5FQ&MNQ/VMJ
M\KD-,J<<Z=$I*?6HC+;3\5OPYSJC,UF!R1>VR^6R_!]KY=EW]OM^(F'26L>Z
MJH5G&6E;4MA#I&DR,B4I)&I/IZ=4GZ <3VH
M                                              &9%ZF?0OW?^D 0
M4Y9<CZO7N.S*BNF(79/MK;;;;6DW''E$I*3))'U\M!_#T,C/U,C/H'G^7Y?:
M^'V>PYM1$[K[._;;MOY?_CXOC1#&G"/CI8^TGR'VE$4]E60(6_A%7-)?FT=5
M))1*N9+#J4]EA8M*[8*3+K&@J-[KYDHB;'%5W55_+XON%FP'P
M                                       X%95UE) C55-70*BLA-DS
M#KJR''@0(C)&9DU&AQ6VH[#9&9F2&FT)(S,^GJ.3WOD<KWN<][N[G/<KG*OP
MJY555^VIQ:UK$1K6M:U/)K41$3Y$39$.>.)R
M                ,?[0PAC8.%7&.+)M,QUHIE.^YZ%%N(9*=@.FKU[&W%]T
M60HB,_9)+Y$1F9 #!_''.G'8<S"[GNCVE1)?BG'D'VOM/QEJ:?CK0KH9+;<0
MI"D_UKB3+X^@')>_?[2_:V^W^_\ *2P X@
M                                          ^'J8 BOR+W_1:NQR<@
MIS1SULN(2A#B?,4X:5$EELB/J9F?ZLR/[R2Z'U,#DUN^ZKY(0?XR:&O^0N:-
M;VVU%<5@L&<N1B=!.2KMR69&=^US'65ET520G4^O=\V=*;)GHIAMWO'UR_\
MEV_=W^%?W/E+AD(0VA+;:4H0A))0A)$24I21$E*2+T(B(B(B+T(B(B] .!^@
M
M                                   !#'=^-3-?YM5[9Q]I3=99RF(F
M4-L),DQK$NB6+!:4$24M6#:22\X9$7MK)J<6IZ<@C')%]GP]OB^+?Y%]OGL2
MFQ#)8>54<*UB.H<\YE!NI29'V+Z>I>GW_0S^]U^X!Q.T
M                                                    (S;]Y 8[
MJJ@G=\YGWB;+B&TH<0;AK-!D3;1$KKW&KYJEE\/5*?G>H?DOY?<^T<D;VW7R
M^5/A_+V%>FDM)Y?RWS,]G[-*= U36SE*@05^:PYE3\=WK[%$,^AIJT*(T6$Y
MOT4KNBQU&X3JV?OEV^[V_P"?[_E]L^N7R_YHGVO_ ,)V^5%W6Y:MK8%/7PZJ
MKB1X%=7QFH<*%%:2S'C1F$$VRRRT@B2AMM!$1$7[_P 3,?#@<X
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M (MD_P"D8BOYKC7'ZW-*?-Y?^E3J_13=_4*OWLO\J/KE^WO[1M;_ ,6R?])
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MS/A5$\V+^B8K5V1=T2SIA]J2RV^RM+C3J26A:3ZD9&7W#(3L[9Y@
M                                                      'Y4I*"
M-2E)2DB,S-1D1$1>IF9GT^!?=^X (A\A^3>-:OI9<:+,:?MG&G&VFFW$FZXX
M:3)*4$E74D&9%W*]#/\ K?3U!._D<FM5>^W;O]O\E(8:1X\YGR=R!K:VY3G5
MVNBD%(I*!Q;L>5DZ$.=R3(C(EQZ4S(VW))&EV7\Y$4R2E3J?O;;_ )_E^_\
M ?57MMM]KX/;^_\ '[.Z%OM555U'70JBHA1JZLKHS4.#!AM(8C18S*>UMEEI
M!$E"$I].A?'XGZCX<#V
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M/>]=_;W.@][Y%YGO<]WZ9[E<OW555/7CJG$
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M23)25)/X&1E_V_>/T&3/IY
M                      <2=.B5T=<J8^VPPV1J4MQ1)^!&?0NIEU/T^  K
MPY'\PJ['&GL6PI9VE]*5[,Q'A=7W3></RT$9,F:E*4HR)+2"5U4?P49D")OO
M^78YM:FV_P"YW]B^Q4\_E3R.FZ X>W>;6T;;7(DG9DB0I,^EP*6I?VLC6ER/
M)R%M70T)Z?.15DKJI*DG,,C[F"^[_!Y?:W_+V?\ Y"N^#X^^WY+OM^Y\"^5H
MT>.Q%89C1FFV(\=I#+++*$M----I)#;;;:")"&T)(DH0DB)*2(B(?#@>8
M                                                     :GCZ>Q]
MY']@ZXG_ *JS+_V#Q2E3EDD;\#WI]QRH4^>(<
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M*B6&UT<L;987))&]$<QS5W:YJIYHOVO^1-V/(9E-(?8<2ZTXDE(6@R4DR/\
M=+[WW2/H8[@/,
M         ,?9ULK&,!K9$^ZL(S/DMJ6;:WD)^!&?1?57W2(^B2ZJ/T]"Z]0/
MJ(J_)\*^15QL/D+LSD'D_P!+O2M7.GN2E&T]/82IN)#BF9I<E2I7HQ"BH(^J
MWGEI+J71)K5T2/NWPKM\";=_9^6YSV1J(OM\^Z?)NFW_ )[_ !DN.//#W%=3
M*8RW+W6<UV6]VOO7$U'GU])(5ZN-TK+I=3<3UZ'/D(\]1E]I3'1Z'\W.*N54
MV_+\OR\NQ- #B
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M>G]_T&;.6VWF>[
M     ' L;2#51UR9\EJ,RA)J-3BTIZ]",^A$9]3/T^]T^^8 @UNWF;C.&I?J
M,:<]Z7"R4RTQ#4E]U3I^B>OE*49=3Z$24>IGZ=W7T#\M_@.:-_3?O_)\OGW[
M)\!'/#M!;NY/V;.4[4FV6"Z_=<)^/ <0MJYM8RCZ](<)TNK#+B?3VJ6A*3(S
M-IEWT#]W][\/Y=PJHB;>?GLGX51>_P 6WV^_E9[K?5F#ZHH6<=PBBB5$)!).
M0ZA!.3I[Y%T5)GS5]7Y3RSZGU6KL1U[6T(3\T#BJJOF9# ^
M                                               &J7>)[+JW1TZ=
MMI8)Z']SMENET]?7[@\7,DG+D;[?TMVTGW)Y$*A?]6__ !G?OJ>K'2.(
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ME1$M"DJ]%>GQ^X7P%L&15JI\AGUIYI]"767$.MJ+JE;:B4DR_<,C,@.)Y
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MB_ 2Z(B(NA$1$7H1$70NGWN@'P_H
M                              #53R9/9DF0H_L+RV3_ -6?(+_V#Q@S
M"<N6RC?TN1NI]RS*A4<O:61/@D?_ /4IZ,8X_,   /ZE)J,DI(U*49)2E)&9
MJ,SZ$1$7J9F?H1%ZF8^HBJJ(B*JJJ(B(FZJJ]D1$3NJJOD@)@ZAX1[IVG[+8
MSZLM?8N_V.'=Y:P_&G2(ZO7S*K'")%K,-2#2XP[-355TEM7<S8J^!WKH;T>>
M(&LNC;LTTTOAY.5WNAFXY(K,L2[+S4\4G+=G56JCXWV$IU96KO':4S5+!7K>
MSG,\-"O_ $DR*CE3_ B[/=\2NY&JGDXM,U!PJTKJGV6QD5!YYE+'EN>_\N:8
MF,1Y".BO,JJ DG4P.QQ).1WGVK"SC*(NRS,;E:%]'[A_HKHVI*/T29F/E=[I
MYQD=B.*5-EYJ6,V6C6Y7(CXI)&6;D*IZMQ26TL%1I\KU9XB9-EZDR(Y$7X61
M_4-V7NU51SVKY/)6>[*W]CX/\4C_ ,F+H\)5^MJ_S,?XIE^1GZ5OWJ?@'NRM
M_8^#_%(_\F'A*OUM7^9C_%'(S]*W[U/P#W96_L?!_BD?^3#PE7ZVK_,Q_BCD
M9^E;]ZGX![LK?V/@_P 4C_R8>$J_6U?YF/\ %'(S]*W[U/P#W96_L?!_BD?^
M3#PE7ZVK_,Q_BCD9^E;]ZGX![LK?V/@_Q2/_ "8>$J_6U?YF/\4<C/TK?O4_
M /=E;^Q\'^*1_P"3#PE7ZVK_ #,?XHY&?I6_>I^ >[*W]CX/\4C_ ,F'A*OU
MM7^9C_%'(S]*W[U/P#W96_L?!_BD?^3#PE7ZVK_,Q_BCD9^E;]ZGX![LK?V/
M@_Q2/_)AX2K];5_F8_Q1R,_2M^]3\ ]V5O['P?XI'_DP\)5^MJ_S,?XHY&?I
M6_>I^ >[*W]CX/\ %(_\F'A*OUM7^9C_ !1R,_2M^]3\ ]V5O['P?XI'_DP\
M)5^MJ_S,?XHY&?I6_>I^ >[*W]CX/\4C_P F'A*OUM7^9C_%'(S]*W[U/P#W
M96_L?!_BD?\ DP\)5^MJ_P S'^*.1GZ5OWJ?@'NRM_8^#_%(_P#)AX2K];5_
MF8_Q1R,_2M^]3\ ]V5O['P?XI'_DP\)5^MJ_S,?XHY&?I6_>I^ >[*W]CX/\
M4C_R8>$J_6U?YF/\4<C/TK?O4_ /=E;^Q\'^*1_Y,/"5?K:O\S'^*.1GZ5OW
MJ?@'NRM_8^#_ !2/_)AX2K];5_F8_P 4<C/TK?O4_ /=E;^Q\'^*1_Y,/"5?
MK:O\S'^*.1GZ5OWJ?@'NRM_8^#_%(_\ )AX2K];5_F8_Q1R,_2M^]3\ ]V5O
M['P?XI'_ ),/"5?K:O\ ,Q_BCD9^E;]ZGX![LK?V/@_Q2/\ R8>$J_6U?YF/
M\4<C/TK?O4_ /=E;^Q\'^*1_Y,/"5?K:O\S'^*.1GZ5OWJ?@/ZFMKTGU3 A)
M/H9=4Q6"/HHC2HNI(Z]%),TF7W2,R/T,<FUJ['(YD$+7)W1S8F-<GR*C45/M
M#E:G=&M1?D0CQL?C1B.8/N7>.NNX;E)*-UNSJ4DTP\[U[B]KC([$NH-?J?KU
M+J?::?0?L?HCE3MYI\'_ )_+W,&MYEN_13Q1\UI9.08TRLDIR*H2Y-C&R1^B
MY3"/,<CJ)/JHE)Z%Z_/Z? <MFKY?<\OEV_+;X_@DG@6_<'S>,TIBRCL25=I*
M;4XGYJS^XI!F3B#(SZ&711>GW .*M5/R[_<^[]S?R,V,28\ILG8[S;[9D1DM
MI9++H?\ P3/_ */C^X!Q/.
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MDB(B^! <3D
M                #5;S%/9E^5(_L,DO$_\ 5LY1?N?>^\0\9<^G+G<TW]+E
MLBGW+DR%1S=II4_ZQ_\ ]2G6QB3\SDPX<NPE1X,"+)G39;J&(L.&P[)E27W5
M$EMF/'92MUYUQ1DE#;:%+6HR))&9C]8()[4T5:M#+8L3O;'#!!&^:::1R[-C
MBBC1SY'N7LUK&JY5[(A]1%<J-:BN<JHB(B*JJJ^2(B=U5?8B$Z=0< -M9[[+
M:9PIK6..N]CGEVS!S,KE,GT5T8QYMUGW<:B)3:CO)E?*CK-+A5LIOT/8[0WH
MR:VU+T;FHE9I#%OY7\MV/KYJ9B]]H\6U[/"JNRM<N0GK31*J.2K,WL9^EIVY
M8V?/_4D2[+ZZ;S*G9>T6Z<OP+U%8Y%_0*6E:BXKZ:TTF-+QW&F[;)&"29Y=D
MWE7%\3I%ZNPEN,MP:=1^J>M-"@K4V?8\X]ZJ/<G0W!G06@4BGQ6);=RT:(ON
MYE^G>R:/3]'7<Z-E>@OFG]05ZSG-7:1TGFLMI8BC1V=%%SRI_P!-+L^3?X6]
MD:SX/4:U53LJJ2,%J&3
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M)J2DNJE$DOOF9$7I^Z?H /06V58_2M+=LK6'%2@NIFMY'IZ&?KZ]"^'W3_?
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M)$1$DO0B(B]"(B^! ?#]
M                              U>;_';W)-F9318W36E[<2LNR)J)5T\
M&58SWU)MYA&346(V\^LD%ZK42#2A/52S))&8\=\GBLEE]79G&XJA<R5^;.95
MD-.C6FM697)>G1>2"%CY%V\W+R[-3NY41%4JB2*26U-'%&^1ZS2\K(VN>Y=G
MN\FM154G!J'PZ,ZR3V6VVQ<-8)4+['3H*M4:VRR0V?J;;[R5/4M*:T&E2'%N
M7$EM1*:DUC"RZEL1H7T5M1Y;HWM;7V:<HNY7KC*2PW<W*Q>_+)(BR8_'JYJH
MK7*Z_,Q45DU2-WEGJ6F;$NS[CTKL7OTV;/F7Y5[QQ^Q>_.OL<Q%+0]6:"U1I
MN*EK!<2@P; VO*DY%-+WEDDTC3T<\^YEDY*::=/YRX4(XE>2C^U0VRZ$6XFC
M>&FBM!0HS3>$K5K2LY)LI.GB\M814]=);\_-,UCU[NKUUAJHOU$#4[$LJ8ZG
M13:O"UKMMEE=ZTKOAW>[NB+YJUO*W?R:AF,3P[H
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M;!BP8R"Z(CQ([4=E)?N-M(0C^_TZ_N@<3G
M                                                 Z7B&NL&P%,\
ML.Q:GH'+:7(G6LN#$05A:2Y+ZY+S]C9.^9/G*-YQ:D%*DNI9(_+92VVE*"P&
M#TKIS3264P6&H8Q]V:6Q=FK0-2U<GFD=+));MOY[-ERR/<K>M*](T7EC1K41
MJ?A#6KU^;H0LC5ZJYZM;ZSU5555<Y=W.[KVW5=O)-D.Z#/G[@
M                                                   !Q)=?!GM*
M9G0XLQI9&E3<J.T^A25>BB-+J5%T/[OIZ@#$>0<>M-9*I;EG@-%Y[A]52(3!
MP'_[RXBFNG7XF9$1]?7KU ^[KY;]O@]GPF);/A?K=PS<QV^S+%G>XU)]@N%R
M6$=?@E+,A/P+]U?_ $?$#[S+VW[[=_M_^1U9[B7GM;W'C.[[ELDGU:;MX'F)
M_P#I%QWC,_@7J2#_ /W'U';>S\O;OV[[]ON?+OPU:5Y2U!$FLV3BENA/J12$
M6,5Q1_<[N]LT?WR,_B 56]NW[B>?Y?'^\?GY-\RZOU91B=P22]"8OFXZE=.A
MD1>U*8^\?I^[T+T ;L^!?+\MOPK\GD?TK#F?&/JK!ZA_H?\ N>3U:NO[A?T8
M7W?OGZ?=^'H'J?\ Y1>WG\'G^7<?*KF.S\U6L67%'\5HR"I67WNO4IA]/O\
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M.F03=33UE:A/P*%!C1O^UIM)G\"^)F!\/;@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M<P
M
M          HU\0/<4W,]IJUM7RUEBVN":9?CM+/R)^6S(J'[.<\E)DEU=7&D
M-4L9+J#7$?:MC95V3G"/SJ])W7EC/:R7256=R8;2J,9+$QR].UF[$+9;=B1$
MV1ZTHI68^)KT58)67E8NUAQ =1W73V_"M=])J[(J)Y.F<B*]R[>?(BI&B+W:
MJ/V^J7> 24FHR2DC4I1DE*4D9FHS/H1$1>IF9^A$7J9C65$551$15551$1$W
M557LB(B=U55\D(Z69ZI\.'(\EH(%_LO,%88_8QVI3.+UE2BSN(;#Z$N-)N)L
MJ9%BU\XDF1O5[,6>ICN)M^2S(0[';VZT7Z*64RV,K9/5N>=@);<3)H\/3HMM
MWH(Y&HYB7K$T\,-:RB*BOJQPV5CWY9)F2M?$V4T],RRQMDM3]!7(BI"QG.]$
M5.W.Y7-:QWPM1K]O:J.W1/SM;PX<EQJBG7VM<P/-7JZ.[*>Q>SJ4U=S*880:
MW$U$V-,EQ+&<:2,VJ]Z-7*>[31'D/R5LQG/FM/11RV)QUC):1SOT0258GS/P
M]RDVG?GCC17/2C8BGF@M6%1%5E:2*JK]E;'+)*YD3ES3$T3'259NORINL+V<
MDBHF^_(Y'*U[O@:J-5?8JJJ(5G*2I*C2HC2I)FE25$9*2HCZ&1D?J1D?H9'Z
MD?H8U&5%:JM<BHJ*J*BILJ*G945%[HJ+V5%\B+$\^ .WY^$[;8U],EK/%=DD
MY!.*XLSCPLIB179%-8LH,S)MZ<EARC?)I)'*5,@*?-28#/9LGZ,FN;.G];QZ
M7L3N]QM6(^OT7N7I5\S!"^6A:C1=^62RV-^.D1B)UEGK+(JI6CY9#IVZZ"ZE
M9RKT;6[=M_5;,B*K'[+[7;+&NW=RN;O]2FUZ@]'"?E<_B&;IE89A%5JW'YBX
MUSL%N3(OWF%FA^-AT-9,.Q.Y)I6V60SS5#4I)J2[7U]M#>3V2B&JOI1\0)\!
MIVEHW&3NAOZH9-+DY(W<LD.!@<D;X-T5'-3*656!SD56OJU;L#VJV8C.I+RP
M0,J1KL^RBK*J>:0-796^>Z=5WJ^U%8U[5\RD\>?)!2?''+@S>;EQ6/GN5Y*Y
MA>,6:WBH(L6L38W=W'8=7'=LC*1)BQJRN4^VXW"=<1,D3B:<>3&8B*BRI6R_
M"KT<\AKW"Q:ES67=@,1<=(F,AAJ):R&0BC>L;[:I++#%4JND:]M=SDGEL<CI
M$BC@6&6:0XS 27H4L32]")RKTVHSFDD1%V5W=6HQJK]2OK*[95Y4;RJ[C\D.
M#][I3&7<\QC)%YIB<%YAJ];D5I5MU0MRG41HTYQ#$F5&LJU4EQIB3(:]D?AN
M2&#5#=C>T2X_Y<5_1WR7#[$/U)B,L[/X2L^-F29+42I?QK9I&Q167-CEFBM5
M%F>R.65G1D@=)&KH'P]6:+YD\#)0B6Q%+UX6JB2(K>22-%5$:Y=E<CVJJ[*J
M<JM54]54W<D#QK:1\O \/G=,O.]>V.N<@F*E7VN/8VZI]]9J?F8?.\QNN9-2
MC-;JJ&4P[6FOT2S7/4S!$:D*4KT0]&'B!/J32]K2N3G=-DM)]!E*61RNEL8*
MSSMJ,57*JO7&RQOJ;]D95?0C1%5JN6>:<O.L5G59';R5>5&*OFL#NS$^/IJB
ML]B(Q8T]BJ6$#: D@ $6]\<M-8:.BRX$B<UE6<I;6F+AE)*:<E,/]I]BLAG(
M)Z/01B,T&M$E+MFXVM+D2MDM]ZT4YQ)XVZ/X=0S5I;+,SJ-&N2# 8^9CIHY=
MO57*6&]2/&0[\JN29'VW,<CX*DS=W-Q.0S%2@US5<DUCORP1N151?^M<FZ1)
MW3S]=4[M8[OM17MS;^;;JRV3EV;6!2)*DJCUE9&);-315I.*6U6U,12W/)CH
M-1J==<6[+EO&J1,??>4:QYQZXUUJ'B#FY<YJ&UU9518J=.'F91QM7F5S*E*!
MSG=.-JKN][G/FG?O+/))(O,0"Y=GO3+-.[=?)C$W1D;?8QC=UV1/:O=SE[N5
M5[F+Q#CJ%MWA?_TENG^%:_\ \5F0W?\ 0]_L;7_^7TS_  >=)CI3RO?+6_>G
M+6ANB2\ "G7Q)MGSYF5XIJ6#)6W3TM4SEEXRVLR1,N[1V7$JVI*.OSO=59'<
MD1_@DSNW#42E-MFC1'TLM869\SA=$5Y7,HT*;,WD6-<J-L9"X^>"G'*GM\%4
MB?+'^A5<@Y5W<QJMA6J+;G30TVKLQC$FD1/)TCU5&(OM]1B*J=]EZGENB%81
M$9F1$1F9GT(B]3,S^!$7W3,:>HBJJ(B;JO9$3NJJODB(10M-U!X<3E[CM??[
M:RNVQZ?:1FI:,4QN-"*PJF7T$XTW;6MDU-CIL.Q22DP(]:M$-PC;5-><[T-;
MEZ&]%)V1Q57):VS=[%V;D+)VX7$PUTLTHY&H]C+MVVRQ&EKE<G6K14U;7<BL
M6Q*[=&2VEIE9(FR7)GQ.>B.2&)&\S$7NG.]R*G-MYM1OJK^B5>R>MW;X=LG$
ML8M,KU7E-GDWN2(_83L6OXL3WQ+@Q6U/2G:BRK6XT:9-990IQ%6[6QW):4+3
M%E.2O(B2.IQ"]%F7"8>YFM&9FYEUQ\$EJSALG#!XZ>O"U9)GT;=1L,4]B.-'
M/;3?4B=,C7-AF=-TX)>%_32PPOFJ2OEZ;5<Z&1J<[FIW56.8B(YR)WY%:BJF
M^SE=LU:PQI^14ME\-7:$]]S--0V,EQ^%$A%FV--N+-104^VQ:S(HC)K,^UB1
M(GU$UJ.WV(;D'92>U2Y3JRW9]$K6-F1V?T-:F=)7@KIJ#$,>Y5\,WQ$53*P,
M557:.66S1L,B;LULJVY=E=,]Q,-+VW*L])RJK4;UXO\ !]9&2HGQ*KF.1$]O
M.OM4MC&ZY,
M
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M:GM2!Z^PD.F&.6_(]/J65G\R^S=SXT1/E7NJ?$U2\0>B1/0
M
M
MC_R.WQ1:%U_-OY;L>3E%FU)@870J61O6ER;71,EYDE$X514FXW,MI'5"":\J
M&VX4V=#;<K+BMQ)QO#73%C)SOBES%MDM; 8QSMY+M_D3:5[$7F2C2YV3W9?5
M:C.2!KTL6(&OQV3R$>/K.D<J+*]%;!'[7OV\U3SY&;HYZ^Q-FHO,YJ+KA3Y\
MRTGS;.QD.2["QER9\Z6\?<]*F3'ER),AU70NYQYYQ;BSZ%U4HSZ#RCM69[MF
MQ<M2OGM6YYK-F:1=WS3SR.EFE>OM?)(]SW+[552LG.<]SGN57.<Y7.<O=5<Y
M=U5?C55W4FGP'UG*S?>,#)WHZE4.MHKN0SWU(,V57$IF17XY"[_ZV0J6X_;M
M%\%-TKY&9&:2/8#T:-(3:BXBULQ)$JXW2<#\I9D5N\:WYF2U<57W]DJS.EO,
M]G+CY$5456[YS3M59\@V54^EU6K*Y=NW.Y%;$WXEW57I_DU+ZAZ4EA&K_N2P
M7:[=VG9K4:E3]BYK+ZF?7YK^263B4E_O4I4E*2+T))$1>A#Q[U[:==USK.XY
M=ULZJU!/\B29:VYJ)\36JC43V(B(53==SW;;OTUJP[[LKU/'J&(F?MG5\%9=
MR9NQ,*B*2?KW)D9+6,F73]TEF0XZ%@2UK;1U9R;ML:JT] Y%]J2Y>I&J?<<?
M*3>:Y4;^FLP-^[*Q#:$'L,6N !JX;/B)K]E;#@(+M1"SG+8B$E\"3&O[!E)%
M^\2"(>.6L($JZNU36:FS:^H\W U/@2')VHT3[2-*GMIRVK+4\FV)D3[4CD/?
M:(L5U.[=16"%&GV?96$FZ9>AG'<R.N9E(_\ I([CJ#_<5Z^@R7#:TZEQ"T/:
M:NW2U;I[G^.)^5JQS-_[43WM^V?ICW<E^D[X+4&_R+*U%^ZBJALXCU[+4(-<
MSN/>?;_>U9784=-&CT$K+7;VUO+ X<.N:M&\;3#,F8[$NPEN/>P3.U$2&ZE!
MLD4AQ@G&U*UUX^<+]2\37Z-J:?6A#%C)LV_(W<C96""JRXW%-@^EQ1SVIWR>
M&GY6P0/:U6;2OC1[%7 9S&V,BM1L'31(UGZCY'<K6\_2Y>R(YR[\KO)J^7=4
MW0XNE^ VK=<O1+S-G3V9DT<T/-(M(:(N*0'T]%$J/CYN22L7&S-2?-NI,V,Y
MT;?:K8CR2-/X: ]&G1NE'P9'4#UU=F(E;(Q+L#8<+6E3946+%\TOBG-7=O/D
M)K$3T1LC*D$B(J<:.G:E;EDL+XJ5.^STVA:OLVC[\RI[5D<Y%[*C&J=XYR(0
MWQ:V4VVE*$(/"4(0A))0A"<_Q5*4I2DB)*4D1$E)$1$1$1%T$C](IJ-X-:N:
MU$:UOT/-:UJ(B-1-3X1$1$3LB(G9$3LB'9SW]J;?_N/XS":]P\O2MRV[PO\
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M)CJZHY4=8FY73.3R39/5C;\+6;KW\W.5R]DY424HN,RP
M
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MC4_LNK_G$/\ "--HP>QA;    1*YS?U+FS/^'A7^<#%127I%_P!QS5_RZ?\
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M8M]T5/+J1JO=6*O947UF*J(NZ*USI4"Y3+@
M
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MISQMEU6]6F1=DZC62)WV6.1>1Z+MY^JNZ;[^LB+YHALNCUN+2
M
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M.CV5+:
M
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M88)F-EK*B6#I^@ZI4665-IK7*]6JFRLB:B]-J_ J\RO7R5.9&N3=I.,;$F?
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M[?I-=5Y%7R?/MZJ)\/31>=53R=R>>ZEWH]#2>
M
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MM(^%B,CGA>]>M$NS62-<Y=D=NNR(O9.ZEXP]$R? R(R,C+J1^AD?J1D?Q(R
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M43&QQL3E:QJ;(B>?VU5=U55W5RJJJJJJJ>\&0/T
M
M
M
M
M
M
M
M
M
M
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M\;0Z^'R-:M/<F?TZ\26IH&1,\1+RQ0*]6H^22-O97(6""I2_
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MI,R"V<?;H=-V02TZLC$M1QK+S)3GYE9NC.5O-MS(29$*+)
M
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ML:]T6&[FTYD?ORJE]7L5?51;3? F_P!J#>G]TFA_R70*,]*/\\.E_P#0UO\
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M78ZK:ITLY6DLUZMWI>*A9'9GK*V;H22Q<RN@<Y.21R<JIWWW1,NB/DL
M
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M[B?#[_1-G_BN0)R"L2[
M                                      CAS"J;6^XJ<BJ6CK+"YN;7
M3.PZ^KJ:F')L;.RGR\8L68L*! AMO2IDN2\M#4>-':<>><4E#:%*41',N'EB
M"KKO1]FU-#6K0:CQ$T]B>1D,$,4=V%TDLLLCFQQQL:BN>][D:UJ*JJB(5WQ=
MJ6K_  MXA4J-:Q<N6M'Z@KU:E2&2Q9LSRXRPR*&""%KY9II'JC8XXV.>]RHU
MK5540JZ\$G6^Q-=T?(MO8&!9I@SEK;:P75MYCBUYC*[)$.'G29:X";J#"5,3
M%5)C)DJCDX3!R&"=-)NM]UX>DOF</F+.CUQ.5QN42O!FTG7'7JMU(5DDQ:QI
M*M:65(UD1C^1'\O-R.Y=^5=M8_0NTYJ'3U+B&W/X',X-UJUIEU5N8Q=[&.LM
MABSJ2K EV"!9DB62-)%CYD8LC$=MS-WYWB]<([3:=+6<C-28Q87FP\:;@X]L
M#',=K)%E<Y=BRW4Q:6]A5M<R]-LKK%Y+R(,Q#$=^5)QN2AU;C<7&6FE_EZ/O
M$R#!69]'Y^]#5P]UTMS$W+DS(:^/OHWGLU99YG-CAK7F-66-7/8QEUBM1%DO
M.<G[^EIP5M:HIU>(>D\9/>U!C6P8_/X['UI+%S+8M7I%3O05J['S6;N,D>V"
M9&1OEDQLC7.<D6-8Q>M^"'K/8^N_JG/I@Z_S;!??'TE_='RQQ2]QCWI[O^FQ
M[?[N]]P(/MWL/MT+VSV;S?9O;(OG=GM#7?W/29S6&S'T$^Y.6QF4\/\ 1)XC
MW.OU;W0ZWN#TNMX:67I=7I2=/GY>?IOY=^1VV.]"O36H]/>^5[OX#-8/QGT&
M^$]V,5>QGBO#_15U_#^-@@Z_0Z\/6Z7-T^M%S\O49O@#E-PXY,\2.4DGE;Q:
MQBVS/%9.6VN=5S&,4\K);#$)N1^V*RK$<FQ2NZV\[$)[5C;1&+&L:7'8Q^84
M29.K+**S,?EFA>(FBM?Z&9H375VOCK[*$&+F=>LLI19"*GT_ 9"E?FVKQ9"%
M8:\CH9G<[[<?4CBGAD=$R \4.$'$GA/Q/DXI<,,9;S.+DRUK.5VXVI)DK&)G
MR"RKE,3D\56_JN?$V&V+<3+%5BQQX^7I33U;,3)7^BW3S7YS\T\(?X_85QLN
M\7:RM4.!F[N*8UF4NPMH[,EE]5;)M[QF-68=C<F4TTNW78OFI<9M,.5=M5SL
M]B;VM-\->%_#;)MU;DM9UKSJ"22XQM^[CHXJ[W,<U)F5ZKGSY&XR-RI7;"S9
M'JLC*SIFQ.BZ>LN,W&[C+A9- X;AQ<QC,JL,&9=B\;EY9[4<<C)%KR7+S(JN
M(Q\DK&K;=8?NL;4AENM@=.R:X#PYN'$KB!IF;695(A3=H[#LHF1Y\]7.E(@5
M7L,5R-0XG#F))*)[- Q)GO29R$FT_;VUH41U^O;AO+UZXP\16<0M1QST&2QX
M/$0R4\4V9O)+/U7H^W?DC556)UM[(FLB54<VO7@ZC6S+(U-M_1XX02\)-'SU
MLI)#-J?4%F+(YU]=R205>C$Z*ABH9D1$G909)/)).B*U]NW:2)[Z[87K0I<U
M7(O@YSSS#:L'3&1Y:Y$V#LZPQ4G\?R*3C&;XQGBLABP)M7=TL1]MUXZR\9EJ
M:B.O2*^TCKKK&,EUF3'+:JO/H_B=PKQV"EU)3QZ28G"17N6W39=QEW%)3?-%
M/6LR,5K>M5=&CI&M9- ])H7JUS'FBERKQ"X)<=,OJBOH[(95T6>U+8Q:/Q^0
MDQN:QF=6_%!-6NTXGHY_AKK)%;$]\E>U&ZO8CYF21E@/B0'N?DEP?XS9<6GL
MU1L*^SF'D66X%C>%9;.L\8<7B>6PGCDTBX4N]@5QO''.-(LFTDZW+BK)Q12&
MNZIN#?T-Z-XFZUQZZBQBXBKC)*>/RMS)8^*"\U,A0D;R64ECJRS<O-SLA<O*
ML;TV3D=M?GI%?1CQ&X*<-LLFD,TW/WLW#D<K@<=ALM/:QCEQ66A>LE)8);T%
M=7K&L4EEJ(]LL2\R]1F\O^'^BWL^\,_#="[.I;W$9&6X+LG&;FOO*>957^/2
M+;/\TDU-JY3VK4.4S,KG7JZ]KVI;32'_ "HKA]S#I*57W$+5#<5QIR.JL)9J
MY!E#*8:[6FK6(YZEQE?$XUD\"6*[I&.CF:V:K,Z-RJS>1O9[=DMKA)H=^>]&
M[#Z$U+3O8F3*X/4>,N5[M2:K?Q\EO/9F2K:=4M-AE9-7>^O>KLE:ULG+$Y=X
MW[K3?J.TYL>%ALC/*9[2UAG>%98J)%LG6J?(K7!<G.D=F^X<FQ;+Z",^W561
M1I\E$BOL&?;4PIWLMU2,38\%V'L3J"'AIQTPV*LMU+#BLG021\+76*<&4H^*
M;%XNE>QUI[%GA5\3%9-"[I++%SU;3HGRMDU TI9XS^B_J/.TWZ-L9S#9588K
M+VU,C:P>3\$^?P.2QF6HQO;5L].>5)*\[>ND,R17:3)HX'0]VHL?YT^(SR9Q
MW8]G09[H'7]9'J**=E%&K+L$HL6P:LL)-C.BX_9SGH$_+\PL7I\Y2%P2D'[P
MF0U3D4]#$;.)C;5OA?P>T5<PT%O%:LRT[[%N*C:3'Y2U>R<\+(8GVX8FRQ8_
M'0MAB14EY/I4<B1+8M2.ZF9HT.-_I#<2L?J*S1SV@\#6CIT9\G17+8.CB\)5
ML2V)X\?9G?!-ELQ9?8G5%@ZB]>:%9TJ4(6K%,_Q9."F>[N9PS=NE*67E68X+
MC98;E6(PW5R,BO<4@S)=I1VU$E]WS[FXI9=A;M3X/FR+FVBSH:H"9,BO./(K
M?@'Q1Q6F79+3.I;,=''92Y[HT,A*U&4ZM^6)D%J"UR-Y:U>U'#7=%+RLK5WQ
M2)*K&3<[+D]*O@?G=:MPVM-&4I<IE\)CO<?*XF%ZR9"[BX9I;5&U121W/<MT
MI;%MEB#GDMVHYX70)))7<R2,LOQ.N<%AJMW3#'&S+HNZY%$6)GLJ#CF<IR=N
M0J,5:Y>Q\!^32G&,R6UUD)FHM?=[%TKVYFC0RENO1-H^"7#&'.MU&[66/DTT
MVUX],++=Q:T7,YUF;5?EO&HCL:CMF+&L'6=63I.M*Y5F6M9O27XUV-+OT:SA
MSEHM:24?<I=1PX[.)DTD6/P[KT>!]S5>S,.9O(DR6N@RZO7921B-KI:KX?&.
M\Q(&M+7(^7V<VUQ>9&_7KPS!;RMQEF]PZDBM23DS\DM*>JB63UUD+LB.?N6S
MGS5T<.N9.2F/:6$Z%!HGBW<X=RYJ"GP]Q=>O5ILF3)92M-==5R-F1S.2*G!8
ML20MK5&L?_5,,,26I)G<BO@ABEEVCX X_B]!INUD.+>;M6[V1D@7#X2[7QC;
MV(I1,DZD^1LTZL5A]S(.D8O@K-B=U*&O&LB16K%B"&P$5,7V4+^*;P%VGL78
M-?R@X^5<W(\J9K::+G6)T;A-Y8=ABR4-8]F>+->8V];S&*Z/ JIM5 4=LP=3
M52ZN)/-^=[%M1P,XK8+#XB;1&KIXJ=!TUA^+OVFJZATKRJZYC;SME;7C=,^6
MQ%/*B5W>(L1SR1<L74T6])_@1JC4.?K\3- 59LCE&5Z<6<Q5)R-RJV,8C68_
M,XMF[7VYF5XX*L]6!WBV>$JRU8;'//T<&3?$\Y_6N$+U1$XXVL3;TFM5CSV;
M0=>9_P#*A$EQGV)=O#P8H/LL/*3ZG(2_T=J&;(S>9H&XZ40FY1'P2X3P9-,]
M)K&"33[)_%MQDN8Q/@58CNHE>3*=7J24?T"MW;8=#ZKK:O595A$WI,<>;6%=
MI6+AW:BU;)57'OS,&G\][J)(Z/HNN0X/H+%%DU_KB.V=498]=E!L:-A;*GPJ
M> F<:&G7F_=X5QTNQ,EHWL?Q##9+[4JTQFBLY,:=<761K:<>:C9%=*B1(L:N
M0\N74UGM[=HI,ZS>@UT%X[<5\7JJ*KI33$WB<12M-MY#(L8L<%VU Q\5:M31
MR-<^G6221\DRM2.Q/TE@18H&RS6AZ+? ?-Z&GO:\UM7\%J#)4GX_$8>5[9;6
M-HV9(YKEW(N:Y[(LA=6****NCEFJ5NNVTJ3VGUZT0O$FT_MK+?$!QW*,5U=L
M7)L9:A:@2[D6/83DMU1-*@3D*G$Y;UM9)KT'"21JEDJ01QT^KW80L#@WJ' 8
M_A+=HW\YAZ5UTFHE;3MY.E6M.26)4B5M>:=DJ]1>T>S/77LW<J;TC-(:LRW'
MK'Y/%:7U%D\:R'22/R&/PN2NT6K!.U9T=;K5I(&K"G>5%D3IIW?L;-XTI/2D
MQ?NO/;'6&I=A9_2X[;Y=>XOBUK8X_B]%56%U:7^0E'4Q05,>MJF)$]]$ZX>A
M,2G([*SBPUORW.UIAQ2<YIK%0YO/XC%6;E?'U;UZ"&W>M3PUH*E3G1UNP^:=
MS(FK%7;*]B/<G4D1D;=W/1%C.L\Y8TUI3/YZGC[>6O8S%VK%#&4:L]VU?R"1
MJRA4CK5623O2>V^&.18V.6*)SY7;-8Y4UP?#;X3Y3NC?FP=C<J]494[B]-3V
M5U,K]HXI?4+.:[ SBRD=DM3%S#K3MVX$9&06T]4;S2AVCU*Z\39OL]VXW&7B
M70TWI3$X?0F>H-O6+$-:.7!WZMMV,Q.+A9O&CZTD_AUE>M2O$C^598&V6M5>
M1VWG;Z.G!?*:QUYG]0\4M*Y1V-I4[%V:OJ?%7J#,UG\Y8E1LRQW(:R7&P1MR
M%NPL7,D%I])[T;SLWO,^M_<+OP;]8_\ V*K^<#6#WV>)'Z\LW^R4_$-W/>%X
M-_WNM,_L'_\ K-?[=7'7<_#3GNWL+0NH-B9+@6.YG3[)PM.$8;DU]3?)/(.\
M\DP$Y]173V(;++3V28<41Z2<Q%(J'*<,O:FG#VQTUK#3?$;A2N(U5J'#TLK<
MQMC#9)<GDJ56SX^IMX++=*Q-$^1SG-I9'J-CZ:VDDC:B]-4-"M9</-9<'N.S
M=0:$TAJ')8''9BGJ/#)A,/D[]3W*OHONE@NO4KSLB:QK\EA^D^594I+#*]4Z
MJ*24\9;7^Q]NY=QXR/6VM-CYE5NZZO9<A>/X)E-L_5^]K.KGPXEU&@5<AZGL
M51U]7*^P1'EM+0ZVXT2VED4,]'/+X;3^/U=3S.:PV-G3,58V);RE&NV?H03Q
M225GRSL;8A1Z;)-"KXW(K51RHY-['],+3^H]6Y7A]D=.:;U%F:SM/WY9'8_!
MY.V^KXJS4GABN1UZLCZEA8UW=7L)'*U6N:YJ*UVU[.B(4RMT?IJNL8DJ!80-
M4Z\A3X$UAV+,A3(N(T[$J)+BOH;?C2HS[:V7V'D(=9=0MMQ"5I,BU<U3+'-J
M?4<T,C)H9L]EY8I8GMDCECDR%A[)(WL56O8]JHYCVJK7-5%15144WBT/#-6T
M5H^O8BD@L0:7T_#/!-&Z*:&:+$U&2Q2Q/1KXY(WM<R2-[4<QR*UR(J*AKQ>$
M;I[;>#<O\DOLVU;L;#J-W5N<PFKG*<(R;'ZIV9)R7$GH\1NQMJR)#7)?:8?=
M982\;KK;+JT(4EM9EMWQ_P!1:?RG#VG5QF=P^1M-SF+D=6HY.E;G;&RG?:^1
M8:\\DB,8YS6N<K>5JN:BJBJAY^^B=I#5F#XMY*]FM+ZBP]%^E\W"RYE,)DL?
M5?-)DL2^.)MBW6AA=)(R-[V1H]7.:Q[FHJ-54_OB$:>VWE/B-4F68SJW8V1X
MLW8:14YDM%A&36] A-=[E]X*7<U]9(KDI@^6Y[8:I)%%[%^?V=JNGSA)J'3]
M'@]:H7<YAZ=YT6ID;2M9.E7MJLWB>BB5IIV3*LNZ=/9GK[IR[[GSC]I#5F4]
M(>GE<;I?461Q;;&BU=DJ.$R5N@U*Z4O$*ZY7K25T2#E=UE63:+E7GY=E+[.7
M%59WG%GD;2TE=/N+BVTAM"NJZFKAR+"RLK"9AES'AP*^!$;>E3)DN0XVQ&BQ
MVG'WWEH::0I:DI/5;A_/!5UUH^S:FBK5J^IL)-/8GD9#!#%'D:[I)999%;''
M&QJ*Y[WN1K6HJN5$0WJXL5;5[A?Q#I4JT]RY;T7J6O5J589+%FS8FQ%N.*"O
M!$U\LTTKW-9'%&QSWO5&M:JJB%3/@B:SV1KMSDU],#7^;X+[X1IKW3\L<4OL
M8]Z>[SVI[?[N]]P(/MOL7ML/VOV;S?9O:XWG=GGM=]]^DSF\-F$T5[DY;&93
MPZZC\1[G7ZMWH=7W"Z76\-++TNKTI.GS\O/TW\N_([;5;T+--:CT\O$KW?P&
M;P?C$T=X3W8Q5[&>*\/]%/7\/XV"#K]'K0]7I<W3ZL7/R]1N\4N;>C^1'&3G
M+/Y3Z]P"[S'$Y^?UNT\9R&MHK3(:%JT=1&>R#%,N13)7)IC=GE9PV_/>A'84
MTMF55S"EHE-P9YPSU/H_6O#"'0N7RU7'7XL5-@[M.:U!3MN@:KVU+^/6PJ,L
MHV)8)%Y&R]&S&YD\?36-TM5\:=%<0>&O&Z?BA@,#=S&*GSU;4^-R%:C:OT6V
M7-B??Q662FCI*?/.EF%O4?"MBG(R6M+U4E;!D+DONGFYSSX_9&Q5<8KS5NI<
M-52Y5D1G#RB_R?9EW'MH573T6&0I./5-A;0HDNT7?V+-123F(+-.I^QR%E49
MFNL<1HO3?#/A7JRF^QK:KG,_D4LT:?TVC5HX2L^"6>S:R4K+EB&O+)% E2%U
MBS$^5UA&0TW)(Z:"0<2-9<:N.F@LA'4X:7=,:3PZT\ID?I.3OY/4MV.U#5I4
M,-!)0J6+<,4UI;]AE2E/' RFLEC(,6)E:S*;PU=([#G>'QR$T]DU#DVM,KV-
ME&XL<IRS"AN<:G1$Y?J3#,<KKSV*SA1;!=:W/6\1RH["DN*ARFF%F\RLDP;C
M/J?$1<6](:BI6Z6:H8:CIVY8]SK5:[%(N/U!DKDU7J0R20I,L*-7IO<BHDD;
MG)RN3>SO1PT5J";@%Q!TCDZ&2TWE=1935^/IIF*-W&SQ)EM)87'5[W1LPQ6'
M5FV%?]-C8J.6&5C%5[%1*V.(^R>0_AO;5V/19EQ6S/-)F:0JS'Y=>W N*NQ]
MJQZ=8/5TW$,M@8UE%9>45DNQD)F-5;,J):J:JY;,]#E83+]R\0,-I#C)@L-:
MQVN\;C8\;)/;CE=-7GAZ=N.)LT61Q\MVC/5M0I"Q8W3N9) CIXW1*V?G;KGP
MGU'Q!]'75&HJ.8X79C,S9F"M1EKM@MU;'5Q\UA]>;$9:OC<I5NT;#K$B3MJM
MEAM*RM*R='5D8_KO-S">;G(;8F,[^V'QNSG&V,PH#I<%PO&,8R+*+3%,3Q.:
MJ3&B95&@5KUK5V,ZQR*=8I5D4&DFV3C\QZ+3P:]F.RGN\,\GPSTAB+NE,1K+
M%W'XZWXG*9*]>IT8+]^_&D;Y*+Y9FUYX8H:<4*I3EM10HV-LEB65[W+C^-6$
MXT\0L_C=>9_ASG,='E\>M+"8;&8S(Y.UBL3BYEDBBRL4%9]JK8GL9">PBY""
MC-9<^9\5."!D;$M>\7K'<TW)Q4TM-U]@6<91/L]G8QE3]!1XE?VN05-;8ZXS
M%WOMZ6#7OV=8<1^PC0IB9T5A46:XB)()N0HFQ0OH^7,;IS7>I(\OE<71BAPE
MVBVW:R%2"I8FAS&.;M7LRS-@GZC8GR1K$]Z21-61F[$W-I_2UQV:UAPNT;-@
M,#F\G8LZEQN4?0HXF_:R%2M8T]EW;VZ4-=]FLL3[$<,R3Q1K%,Y(I$;(O*2K
M\,K&LCP_@_I#',MQ^[Q;(:YO8I6%%D55/I+F![7MG/)T7VRKLV(LZ+[3"DQI
MD?SV$>=%D,2&^YIUM:H+QKNT\CQ.U-<Q]NK>J3+A^C:ISQ6JTO3P&*BDZ<\#
MWQ/Y)6/C?RN7ED8YCMG-5$M'T:L;D<1P4T5CLM0NXO(5TU%XBCD:L]*Y!U=6
M9V>+K5;,<4\74AECFCYV-YXI&2-W8]JK/$567H:S&7Z@VT_XP$3.V-7;%>P=
M._L(M%9DUA.2N8H5;'J*!$BQ/(D5AU!06%M.(>EG,]G:4VM*W$FA1%NGC]0X
M!OH]28IV<P[<HNE<G F-=DZ27^L^S;5D/@UG\1U7(YJMCZ?.Y%14145#S;RV
MD=5O]+B+.LTQJ%^$37>%LKF6X7).Q25XZ5!DDZY%*RU.BQS7-?+UN1KFN1SD
M5%.7XQ_&78M_R"PS:&M-<9KFL/.-?QZS(UX;B=YDRHF1X;8/0BD6:J.!-.%[
M9CUGC\6$4ORSD%52C84X3+B6N'HZZVP]3262P>:S.-QLF,RSYZ:9*_5I))3R
M,+9.2!+4L74Z=N"V^3I[\BSLYMN9%=^GI?\ #7460U]AM3:;T[FLU#F\!'6R
M*X;$WLFL61P]A\/4LK2@FZ/6Q]FA%"DO+S^%EY%<C'(R3VM>/V7ZZ\'K/L)+
M#<D^F5L+%,KS:WP]FALUY0Y<7V10HM3!.@1%.W.R1B--CZ9$)40I33C3K:FB
M)L0G-:MQ^8](;$Y/W2I>XN(OT,;7R+K<*46UJE.62Q+XM9/#]%<A9MJV1).F
MY'-5'+S%E:<T#EM/>B+G<*F&R/T2:@Q>4S-S$,H65RCKE[(P15(%H-B6VMEN
M)IT&OA6+JL<QS5:B-[<[P8=99IANGMY4>R\!RO$??N<U9-U>:XQ<XZY;5CN+
M^QRU,1;N%"<EPU=ZX[SC2%M$HU-J42O0?EZ1^;QN2U#IBUA<M0R'A<7/S3XV
M]6N)!,E[J1HY]:65L<B;(]J.5';)NB;'8]#K369P^D=;4=28'*XGQV;J\M7-
M8RYCG6ZSL9T959%=AA=-"N[HWN8CF[JK57?L0-/4'*[PM>2]_L;6.L[K:FI+
M1JWI(5G7U5Q>4.0X#:6$>RATV3RZ%B7-Q'+*9Z#7FB=/C-M.V,!Y^"BVII<F
M._:GT0Z#XY:+JX?-YJM@M00.KVI(9IZ]6U4RT$+X9+-&.T^.+(8^PV6;>*)Z
MJV&5K95KV(XWLHM=(\4_1AXD7]1::TW<U1I.RRW2BLUZMN[0R&!M3QV8:>3E
MHLEFQ.5IO@K\L\\;6NL5WO@2W2FECDRW+Y7^)3S+VMAT;CSK[+^/^-U;:X$^
M7[#*FX9'7/DQW+#(,ZRK+\5BT=DF!'BI.KIHM*NR2RF>S60;2;.<0J/QZ#X,
M<.<#D7ZOR^/U;=G<DL4:2LBR3TB8](:F+H8Z^^U"LKWKU[,EE(%<L3IY8(XD
M4E<O%3TCN,.JL/'P^P&6T%C:K5@GF\/+/AXW3R1NL7\YE<OBXJ-A((XF^%I1
M4ELHQ)V5H+4T[D6RCGSP[R[D]Q@Q_"ZV_9RC=.LCJ,CHLAMH]5CR<\O(5(JH
MRJ#+:@,PZ/'W,P0ZY9Q6HS$.HA7<2JB..0*GVB0S3/"GB'C]$:WMY*:HZCIO
M-)8IVJD#I[:XJK+92Q1EC=*Z2U;3'JUL,CGOEL2UI)Y$;+8Y&.V-X[\(<MQ,
MX9X_#5K[<IK/37A,A1R%J.KCTSUV&DM3*03-@9#2Q[LNCG6HFQLAJ0W8:L3G
M05.I(RJ30G.GF)PWUM'X\YKQ7RC*96(KLH&#2\AJ,RQ^QJ6)LR5-;@2TPJ"S
MC9C31I\IYRI=JYE8I=<XB)'M'XK<-QF^-5\+N'?$7,OU=C==4:$>02&7*1U+
M&.MPV'QQLB66-9+<#\=9?$QK;#9XYT29%D? V19$=JSH3CAQ=X/Z<9P_S/"_
M)Y27$NLP827(5,QC[%1DTTDS8)4AH68\Q3CL2O=4=6FK*ZNYL4=I\+87,G3X
M<9>(9G>776SN2V8Y?CFHGF+:13:]S3&J*MNLIO;EU:XKD"%9499?C&(XZV\Y
M+A*.?6%8/)J8<!NQJ$V1HJ[C$O"+%X^MA-%X['7-0-?799R^-NVIJU&K61$D
M262"TN/O9"VYJ1RITINBU;$DJPV.BA>/H[IZ0&<RUW4O$C+Y;':3?':DIZ?S
M&-I5[F3O7'N=$Z"&S23+8S$X]KW2PJL];Q#DJ0P-L5$L*V%'C'Z*VZKD7BN[
M<5PC)<EPN?@>-5JKZ@I+"[AT>38Q<73CM;=E7,2%5I/PY-9-@OSB8CV)/2V(
MCCKL"6AJR_1UU1I]-'W]-7\G2I9*+*W9DJV[45:2U2O5ZR-FK=9[$FY9&3Q2
MMBYWP\L;I$:V6-74QZ7VA]6>^'B]:8O"Y')8>Q@\;66]1I6+L-+)XRW<5U>Z
ME>.3P_4ADK30.FY(['-*R)SG02HV<>/\AMX<P.#?+N9G&CKC LACX%D6/X51
M5.-9BIW,V[+#Y#CBZ1NXBG*O)A6J78Y1:=EXXZ'X4=WSGW"==K"WI'3'#SB?
MP_CQFIZV5INRM.WDK5B[CD;CEAR#6HEEU>3IU8^@K7\]AS>=6R/;RM3E;=F/
MX@:VXN<$N+,V;T3<P60CP.1Q^&HU,=EU=F4LXB1SEHMMQ++=F2TCH^E48]8T
MDAC=SO<CG8K\$C6VQ==U7(]&P,!S7!5VUAJI54C,<6O<959IA1MA%,57INH$
M(YJ8ARHI2CC$X3!R6"=[#>;[L]Z3&9P^8GT:N)RV-RB5XL\DZXZ]5NI LK\1
MTTF6M++TUDZ;^3GY>?D?R[\J[1?T+M.:AT]5XB-S^!S6#=;L:76JW,8N]C%L
MI#'GTF6NEV"!9DB66-)%CYDC61G-MSMWC-I?3VVZ_P 7JXSJ?JW8T+"'.1.^
MK5O,I>$9-&Q5=79QMBE6V2,A>K$5"H%@<N*4&84PX\LY,<F''#>;[IKJ746G
MYO1]K8N'.X>7)IH_2<"XZ/)TGWTG@=ANO"M-LZV$EAZ<G5C6/GCY'\Z)RNVK
M;1>D-65_2TN9VQI?44&$=Q"U[:;F)L)DHL4ZM:9J-*UE,@^LVHL%A98D@F2;
MIRK+&D;G<[=[3?%@Q+*\VX;Y7089C.0Y=>OYC@;[-+C%+97]L\Q&OFG9+S5=
M51I<QQJ.V1N/N(9-#2"-;AI3ZBB^ V0H8SB+0MY*[4Q]5F/RK76;UF&I7:Y]
M1S6-=-.^.-'/<O*U%<BN7LFZFT'I3XG*YK@_E:&&QF0RUY^6P3V4L93LW[;V
M17V/D>VM5CEF<V-J*Y[D8J,:F[E1#&OA6ZCN&^$6::OVUA>38PSF.<;+I;K'
M<JI+3&[69C63XOCU-,<1"MXD664:;%<FL,RB84TI:'20I2FUD6:XZZ@K.XF8
MS.:?R=*Z['8O"V:URA:@NP17:5^Y9C19:\CX^I$](GN9S(Y$5JJB(Y%(WZ+V
MD[C>"N9TQJS#9+&LR^;U)3NX[*TK..M38W)XS'TYG)!<ABE2.:)TS&2]-6*K
M7;*JM5"K2DTGSQ\-+?-_D&H-:WVU<5M69=%'N*3"\@SK"\[Q-V:B75IR.LQ)
MPKC%\AANLLNI:>E5DR%8HF,U\NVHICR[*\K.I>%G&C2M2IJ',U<#?@=':?7L
MY*GB\EB\@V-8YUIS7T6O>IR(YR;MCFCEA6-TT=>U&U(-8:.C..?HWZZOW]):
M;O:IQ5IDM&.Y2P]_.8?.8ITS9JONC6Q3O%XO(0N8Q4;))6FAL),RO+;HS.=9
MZ-X@5MS.VMAFM]X<J,9K-7X_+O[/$=9:HB5MA1S:XI%8FUO\FLJ*VGVEW72;
M#W?605'D4Y%G(.(9QJFJKFF56&4X35^'&!R.8TQH6[-G+<=2'(9O/2316HY5
M9-X>I2AM0105IF0]6>5$IQ+"Q)/7L6)G.2'!<>[7&/5.'T[K;BCC:VF<?+?L
MXG36EHJT]&:NDE?Q5_)6:-J>U>K23^'K0+[HSMLR+%O%4JUVL6QL(^&PE2>#
MG'@E)-)GB-FHB,C(^U>6Y$M"O7[BDJ)23^!I,C+T,:D<95WXG:OV[_\ I"%/
MN4*B+]Q>RF__ *.:*G!/A]NFW_HBPOVERE]47[:*BH3B%8EU@
M
M
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MJ(9)&&)&
M
M
M
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MJ!CY,#G</FXX]NI)B,G2R3(]^R<[Z<\S6[JB[<RIO[#N8QIF
M
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MDW^XGR'HNF^R;]U]JHFR;^W9-UV^3=?E4_H
M
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MDT[@),XWDS;\+BGYAFR-Y<JZC N0;RM1&MY;:S)LU$1-MD1$['=QC#-
M
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M3IZ['/>]D2/>YRXIU)X:G#G3.2P<QQG5;=QD]3);F4]IFM[=Y:BIELK)QB7
MJ;::[0MSHSR4/P[!RJ=L(3[;;\.4PZDE#/9_C/Q%U'2EQUW.K7I6&+'8@QM6
MMCUL1N16OCEL5XFVEBD:JMDA2=(96N5LD;FKL172GHX<(-'Y*#,8W2[;>3J2
M-FJ6LS>NY9M65BHYDL%2U,Z@V>-Z-?#8=5=/!(UKX98W)N2JVSJ77V\L"N]8
M;2Q_Y48-D:JM=S1^];ND]L536\&]K3]Y8[95%Q']FM:V%*Z1;!@GO)\B03L9
MQYER"8#/Y;3&5JYO!V_ Y2FDZ5K70K6>FEFO+5F^DW(;%=_/!/+'],B=R\W,
MSE>UKDM'56E,!K;!7=,ZGH>Z>$R*UEN4O%7:766G;@O5OZIQ]FI;CZ=JM!+]
M*L,Y^3DDYHW/8[KNC>/6G^-F*V6$Z5Q#Y&8Q;Y!)RFQK/?\ E&1>T7TRNJZF
M1/\ ;<LNKVP:\ROI:R/[*Q+:AH]F\U$=+[TAQWN:HU=J'6=Z'):ER'NE=KU&
M489O"4:?)5CFGL,BZ="M5A=M-9F?SNC=(O/RJ]6M8UN/T1H#2/#G%V<+HW$^
MXV,MY"3*6*WC\GD.I>FKU:DD_6RMV]89S5Z5:/I,E;"G3YVQH]\CG8YV7P@X
MO;@V;'W'L76/RBV/%70N,9'\M-A5'EKQDV3I#]T4665E$KV(V&O1=6HI/9_1
M92.Y77,87B;K?3V$?IW#YOP>'D2TCZ?N;B+&Z74<EG^J+5">TG51SO*=.3?Z
M7R;(1[4G!3AEJ[4L>K]0Z:]T-11K1<S(>[.H*G*N-Y/!+X2CE:U%>CTV>=9>
MIM]-ZFZ[R@M*NLNZV?3W5=!MZBTB2(%G56D2/85MC!EM*9E0I\&6V[%EQ)+*
MUM2(TAIQEYI:FW$*2HR.$03SUIHK%::6O8@D9+#/!(^*:&6-R.9)%+&K7QR,
M<B.8]CD<UR(J*BH69:JUKM:>G=KP6ZEJ*2"S5LQ1SU[$$K59+#/#*UT<L4C%
M5DD<C7,>U5:Y%1=BO#*O"?X.Y3=NWBM4S<>=DOJD2Z[%<RRNFI'W%J-2DM5+
M=J[#K&#_ %*8M,W6QFDD1-,M^IBW:/'KB=1K-J^[T=MK&HR.:]C:%FRU$39%
M=86NV2=WM62RLTCE7UG.[;:_93T5^">4NONKI:;'ND>LDM?%YC*TZ3W*NZ\E
M1MI\-9GL2*FVM$U/J6-7N2\TSH'3G'O'7<6TY@%%@U3*<:>L#K6Y$FTN'V$J
M0Q(O+ZS?G7EV^PA;B([EK8RU1D.+;CFTVI23K_4>K-1:NN-O:BRUK*6&(YL/
M65C(*['JBN95J0,BJU6.5$5[8(8T>J(KN94W+:T=H+1^@,>[%Z/P-'"5)'-?
M86NV26U;>Q%:R2[?LR3WKKV(YR1NM6)5C1SFLY6JJ'2=[\/>.?)FTH+K=VN_
MEM98O EU=%)^5N=8W[#!G2$2Y3'DXCD]#'D^;(;0YYLQJ0\CM[6W$(,TGDM+
M<0]8:*@MUM,YCW,AO2QSVF>Y^+N=66)BQQNYLA2M/9RL<J<L;F-7?=45>YA=
M<\(N'G$FS0N:UT][M6<9!+6HR>ZV<QW0@GD;+*SDQ.2H1R\TC6NYIFR/;MLU
MR-W0S[28[2X[CM1B51!1&QVBI8&.U=8ZX_-;CTM9!:K84%QZ>[)DRT-06&HZ
MW)CTA^0E)JD.NN+6M44LV[-RY8OV)5?;M69;<\S4;&K[,\KII)4;$UC(U=*Y
MST2-K&L5=F-:B(B3RECZ>/Q]3%5(&QX^C3@Q]:LYSYFQTZT#*T,#GSNDDE:V
M%C8U=,^1[T3>1SG*JK O*?"OX099ECN73-0G5ORY:IMA1XWE>58[B\U]:S<7
MTHJFWC1:J.LSZ'#H/=$-*2Z(82:E&JU*/'3B;0H-Q\>H>LV./I16KE"A<O1M
M1-DWM6*\DD[T_5+?B)%7S>J(B%%9/T7N"F5RK\M-I+PTDTJSV*6.RN5Q^,FD
M5W,[:C5MQQ58U\NC0\) B?4QHJJJY$S3P^N'FP)^&V62Z4J%OZ_QJMQ'#V:/
M),XQ&MI<?J+FWR&%"9I\1R>CJ)+I7=];V<JPG095E82I[R["9*^82,/C>+7$
M/$PY&"EJ6PC,M=GR&1=:IXS(36;=BM7J2RNLY"E:L,;X:K7@CABE9##'$U(8
MX^^\AS/ +A%GI\/9R6C*BR8#&UL3B&4<CF\36I4*ERWD(864\3DZ-21WC;UN
MS+8G@ELV)9WNL32]MI6Y-C&.9I06N*Y=15.38U>PW*^YH;V!&M*FSA.]#7&G
M0)C;T:0T:DI627&U=CB$.([5H2HH)2O7,;;@OX^U8I7:LB2UK=65\%B"1OD^
M*6-S7L=LJINU4W151=T54+2R6,QV9H6L7EJ-7)8V]"ZO<HWH([-2S"_ZJ.>"
M9KXY&JJ(NSFKLY$<FSD14KRLO"0X,65RNV+5]U7,NO&^[2UNP<WCTRU*5W+0
MAI=V]-BLK,SZ,PY\9IE)]D=+*$H2FW8>/_%"&LE?W<K3.1O*VS-B<8^RB(FR
M*KDK-B>Y$_12Q/<Y>[U<JJJZ_P!GT4."-BXZW]#-RNQS^H^E6S^:CIJJJKG-
M:Q;KYHF.5=N2&>-C$V;$C&HB).?5^IM;:6Q*'@NJ\-I,'Q6$XM]NII(QM)?E
MNI;0]86,MU;T^VLWT-,HD6=I*F6$A#+*'I*TM-DFK\YG\SJ2_)E,[D;63ORH
MC73V7\RMC:JJV*&-J-BKPM5SE9!!''"Q7.5K$5R[W=IG2FG-&XF'!Z7P]+"8
MN!SGMJ4H^5'RO1J/GL2O5\]NS(C6-DLVI9K$C6,1\CD:U$PH?"#B\>Z?JACU
MC_[\/RF+,?E?\M-A_P#QC))(*Q^3_P K/DO^I(B]C]R>P?=]EZ^HDOOFZX^A
MOZ$?=O\ ]7O!>YWN?[FXC^P]]^CXOP'CO/\ Z3Q/5_PR&>\IPR^C+WP/H:_]
M;O=+W7]U_=G4']L=MO$> ]U?<SR_Z+P70_ZHE<(&6F0FW-X=_$7>^03<NS?4
M\*+EMD\N39Y)B-M<X?/M9+IFI^9;1J&=#J+6?(7\^196-9*L7E>KDL^JNMEZ
M<XO<0=+5(\?C,_*_'PM1D%/(5ZV1B@8U-FQUWVXI+$$+$[,AAF9"U/*--D*7
MUCZ/O";7%^;+9K2L$66LO=)9R.)M7,1/:D>N[YK4=">&I:L2.]:2S9K2V'KW
M=*NZ[_W2_AX<1M#9#"S#!M4Q)&7UCR9%7DN6V]UE]A4R6SZLRZF/>SI=153V
M%=5,6==6QK)E1GV2RZ$1-2<7N(&JJ<F.RF>D9CYFJR>ECZ];'Q6&+V='8?5B
MCL3Q/3L^":9\#O;'YGW1OH_<)]"Y"'+X/2T,F7K.22MDLK;N9:Q5D;W9-4CO
M3RU*MAB]V6:U:*PU?*5.VTV!6A<X
M
M
M
M
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MB?.D4*2N:U$YG)$Q.951$V3=<LC $K
M
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M
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M=Q5_NCZS_P!/7?\ ZT-F^ _]QSAU_JOC_P#Z7$NQ7Y;0
M
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M"O9OK,E2)T&1IW'+,M>*>9&K'6>UO)$]>=S=T1NZI'KPY^'>=\.==;!PW/\
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M;E*ICJ:,2K/&CX5=-RVI6(QC7NYK>1KZ;:
M
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M6EIU;LE%F.I8NO8V2QX&GXF[(MN=B="6[+:5RUE?###7;/826SH4D;+
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
-             !__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g463041g18l82.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g18l82.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0E.4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              )P   -     & &< ,0 X
M &P .  R     0                         !              #0
M)P                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     !K(    !    <    !4
M  %0   ;D   !I8 &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  5 ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M'UHZF[J6]C/M&#$U.=79;D4LNR+/TU^,RZ_UOLFRC']7T=_JX^/54HN_Q?\
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MVKT?YW]#_I%\Q))*?JI)?*J22GZJ27RJDDI^JDE\JI)*?__9.$))300A
M  !5     0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P
M$P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #8 +@ P     0 X
M0DE-! 8       < "  !  $! /_N  Y!9&]B90!D0     '_VP"$  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$" @(" @("
M @(" @,# P,# P,# P,! 0$! 0$! 0$! 0(" 0(" P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __  !$( "< T ,!
M$0 "$0$#$0'_W0 $ !K_Q !L   " P " P$             "0<("@0& 0,%
M @$!                     !    <!  (!! (" 04      @,$!08'" $
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>\]9Q3PH0S"Q_$)R\ \ \ \ \ \ \ \ \ \ \#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g463041g20j69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g20j69.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ NP#_ P$1  (1 0,1 ?_$ )H  0 " 04! 0$
M       '"P@!! 4&"0H" P$! 0$! 0                $#! (0   & @$
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M@VX4,7NJ@\IM:I&<F0K3TYZM* X.OR/M'NS<@,NG#K(+GKMAF,363M!/Y)J
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MNDB+)]?F18S9@I@,!@,"*[T_!&X^JNPNB3OEBXK'<W0P& P+3;.=3 8# 8#
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M1N/JKL+HD[Y8N*QW-T,!@,"TVSG4P& P& P*QR\_QLN'K3L'I:[YT19$68#
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M4A_0?#'AD6:F(,XY40 Y:<>G1DC@,3":K4)BSCE)"8L2'0SSDY2<P0P@UL0
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=7T6\Z?RWG[R;P_&>#_,^:_+/)_YCQ6,\43)__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g463041g38o41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g38o41.jpg
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MEK;4U3<X.4%XE[<:)%'7)3(S-H&$AY&UN-/_Q  < 0 !! ,!
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M\91IEL3D/O9F7H^I6QWDXD:J!@9MNY;0]/&<*:Q3X\\<6 >SYO-<IFO.Y'+
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M',%>*GW3TH(K6FJO,4!"0FX/*N'&\(W&.>'](FP59_[]7+.<Y_.>;SG.<_\
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M68<C*.#0R2(>...1YBN79A'),.4HJ@-29C ;[D]!462H1@-254\K&1JLL<;
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M(_J><0ICI/=@C^R8XI_^MW_V*VWU5[NC?=CF_HR__P!918L?L#]R>5^FN_\
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D19QT:8IM:5$@&%!O96.0\VO!ZOZ'N.-QU_T_>,:+]:8WQ__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g463041g46q41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g46q41.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ N@#_ P$1  (1 0,1 ?_$ *$  0 " @,! 0$!
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MCI!+'LW!&@3\NF:E49@5ARF9XXZNUTVAA-=Z_-EKCMT@<@0Q29W$]1B2.#E
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M> POBA7OI$E%GPE<U%YJ.W$^[NNB?!RS\3T3+S?:3Q%
M                     !%]J> POBA7OI$E%GPE<U%YJ.W$^[NNB?!RS\3T
M3+S?:3Q%                                      !%]J> POBA7OI$
ME%GPE<U%YJ.W$^[NNB?!RS\3T3+S?:3Q%            8V[I[2GE2UHVO\
M7C7&5+T\V% 8>ND$W=,V6%0:/260ID3[+)(Z%IU>J#'!!IDWMIQA)J0E[<$1
MBS'5%BH 14][F9T\O>WMJJADCY[A==(7=-"(-:VAT:FS7:4"AL&>HA7DY7L3
M@O1P9P1ODF5H94DQ:ERM"H29]RYG>YA9H=KVQW1-;&=K+B<^(<%KY!90<TDO
MZ2&-L1C*QF\01%_9EY)2><312M,E*"88*D2T@XQF7)4YF")2I,1JS-0R\
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M7KW<6Z+^E8KUDPL=<?M!K[1L@ RGV,>VUL[_ +I]OG6U$1+E1LCQ@H
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MET<QC^'B]N7[,(?<CV?_ )9J2Z.8Q_#P[<OV81V>-;6=N,,S5FP^E*YBAB_
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, /2>3O\ W?, W?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g463041g77k04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g77k04.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ N@#_ P$1  (1 0,1 ?_$ )(  0 " @,! 0$!
M       '"P8( 00)!0H# @$! 0$! 0                $# @00   & @$
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MIC=PTNAG"#E;%./_ &4M<&,3A3\\[.QKO60<F+J:9<UF)9HW&TA9$!>VBNI
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MNM!HZ.RD6//I)<U%ZJ.W6?=WSHGP;K<(T(LQG5)XB@
M                    B^R?+JNZT&CH[*18\^DES47JH[=9]W?.B?!NMPC0
MBS&=4GB*                                      "+[)\NJ[K0:.CL
MI%CSZ27-1>JCMUGW=\Z)\&ZW"-"+,9U2>(H
M    Q6=2K2"PB8S8QDD4F+AT5D,J,C<0:5#_ "R0:1YH6.^S)%V))C*IZD3M
MJD\ B2%?]Q2I,T+U_'; #2YL[0""+F%BE&\&EA\<>>/<UY!)I$P[$OL2DC?
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M92+'GTDN:B]5';K/N[YT3X-UN$:$68SJD\10
M    !6.7G^]EP]:=@]+7<>B+$18   "QE[.;Z#N(W4%6W1M$,=WU*MT1R "+
M[)\NJ[K0:.CLI%CSZ27-1>JCMUGW=\Z)\&ZW"-"+,9U2>(H
M                K'+S_>RX>M.P>EKN/1%B(L   !8R]G-]!W$;J"K;HVB&
M.[ZE6Z(Y !%]D^75=UH-'1V4BQY])+FHO51VZS[N^=$^#=;A&A%F,ZI/$4
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MI5NB.0 1?9/EU7=:#1T=E(L>?22YJ+U4=NL^[OG1/@W6X1H19C.J3Q%
M         ! 7*WZ7.2?4%<7R[D0L6BM&&Z   RJ"^N\._54>_-T838+0P>=0
M      5CEY_O9</6G8/2UW'HBQ$6    L9>SF^@[B-U!5MT;1#'=]2K=$<@
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M$=N9_KBMS]55-\R8V.]GT/P@#5   ;\]EM_L'XI=:C?^6N8F[YD6'HP4
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FV/N>AT.SJ;?_ %X_]?'E3]^Y'DWJ/+/4[_\ 1O0O_E]P7JO9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g463041g82y68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g82y68.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0IP4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              /0   .8    & &< .  R
M 'D -@ X     0                         !              #F
M/0                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     !]0    !    <    !X
M  %0   G8   ![@ &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  > ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MS?L_I_X+[.DI_]DX0DE-!"$      %4    ! 0    \ 00!D &\ 8@!E "
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M-9;G2$+:JOVI9\F4)B5:<R,SR..0E"4\O)I*@DHE?[HRA@#G.,X#TZ8SP)
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M>19)P# 7?\"JG<\MU=/(IX;VA C]]"RW'N79#XK#@P9B!O8M(+<KM.,P(0"
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-7^?KT_MZ>G7@.!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g463041g93r44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g93r44.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ N0#_ P$1  (1 0,1 ?_$ )\  0 " 00# 0
M       '"P@!! 8) @4* P$! 0$! 0                $#! (0   & @$
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MT54^MMG_ +W;H\O@^KMQ#2;\T\T54^MMG_O=NCR^#ZNW$-)OS3S153ZVV?\
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M$U468J=6NHORI+=)^[O71?@]L]IX)CO?*3Q%
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M=C?$U468J=6NHORI+=)^[O71?@]L]IX)CO?*3Q%
M        %8YO/TV;AZ4]@^-LN.B81%@   +(_@Q[$O#OW6./GJEJ(PN;^JRG
M$ !%]D]*FL/L78WQ-5%F*G5KJ+\J2W2?N[UT7X/;/:>"8[WRD\10
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MQG7;Y)@Y<FP7L=G'9[(GQ35])0\*      "L<WGZ;-P]*>P?&V7'1,(BP
M%D?P8]B7AW[K''SU2U$87-_593B  B^R>E36'V+L;XFJBS%3JUU%^5);I/W=
MZZ+\'MGM/!,=[Y2>(H              ,6.<_L2\Q/=8Y!^J6W"S,_16X#=
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M@-T  !*>C/39I[I3U]XVQ 7 LXQSJ      "L<WGZ;-P]*>P?&V7'1,(BP
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MO^67R6_N;_S :J'KT_H? N-D  !GSU6W\P?BETJ1_P##9,3V_FBP]&"@
M#%CG/[$O,3W6.0?JEMPLS/T5N W0  $IZ,]-FGNE/7WC;$!<"SC'.H
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MIU=&_(7TY;8_^]V/^(K#H]?YC#V_J_J'!Z0
C             &1?'/\ ]WNCW=-O?P5N//MT_8]>O7\?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g463041g96o06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g96o06.jpg
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M 0$! 0$! 0'_P  1" $: =@# 1$  A$! Q$!_\0 'P !  $$ P$! 0
M      D%!@<( P0*"P(!_\0 61   00" @ !!0@+# 4, 04!!0,$!@<! @ (
M"1$2$Q18%188&3EXE[4*%R$V.%9V=]'5UB(W5W1UE)6SM+:WUR,Q<Y;4)"4R
M,S0U05&2L;*X81I5<:'2T__$ !@! 0$! 0$                ! @,$_\0
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M;&FB>FF,[;[[[[9QKKIKKC.VVVV<8UQC.<YQC' /WP!P"Q EGU[))Y.JO S
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MX:."647KJ.R4TBB0*.&[-4V_9LX\*W725,EAS??"W!SIQ6]8M+/:0/\ V+3
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M$F6U"*A<N5Q[]D0=AB@\DY.]-:D[-JEU)M*:6IE1.\DR[/>'[0'C60"C[2[
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MPUIGU#./W=F]Q;;[:@ $[LJ>TN'MH3I@O6QVU6 H))S1F6OI/*BTUDJ$;&D
M((@TTAH$0VG=GND8KN]FRZX\:=4X)*Y)QG'+*=R)5^#(X X X X X X X X
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MU09.RR;)MH2=,VN^ZC9HY?:IX=+M6^ZJNZ""JNR2.ZF^R>FN=]LY J' ' '
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M=FO9.2NA=1&(W(@HMY6L>0P2- )7VADJJAEV$/A5C#!]IVGEK1HU/:FGD6<
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MC/D__OF31^N . . . . . . . . . . . . . . . . . . . . . . . .
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M 1+OF#.;2+14#%UBI9%5GH$/[]RST*R!MVM)/*GD) 3(,4D[/:3IY&-EE/\
MERL&+L(].T0KW=+0?(%X'(BHR.SM $[(JPN0$6(.3Z"BKM!HH!6; ^\.;?DC
M)/J9[RK%;US(\'N?(J<:^]R/_P B"O[ AP\7O?,+!;ER*WR%' (J/&Y^2][2
M?Q*IO\=ZNYJCO+CR8/GC<[ < < < < < < V&ZB_A7]8?G#4M_B3&N1X/<^0
M/J%<X P)VJ_!@['?F(MS^X$@Y5BMZYD>#W/D9V0_ZA'_ &2?_P ,<A3EX X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX!&OXQ?R6G?+YM-E?4RG!JCOT_E3S1P^#;\ECT/^;?7OU=G@5]^K\JN;)+N#
M)!!):CM()*^V$,I&GYC8E(W#15XF+,ZPW0+*,0T5MV7A;%?-Q],VCL7 $\ +
M7F\ADK-W!HE+BT;1:2EW)8/)ZL09IL2 U-ZR:B&M->%T9ZF9:>CED536-]4O
M*3UOV \OZQ'-8TGV?G%=R@);<F)S'K<T9@9#?C!8>)(L$:M<Q-K7K&S!\0C
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MCVCD8L\)!R#LCHNHEL6?JH;(.%/2KXSME%YLJCHAHV;ME&ZU5-[;V;/MZG[
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M8$0IL-8L2XCXSG/W6<KM6:X>,7\EIWR^;397U,IP6COT_E3S1P^#;\ECT/\
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M9,G#YF@\);+ZCFBSE%)R0V;)>G<ZLD-]]576S=#_ $R^$-%,I)?Z13S=/N\
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MW1CIF/M3A-YLZ"0J*5PX2E$@4C1=X68.!X=B0%"J+YC+&?:/>?\ =LNK<"L
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MRHDW;()ZXSLHJLIHGIC[NVV,<I"U'-G5JR>9'/+"@[0AJ*5.[,7,L (/-0B
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M; N?IX3=K-10:SK5A,^04C*FR.F[PE'0T0W YP_;CVYE^1U+;;"T6?N<ZO\
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MIA_6L>>3MN_P1UHPX_"-C[@_?+ZJ?GOE7_UH[ \YK![OE%?>IX\C/_(:' '
M(U_&+^2T[Y?-ILKZF4X-4=^G\J>:.'P;?DL>A_S;Z]^KL\"OOU?E5S9)=P9'
M ' ' ' ' ' ' +1L#[PYM^2,D^IGO*L5O7,CP>Y\BIQK[W(__(@K^P(</%[W
MS"P6Y<BM\A1P# _9HJ+!T?.2AHD/$#&J8#+HB4>-Q[!MA:5 VZ65W;M1)NCZ
M5=5)%/TBFOGJJ)IZ^7??77.J.\N/)F:NZ_N9$/\ ;9JO^$NO_P#?*.?K+G8X
MC[;-5_PEU_\ [Y1S]9< _&EJU1IG?.ED5YIE7?TBF=)A&]<J*>;KIY^^<$<>
M?OYFFFOG;>7;S=-=?+Y-<8P!^_MLU7_"77_^^4<_67 /QFU:HRIJKFR*\RKI
MKOIHIF81O*FFBF=-E--=_='SM=5,I)YWUQG&-LIZ9VQG.FOD _?VV:K_ (2Z
M_P#]\HY^LN /MLU7_"77_P#OE'/UEP"[Z^M"LWD]A#1I8D%=.G4OC3=LV;RX
M NX<.%S+))%!!%(ALHLLLIMJFDDGKMNIOMKIIKG;.,<CP>Y\@3@\X'H-3[FO
M6K3,"M6OHS)%II.",1G,.:Q:"1^2SDQ[YG88H$2$NF\3#F,#EDRBFK1XL2W:
M-!^VJBC]PV1154TTD[GE*O=QEM0TG+:>%_(V-A[-R/B,6'O4MF[QC' C-VAO
MG7.R+EL,:HKI;9USMKG9-73?3.==MM<YUSY,YQ]WF31<? ' ' ' (Y^^SJLV
MSBK?MAN8*AONC,O<GWYK1]+;;752+^O>YWNYMKG;7&<M/6O5O+C&<M_3?ZT^
M=.S;4PXP^3E7BMQ'K[I]:O\ ]PHW^=P'_P#Z<ZR]7YLP0EQ"7J5?V@[!#8 !
MK+LN&DNM@D8;(D7]<P2S:N=O[:9>[L+E;>R#\>JR7 0+(J4?TN:D!P&[,QB(
M,1T?:JQE]G93DG5:JB7,YQGK]R/0[+IHEV(B5C2_ZXYU:*I)/&7LU:(V),?@
M+* VU+R+&6_9L^9>R?%B48ZF1#=SW6'$VL>DR#JRL6 2CWO67)Q;=\.%&8V;
M?.DI,2,BZ]":'#MFJS']EF]7?G?/M>]%CJ*/Y.]3W$HAO#LW>KHE8WWW1B;D
MI]@(5!>^\ILV]ZW1@-/QKJK8R"SA(C55C0D8-1O&&MXQ)8_%ZFDTY?NRQL6/
M9:%VNX;>Q?6BSXD_#CX"$2W!+52JFJ5=K-T_OWT,64^S2IJ3;K5UZ<V<+TE=
MO:R4LTWN1>T7.]N+00C&]I+DQW<=6@H,=!-</*C=7Q0+JH4@6$=\;KNE:5Q*
M,54V&:['4XMB5M B>FV3*.8V[X;G^S;U4K/2#:_CA3$?^.S.MEVIT_MCM>C/
MU9>\^R7[![ WT7V@[G?N>CU!T!NXWC1K/E>U%!XK10'JAOZ-JHJS3FZU5N'&
M-&&(%[Z%HOOK$MR6VQMP[[K[-]W>6'7R"L13*O\ Z6];+IJM+E.V'B>DYH3Z
MYX:ML/2-$9>8;H^MY0=0/"&7/H]?3Y1QNIY^$LJ^?Z/&W[K&GD\[[OEYUEZO
MS9Y3='HZ\J%Q;9S2 NJW7,XK\OLXTB"\85)X&XD$6PMLMJ%VV=88X<[-,*YW
MQZ#T^6V-_P#292YCM&VE+>/PS=&/#H;YR/L+2\3-$(T:L /I)!2VK<C'1J9
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M&*8D^V&P[YRFZIDVX'>0UW#S6\8%;@06Q,$/>;#X^HY&/E8ZGE9'?*L=5(!
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MM=MM@*_P!P!P!P!P!P!P"-?QB_DM.^7S:;*^IE.#5'?I_*GFCA\&WY+'H?\
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MEP=@E[G20"X!%3N,E<"Q'2Z<?F_:M5M1NCP0< < < < < < < < < < < <
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M(J!:>N:?%8;.N<E8>^$]U*?RAK+%VMH)O42W5R3NV#&RSHT.8FG38$A&.O\
M-2[$=AKZW((?'VK,6XTT51"'$V;9V7#.R2>7NP6GS\JL5]O+20\&OIFW:R-@
MDE<61\I@'8NJRC%U;DE(-OM==IIJE8-NQ5MH2R[V;MR\I]>(LR^-]I(V5*NU
M7!IXY:AW L+56OA>"_Y4++)&SMV])J9[ T97'7BQ%YLO6]7%*T-QQN&D>@<T
MN8J+#'> D"YEN.V<O%0ST:S)*(HX:LR3U'&239TVSEMD1-IRL;]N..):*?AS
M]8$#A6>-XR<1N(U?(/LR2O'<\H]M!Q=,;CI*&!91A^2;/8V@)'PHR9A[6 -X
MPE7#8$5?)-HBB\6]=U"T]<HX:&*B7A!=+'T8=0MG%YJ BK[K,7ZD/0H*;D6R
M#RF)+:6EU2\<Z<NT7I!:3S"SLNI9(YMN\S*'CXD131)-6SK*&HMNJ9F^9P6,
M1IIEAL+L*>%YU;,VAI;3]&S-I-]M^B;_ '#)K8QL;&WMU==(-I75:V*[ C,,
MV:AEK%4&K(PQU]''BRK75TL%37=$-G@6G$3=#7!N7[ZF?Z.ZIU30,JG4\AR1
MPI/+(B]80N:3:4O6!&3R.,4XQD;"O69\F/%B5)*6#HRZ19>S23ZFI[),D$4Y
M/*3+80#0&"2\,K_?$V4X(. . . . . . . . . . . . . . . . 1K^,7\E
MIWR^;397U,IP:H[]/Y4\T</@V_)8]#_FWU[]79X%??J_*KFR2[@R. . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g463041g97f40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041g97f40.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1LX4&AO=&]S:&]P(#,N,  X0DE-! 0
M     %T< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  (<G(Q-30Q-# < @4
M-$UI8W)O<V]F="!7;W)D("T@340@+2 R,#$T(%!R;WAY(%-T871E;65N="!&
M24Y!3"YD;V, .$))300E       0VF2D#7HC!:#DYFFF?)4O&SA"24T$.@
M   !%P   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L
M 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N
M0FET8F]O;      +<')I;G1E<DYA;65415A4    &@!< %P ,0 W #( +@ Q
M #D +@ S #( +@ Y %P 3 !+ $, 30!7 %0 4 !2 $X ,P X       /<')I
M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0(+            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! #P     $  @/      0 ".$))300F       .
M     #^    X0DE- _(       H  /_______P  .$))300-       $
M>#A"24T$&0      !    !XX0DE- _,       D           $ .$))300*
M       !   X0DE-)Q        H  0         !.$))300(       0
M 0   D    )      #A"24T$'@      !      X0DE-!!H      S4    &
M              %:   !H0         !                          $
M             :$   %:                      $
M        $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   %:     %)G:'1L;VYG   !H0    9S;&EC97-6;$QS
M     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M      =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/
M<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54
M>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !
M6@    !29VAT;&]N9P   :$    #=7)L5$585     $       !N=6QL5$58
M5     $       !-<V=E5$585     $       9A;'1486=415A4     0
M    #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M    "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U
M;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F
M875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
M    3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N
M9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L
M;VYG       X0DE-!"@       P    "/_         X0DE-!!0       0
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M!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$
M A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46
MHK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A
M,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8U
MPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:V
MQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#U1K6L:&M :UHAK1H !V"=
M)))2DE"ZZJBI]USVU55-+[+'D-:UK1N>][W>UK&M7E_6O\:G5^J6Y'3?J;@7
M6V5N#F9S&&^PU-(%EK,#T7^BRRUS&>I?ZGZ'_ TWV?H4I[OZP?6WH/U=J+^I
MY366ENZO%9[[WZ/V;*&^YK+'5/K]>WT\?U/IW+S3-^LWUL_QB9PZ1T-KNG]-
M+?T[AZC6@OI/JT]2S,<7;L=]M>53BL]*EF3[/7H]3^9M_5S_ !+VEU&5]8<E
MK6AP?;T^@%Q<W:'>E;F!S/3?ZOZ._P"SLM]G\QE?I/4K]*JIZ7T#I!94QN)T
MWI]+GEK02&5U@VVOAN^VQ_T[+/IW6O\ ^$24^4?5SKGUG^J/URI^J_4<K]H8
M]EF-AOI-CWUUBT5_9K,)]S6OI^SLO9OJ]/TK6?HO]!?5[*O%_P#%OBU?6+Z_
M9O6\C'<*JG79[&0'ULONL_5ZK;'5[7/K;;==C_S5GK8WK,_FE[0DI22222E)
M)))*4DDDDI22222E))))*4DDDDI__]#U5))))3SG^,2K-M^I?56X1<+12'.V
MNV'TF/99F>Z6^S[(V_U*_P#"L_1+"_Q/XOU?_87VS#;6>L^ZKJ+Y<;&CU++,
M=NVP_HJK:?2_F/T5[ZOTF^['_1][=35?4^FYC;:K6EEE;P'-<UPVO8]CO:YC
MFKQ5XS?\5OUPMNKQG9W3\FE]>,^T^F;*G&NUS675BQC<C%O977=^A][/TGV>
MG[32DI]M7!?XW^O86)]7'=&+FOS>HNK(J#O<RJMXO=DN;M=['6T>@S?Z?J;[
M/3_H]J[6GJ&%=T]G4F7-&%92,AM[_8WTG-]87/\ 5V>FSTO?^D^@O+.GOK_Q
M@_XQ_MUF+7=T7I-99[@_9;6QUOV-UNYK6^KDY-WVG[+<VIGV6JRFSUO2M]9*
M>S_Q=?5QO0OJSC-MH;3U#+;Z^:Z'!Y+BY^/5=ZH:]C\:A[*GT?0JN]?_ $EE
MEG4)))*4DDDDI22222E))))*4DDDDI22222E))))*?_1]522224I<_\ 7CZK
M?\Z>ANZ>R[T,BJP9&,\_0-C6OK:R_1S_ $GLM>W=7[Z_YW]+_,V= O.O\9G^
M,+]ELNZ!TBRRKJGL&3D!L"JNQIL<RBW<U[<MS'4?I&5/975;^CM9E?S24\3B
M_7CK/0?J_P!2^IN5C5V$>MB,>YPFC>ZRO.J/HRS)][[?0?ZOZ*W_ +D4^G2N
MF_Q%_P#>W_Z"_P#NVO++KK;[7W7/=;;:XOLL>2YSG..Y[WO=[G/<Y7NF=?ZS
MTFC)Q^F9=F&S-V?:#40UY](N=5MO;^FJV[W_ ,S97ZG^$24^[]0_QA_4[IV;
M=@Y?46LR<=VRUC:[; UP^DSU**K*M[/HV>_]&_\ 1_36GT3K_2>O8K\SI-_V
MG'KL-3G['LAX#;'-VWLJ?]"UB^;^H8/V"S[-:_=EL@WU@>VO<RJT5/>X^I]K
MILLNQLW'?2S[-?1L]2W_  ?O7^+_ .JV5]5^AOP,RZN_(NR'Y#S5.QNYM=+6
M-?8&/L]E&_=Z=?T_3_X1)3TR2222E))))*4DDDDI22222E))))*4DDDDI__2
M]54+KJJ*GW7/;554TOLL>0UK6M&Y[WO=[6L:U37A_P#C$_QB?\XO\E]+]2KI
M=5A-EA,?:HV>B]].QME555C;'UUOL_2_HKKJJKJOT:4V/\8'^,S-ZE;F=$Z2
M6T]+#C3;DL.ZR\-+F7;+:W.J;A7_ /!^^^GZ=OI7V8RGT'ZI_P#-OZKYGURZ
MQ58SJ-%;ATS$?7#L>YS_ +)C9N11E!C7VLR7UVU,>STZJ/UG]-?Z7H;OU _Q
M8-Z>T=2^L=#3U!EU=N'2VQTT&EQ<VRQ^-;Z%S[G['^E^E8QE?_"VU5Y_^.;Z
MS85XJ^K5+7/R<6YF3E6G1K":WBJALC]*]]63ZSW_ $*_T?\ ./\ 4]!*?+Z:
M;;[64TL=;;:X,KK8"YSG..UC&,;[G/<Y>E]!Z95]0_JS=]9NJ44_\X[VD=+P
M\FP->RMQJI<YN/[;?M#?7];+97^F9B_J_J8?JY*M?XJ_J$UK:OK+U:IKR]K;
M.F4NW2P[GC[5=396UN_:VJW!>VRQFRS[1_.^@^OD/\8GUGM^L/UAN+7-^Q8#
MGXV&*WE['-:]V[+:Z?2WY7T]]7^!^SU_I?2]5)3=_P 73^G9GUNNZW]8<O'J
M]#?E"S)LIJ:_+M=['>C=LW[-]^1^KL_5[ZZ/YO\ 1^I[JOE5?4]-U5]3+J7M
MMJM:'UV,(<US7#<Q['M]KF.:DIFDJ^;U'I_3ZA=GY-.)4YVQME]C:VEQ!<&!
M]KFMW[6N4L7+Q<VAN3AW5Y./9.RZIP>QT$L=MLK+F.VO;M24F22224I))9G6
M/K+T'HC2>J9U.,X-#_2<[=:6N=Z;7UXM>_(L9O\ ]'5_U"2G327F77O\=6%4
MUU70,1V1:'.;]IRALJAKF[;*Z*W^O<RYGJ?SK\-]7Z/_ (I<CU/Z]_XQ,O =
MEW9&1B],R["*KJ*137(<Y_H8V<RMMWL])[/Z5ZNRNSU?4_2)*?>TEPG^*OZS
M]6^L&+U!W5LO[5D8]E8:W:QFUCP_:[91C4,_2/8_W?:;_P";_F,;^<RN[24I
M))))3__37^-[ZX_SGU4Q6_Z&W.NGXWLP_3?5_P"$\K[13=_P'^E69]6<CZI_
M4KI^-]8<K*;U;KN72_T,'%=6]N.'M:]OVA[AZN+D?]I[[OI_K%]%.+D>E;:N
M@=_BQZ9]:,K'^LUN7=BT=6I9F9&%6RK<'WL];;3E,KIJ:QGJ5[O5PKKK]EEM
MUWK7[U=Q?\3?U1HO;;:_+RF-F:+;6ACI!;[CC4X]WM^G[+DE/&]<_P 9OUI^
MLMM6!T*B[IX>TAU&(YUV18YI]8N9?557?6RME?T,=K/\-ZUEM7\WN_5#_%3>
M<IO6?K:[UL@V/L=T]Y%N]\RV_.R0^QE^]_J6OQ_?ZOZ+U[OY_%7HO3.E=-Z3
MBMP^FXU>+CMCV5B)(#:_4L=].VUS&,WW6_I;$NK9W[-Z5F=1V>K]CQ[<CTYV
M[O28ZW9OA^S?L^EL24^=?XU?K=BXG3:OJUT/(K:737FMQ7 "JFO] .GN;6W9
M5ZK_ &VTLLKLJJQ_1MJ]')7*87^*KZW9F!C9M=-=?VFS8['O+J;J6ASZW7Y-
M5];/T7LW_H?6O].ROTZ5/ZE_5VWZ[_6G*S\]C?L+;G974FUN-<NO=9;5C4C]
M)=LMN:[=[O9CUV?K'K^BO>$E/E_3_P#$E0RBW]H]1]2ZW'VUBJH@4WDL?ZS;
M'6_K53-EE/IV44^M5;_VGM^ACYWU)_QF=":_&Z3F9.3TVAK[*CA9+JP&[GOV
MC!-M=OVA_P#.NIQF9'OM_1VW6+VA))3X?@?4+_&!]9WX[^LVY%.(W<6W=1M>
M][ 7-KN;5AV/?DLM>UGJ-;:S&JN]+^?_ )I:N/\ XK_K]TWU,?I/7*\?$-CG
M-%>1DT;OS6VV445/K9:^MC-_Z2W_ (Q>MI)*?%+NG?XX.B>AG^MGY#G2/39<
M<W8X^HS9?B;LJM_Z-GJ^IZ5M%?J4_I?M/Z-E=E7^-[K.;8YIZK5:6[G;G/P:
MH;MK_1M></$W_P#!U>]_\[_I%[FDDI\'RK?\;0:S"M'6(Q'/:'5-N))+O?OS
M,<;LQFYOZ&Q]][-G]'_1+;Z/_B<ZIU!HSOK#G.Q<FVXOR,=H%]KFETO?9F>J
MZIN1?[W?0RO])9[_ %*5ZZDDIYSI?^+WZG],J].OIM.0YS6MLMRVC(<XL$>I
M^L;ZJ7V;OTGV>NEG_07#_P".#K[*?L_U5P?T./177;>RA[6UQ[FTX=V*RO>S
MT&5T9%#?795LL9^K?T:VKU#JO4:.E]-R>H9#ZZZL:LO+K7%C)'\VQSV,NL_2
M6;:_T=-UO^BIML_1KQKZM-O^OW^,#[;U1V_&HW9;L:PAX;14]OV; K::O2LJ
M]6ZEE_Z*KUZOM-O](M24^H?4+HW[%^JF!B/9LR+*_M&2#7Z3_4N_3.9>SZ?J
MX[',Q=UGO_0?F?S:Z!)))2DDEQ7^,CZZ]5^JG[._9U6/;]L];U/M#7NCTO0V
M;/2MI_TS]R2G_]3U5))))2E"ZFJ^I]-S&VU6M++*W@.:YKAM>Q['>US'-4TD
ME-3!Z3TKIN_]G8>/A^K'J?9ZF5;ML[-_I-9OV;W[5;2224I))))2DDDDE*22
M224I))))3YE_CD^LF;A-Q.BX.4ZD9=-CL^EK8+JG.8S'_3%NYK+'59==E=-O
MO9_/_HK%M?XI>F.P/J?5:ZQMAZA=9E0TM<& AF.VO?6^QKG[<;?9]!]+W_9[
M:_5I7FMV"WK?^,^_!R&-=5=U6QES&L<T.JKM?ZK8PF;VOLHJ_29'[_ZSE7U_
MILA>^I*4DDDDI22222G_U?54DDDE*22224I))))2DDDDE*22224I))))2E@_
M7GJ5O2_JEU/,IL=3:VGTZ[6 ES76N;C,<S;90ZM^ZW^>]3]!_/>E?Z?H6;R\
MW_QV9V..BX?3P]IR79+<@L#V;FL;7?4U[J=_VC98]_LM93Z/Z*SU+:W^EZB4
MY_\ B7Z#9ZN3URYKF-#15BDMO9O!+FVO;:'58.3C[F;'T[<M[,BFNS]4]*O[
M3ZPN<_Q>]+JZ9]3^FUU[7.R*6Y=MC6AA<[('VC])&[U'TU/KQ_4_<I_L+HTE
M*22224I))))3_];U5))))2DDDDE*22224I))))2DDDDE*22224I>+_XTLD]3
M^O>)TISG648[:*#36ZPD.O=ZMI:QN/?Z>1;5;2W]5Q\_V5X_\[=^J5>RW/=7
M4^QE;KG,:7-J9M#G$"16SU75U;W_ /"65L7@OU*QNG?6#Z_UNS:VG%R+K\D8
MF0^RXO(%N150^YS7.R7UN_2VOR_9DLIM];?ZGHVI3[OB8S,3%IQ:S+**VU-.
MUK=& ,;^CH952SZ/T*:JJO\ 1UHR222E))))*4DDDDI__]?U5)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?ISKA Z+U EK7@8UQ+
M'NK8T_HW^U]F8RW$K8[]_*JLQ_\ 3U^DO-?\33.@MZGU X]UUW4C3%8MJ](#
M'%OZ1S'59&34]]OZB^YEOI^@_P#1X]F17ZUJ\M224_522^54DE/U4DOE5))3
M]5)+Y5224__9.$))300A      !5     0$    / $$ 9 !O &( 90 @ %
M: !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H
M &\ <  @ $, 4P V     0 X0DE-!"(      49-30 J    "  ( 1(  P
M  $  0   1H !0    $   !N 1L !0    $   !V 2@  P    $  @   3$
M @   !X   !^ 3(  @   !0   "< 3L  @    D   "PAVD !     $   "\
M    Z !;C8   "<0 %N-@   )Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*0 R,#$X.C S.C(R(# U.C$P.C4W ')R,34T,30P       #H $  P
M  '__P  H ( !     $   &AH , !     $   %:          8! P #
M 0 &   !&@ %     0   38!&P %     0   3X!*  #     0 "   " 0 $
M     0   48" @ $     0              2     $   !(     3A"24T#
M_0      "           _^$!2$U- "H    (  @!$@ #     0     !&@ %
M     0   &X!&P %     0   '8!*  #     0 "   !,0 "    '@   'X!
M,@ "    %    )P!.P "    "0   +"':0 $     0   +P   #H   #P
M  $   /      4%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z
M,#,Z,C(@,#4Z,3 Z-3< <G(Q-30Q-#        .@ 0 #     ?__  "@ @ $
M     0   :&@ P $     0   5H         !@$#  ,    !  8   $:  4
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ASY#8UA>2Y9R;6X #^N)"$BQZ*U(=PZP_+_07L2^>>__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g463041pc1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g463041pc1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MO;N:ZN/#UL\TSF1VRPRQ.2< XH M:-X \+>'M16_TK1H;6[52HD4L2 >O4T
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,7:#_ +HH V: /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
